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This research looks at the feasibility of colonoscopic high frequency ultrasound in the 
colon using mini probe technology. The objectives are across four different areas with 
assessment of colonic cancer, malignant colorectal polyps, rectal polyps and 
diverticular disease 
 
High frequency 12 and 20 MHz ultrasound were used to locally stage colonic cancer 
and compare this to conventional CT in patients undergoing elective colonic resection. 
In addition, depth of infiltration of rectal polyps was determined by 20 MHz 
ultrasound and these findings compared with MRI in patients undergoing TEMS 
procedure. Malignant colorectal polyps were assessed after endoscopic removal to 
assess for the presence of residual or recurrent disease in the colonic wall and also to 
stage the local lymph nodes. Finally, the thickness of colonic wall in patients with 
diverticular disease was measured using 20 MHz ultrasound and this was compared 
with normal controls. 
 
The research has clearly shown that colonoscopic high frequency mini probe 
ultrasound is feasible in the colon with reproducible results. Overall, 12 and 20 MHz 
colonoscopic ultrasound are superior to CT for local staging of colonic cancer. 20 
MHz ultrasound offers greater accuracy for assessment of depth of infiltration of rectal 
polyps compared with MRI. This probe may also be utilised to assess the colonic wall 
for residual disease in the polypectomy scar of malignant polyps but larger numbers 
are needed with longer follow up in order to draw firm conclusions. Finally, it was 
feasible to measure the thickness of colonic wall in patients with diverticular disease 
and this was greater than that seen in normal patients. 
 
In conclusion, this research has been promising in that colonoscopic high frequency 
mini probe ultrasound is feasible in the colon and can be used to assess colorectal 
polyps and cancer and diverticular disease. In order to draw firm conclusions, this pilot 
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1.1 ENDOSCOPIC ULTRASOUND 
 
Endoscopic ultrasound (EUS) has been used in clinical practice for over 20 years 
(Caletti 1986) and has been one of the most fascinating aspects of endoscopy. There 
have been more than 2000 papers which have been published on the use of EUS in the 
clinical setting not only in the Gastrointestinal Tract (GIT) but also in the lung, 
mediastinum and pancreas all of which have demonstrated high accuracy for the 
diagnosis and staging of benign and malignant conditions. At high frequencies of 
ultrasound, the GIT wall appears as five or more layers which correlate with the 
histological layers, allowing in depth examination for staging of tumours. At lower 
frequencies, the depth of penetration increases allowing for examination of important 
extra luminal pathology such as lymph nodes. 
 
1.1.1 Principles of ultrasound 
A basic understanding of the principles of ultrasound is of paramount importance for 
an endosonographer in order to obtain images and accurately interpret them.  
 
Sound is mechanical energy in the form of vibrations that propagate through a medium 
such as air, water or tissue (Hedrick 1995). The frequency of audible sound ranges 
from 20 to 20 000 Hz. Ultrasound involves frequencies greater than 20 000 Hz with 
medical applications utilizing frequencies between 1 000 000 and 50 000 000 Hz (1-50 
MHz). The propagation of ultrasound results from displacement and oscillation of 
molecules from their average position and then subsequent displacement and 
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oscillations of molecules along the direction of propagation of the ultrasound wave. 
The velocity of the ultrasound differs depending on the physical properties of tissue 
(Table 1.1). Imaging is achieved by transmitting short pulses of ultrasound energy into 
tissue and receiving reflected signals. The signals that return to the transducer 
represent the interactions of the ultrasound wave with the tissue. Any propagating 
wave can therefore interact with tissue and result in absorption, scattering, refraction 
and reflection. 
 
 Table 1.1 Physical Properties of Tissue (Duck 1990) 
PHYSICAL PROPERTIES OF TISSUE 
Tissue / Fluid Density kg/m
3
 Acoustic velocity m/s 
Water 996 1509 
Blood 1050-1075 1590 
Liver 1050-1070 1578 
Pancreas 1040-1050 1591 
Bone 1963-2017 3760 
 
Absorption 
The absorption of ultrasound energy depends on the frequency of the ultrasound and 
also on the properties of the tissue medium. Higher ultrasound frequencies cause more 
tissue vibration and results in greater absorption. 
 
Scattering 
Individual cells, fat globules and collagen are examples of scatterers in tissue. This 
occurs when an ultrasound wave interacts with tissue and only a small proportion of 
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the acoustic intensity is reflected back to the transducer. This phenomenon occurs in 
tissues with heterogeneous texture and is responsible for the different images of liver, 
pancreas and spleen. Tissues containing fat or collagen are greater scatterers which is 
the reason behind the bright hyperechoic nature of the submucosal layer of the GIT. 
 
Refraction 
This occurs when the incident beam travels to the surface of the tissue at an angle other 
than 90 degrees, thereby causing the beam to diverge from the incident path.  
 
Reflection 
Ultrasound waves are reflected at interfaces between two media where the acoustic 
impedences differ. Acoustic impedence (Z) of a medium represents the resistance to 
sound propagating through the medium. At this interface, a proportion of the 
ultrasound wave is will be reflected back to the transducer and the remainder will 
travel through the medium. The simplest example of this is when the incident beam is 
perpendicular (90 degrees) to the interface.  
 
1.1.2 Principles of ultrasound instrumentation 
An ultrasound imaging system consists of an ultrasound transducer, processor and 
display. 
 
The key component of any ultrasound system is the transducer. This device is initially 
responsible for the conversion of electrical energy to mechanical energy resulting in 
the transmission of an ultrasound pulse. Thereafter, upon receiving the reflected 
mechanical energy, it is then converted back to electrical energy and processed and 
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digitized by the ultrasound processor to give real time images of the tissue in question. 
The active element of the transducer is made from piezoelectric ceramic which are 
polar crystals in a specific orientation that upon application of an electrical stimulus 
are able to change shape (Christensen 1988).  
 
The processor contains electronic components that are responsible for the control of 
the transducer, amplification of the received signal, time gain compensation and signal 
processing that will result in an output signal to the display.  
 
1.1.3 EUS Equipment  
Echoendoscopes are available in two different forms: radial or linear with both being 
available in mechanical and electronic formats. Radial echoendoscopes give 
circumferential views at 90 degrees to the shaft of the scope similar to the views 
provided by computed tomography. This similarity makes this more attractive to the 
majority of trainees in echoendosonography. The linear scopes, on the other hand, give 
views analogous to that obtained by trans-abdominal ultrasound as the view is in the 
same plane as scope shaft, making orientation more difficult and clinicians are easily 
lost during the scanning process. Therefore, for imaging of the layers of the GIT radial 
echoendoscopes are favoured. 
 
Radial systems 
Mechanical radial scopes produced by Olympus were for many years the standard 
instrument. A heavy motor in the umbilical cord of the scope drives an ultrasound 
transducer which sits in an oil bath at the tip of the scope beyond the oblique viewing 
lens (Figure 1.1). A balloon is fitted over the tip of the scope and is controlled the air 
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and water suction buttons housed in the scope. Once filled with water, the balloon 
enables acoustic coupling to the mucosa. The mechanical nature of these scopes 
demands care to be taken when placing or removing the balloon so that the oil bath is 
not damaged. Degradation of the quality of the images may be related to either a 
bubble developing in the balloon or is a sign that the oil bath needs refilling, a task 
which may need to be practised once or twice a year. 
 
The radial systems also house a processor (for example, the EU-M20 or EU-M30). 
These allow for a range of frequencies to be used (5-20 MHz) and the newer models 
(EU M2000 or EU-M60) allow for greater focus and greater image manipulation with 
instant video playback.  
 
In relation to GIT imaging, these radial echoendoscopes both mechanical and the 
newer electronic forms have been widely used in the evaluation of oesophageal, 
gastric, duodenal and pancreatic pathology. They have also been adapted for use in the 
rectum and distal colon. The main disadvantage for imaging in the colon is the bulky 
nature of the scope limiting the manoeuvres in the left colon and therefore only being 









Mini probes (Catheter probes) 
The main advantage of using mini probes to image the colon is that they are introduced 
through the working channel of a normal colonoscope and can therefore be used to 
image pathology in the left or right colon. The scope can easily be manoeuvred into the 
caecum during routine colonoscopy and the mini probe introduced once the pathology 
has been encountered.  
 
Mini probes range in size from 2 to 2.6 mm and are mechanical radial probes which 
require an additional small motor drive unit between the probe and the ultrasound 
transducer (Figure 1.2 and 1.3). The probes are usually of high frequencies ranging 
from 12 to 30 MHz (UM-2R 12 MHz, UM-3R 20 MHz and UM-S30-25R 30 MHz) 
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with the highest frequencies offering only a shallow depth of view suitable for imaging 
small mucosal and subepithelial tumours. One particular technical issue with the mini 
probes is the difficulty on occasion of excluding air from the site. After suctioning of 
the air from the site under interrogation, water flooding of the colon is required for 
acoustic coupling. Balloon sheaths are also available for the mini probes but these will 
require the use of colonoscopes with large calibre working channels. 
 
The mini probes are not single use and undergo similar cleaning and sterilization to the 
endoscopes. However, due to their fragility, one must exercise caution if the full 











Tip of mini probe 
12 MHz mini probe – proximal end 
which attaches to driver unit 
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1.1.4 Imaging artefacts 
 
The interpretation of ultrasound images improves with experience and a thorough 
understanding of imaging artefacts which do not represent the tissue being examined is 
vital. There are some common artefacts which are explained as these patterns are 
important to recognise especially when accurately staging GIT cancers. 
 
Reflection 
This is a common finding during colonoscopic ultrasound as a mirror image appears as 
an artefact when ultrasound is undertaken near an air-water interface such as that 
which occurs when the lumen is partially filled with water. The ultrasound pulses 
reflect off the air-water interface due to impedence mismatch creating a mirror image 




Figure 1.4  Reflection (mirror image) artefact with an image of the transducer 
and the colonic wall produced by reflection of the ultrasound signal 








This form of reflection artefact may occur when there is a significant impedence 
mismatch. Therefore the majority of the transmitted ultrasound pulse is reflected with 
minimal transmission through the tissue. The resulting image is hyperechoic at the 
interface and a shadowing beyond the interface due to lack of detection of an echo 
signal. A classic example of this effect is demonstrated in the imaging of gallstones, 
but in the GIT this may occur when interface is curved such as that seen with a large 
tumour (Figure 1.5) 
 
Figure 1.5 Acoustic shadowing resulting from the refraction between normal 






This ring effect is important to recognise as it may be easily rectified with some 
technical adjustments. This occurs when a transmitted pulse undergoes multiple 
reflections. The pulse is bounced to and fro from the reflector to the transducer and 
back multiple times, which produces equally bright bands. The two common reasons 
for this artefact are from the housing of the ultrasound transducer or from small air 
bubbles (Figure 1.6). 
 
Figure 1.6 Image of reverberation from an air bubble. Note the multiple 








The assessment of the layers of the GIT requires the ultrasound probe to transmit 
pulses perpendicular to the gastrointestinal wall. This is crucial when staging cancers 
of the GIT or during measurement of the thickness of the wall. If the ultrasound 
transducer is at an angle other than that of 90 degrees to the pathology in question, then 
this may result in over staging the tumour or overestimation of the thickness. 
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The aetiology of the majority of tumours in the GIT can be determined by the 
appearance on endoscopy and endoscopic ultrasound with histological confirmation of 
the diagnosis in question. The advantage of radial endoscopic ultrasound is that it is 
able to visualise the different layers of the gut wall as distinct entities comparable to 
that of histological layers. This is seen as a series of concentric rings of differing 
echogeneicity. On classic 7.5 or 12 MHz endoscopic radial ultrasound imaging, the 
first 2 layers are hypoechoic which corresponds to the mucosa and muscularis 
mucosae. The 12 MHz ultrasound does not differentiate between these 2 layers as they 
are both hypoechoeic. The third layer is hyperechoeic and is the submucosa. The 
echoeic layers alternate as you traverse through the gut wall thereby demonstrating the 
fourth layer as hypoechoeic (muscularis propria) and the fifth serosal layer as 








Accurate staging of tumours in gastrointestinal tract is crucial for optimal patient care 
and gives a good indication of survival. Tumours are staged according the American 
Joint Committee on Cancer TNM classification (AJCC 1977) which describes the 
anatomical extent of the cancer. The T stage is related to the depth of invasion of the 
tumour through the gut wall; the N stage refers to the presence or absence of lymph 
nodes locally; and distant metastases are depicted by the M stage. The purpose of 
endoscopic ultrasound is to determine the T and N stage of tumours. The T stage of 
tumours for oesophageal, rectal and colonic cancers are shown in more detail using a 
schematic (Figure 1.8). Both benign and malignant lymph nodes are visualised with 
endoscopic ultrasound and there are certain features which point towards malignancy 
being more likely. These include the lymph node having a short axis diameter greater 
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than 5mm, round shape, distinct outer border and hypoechoeic features (Bhutani 1994, 
Catalano 1997). 
 




Inner dark circle=muscularis mucosae; outer dark circle= muscularis propria 
 
1.2.1 Lessons from oesophageal cancer staging 
Oesophageal cancer is a global health problem with nearly 15000 patients diagnosed 
with the disease in the United States each year, of whom nearly 14000 will succumb to 
their illness (Jemal 2005). Despite the improvements in the management over the last 
decade, overall 5 year survival rates remain poor. The outcome of patients with 
oesophageal cancer is dependent on stage and endoscopic ultrasound plays a major 
role in the decision making process. T1 and T2 tumours without evidence of local 
lymphadenopathy would typically go for primary surgical resection, whereas those 
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with any nodal disease or locally advanced cancer (T3 or T4) would receive 
neoadjuvant treatment in the form of chemotherapy with or without radiotherapy.  
 
The accuracy of EUS in the assessment of T stage of oesophageal tumours is far 
superior to that of CT imaging. Two metaanalyses by Rosch et al 1995 and Lightdale 
et al 2005 have shown an accuracy of 85-90% for EUS compared with 50-80% for CT. 
In addition, EUS is also superior in the detection of local lymphadenopathy, both 
peritumoural and coeliac. Both Rosch (1995) and Kelly and colleagues (2001) have 
revealed that nodal staging for EUS has an accuracy of 75-79% considerably better 
than that obtained by CT (Table 1.2) 
 
Table 1.2 Staging of oesophageal cancer – A comparison of EUS and CT  
 
STAGING ACCURACY OF OESOPHAGEAL CANCER 
Imaging T stage (%) N stage (%) 
EUS 85 (59-92) 77 (50-90) 
CT 45 (40-50) 54 (48-71) 
(Rosch 1995) 
The studies in the literature quoted used traditional echoendoscopes rather than mini 
probes. The latter have the added advantage of traversing constricting tumours of the 




1.2.2 Rectal Cancer 
 
1.2.2.1 Background 
Colorectal cancer is the third commonest cancer worldwide (Jemal 2005) and the 
second cause of cancer related deaths in the Western world. The development of 
cancer from adenomatous polyps is well recognised; a process which may develop 
over 10-15 years termed the adenoma-carcinoma sequence (Vogelstein 1988). Rectal 
cancers account for 30-40% of all cancers in the large bowel. It is defined as tumours 
within 15cm of the anal verge on rigid sigmoidoscopy and anatomically the rectum 
begins where the two antimesenteric taenia on the sigmoid colon fuse together. The 
distance from the anal verge helps to classify the tumours into upper third, middle third 
and lower third according to the International Union Against Cancer (UICC). 
 
The mesorectal fascia is an important anatomical landmark for the evaluation of local 
tumour spread. This connective tissue sheath forms an envelope around the rectum and 
perirectal fat including lymph nodes and behaves as the natural barrier to for cancer 
spread. Modern imaging techniques are able to visualise this fascia and the relationship 
to the tumour margins. In addition to the mesorectal fascia, the other import factors 
responsible for determining prognosis and local recurrence are the depth of invasion of 
the tumour into the rectal wall (T stage) and the presence or absence of lymph node 
invasion (N stage) (Table 1.3) Historical data shows that if the tumour is confined to 
the mucosa and submucosa with no evidence of lymph node involvement, the local 
recurrence risk is 5%. This increases to 10% if the tumour invades the muscularis 
propria (T2 tumour), 25% if the tumour extends into the perirectal fat (T3) and 50% if 




Table 1.3  TNM staging in rectal cancer (Sobin 2002) 
TNM STAGING IN RECTAL CANCER 
   
T1 Mucosal involvement (T1m) 
Submucosal involvement (T1sm) 
 
T2 Invasion into muscularis propria  
T3 Invasion through and beyond muscularis propria  
T4 Adjacent structures involved  
   
N0 No local lymph nodes involved  
N1 1-3 perirectal nodes  
N2 > 4 perirectal nodes  
   
M0 No metastases  
M1 Distant metastases  
 
There are several factors that determine the best treatment strategy employed in 
patients with rectal cancer including tumour location, T and N stage and grade of 
tumour. The local recurrence rates even after curative resection of the rectum vary 
from as low as 2% up to 32% (Sagar 1996). Lateral circumferential extent of the 
cancer is more important as a prognostic indicator for local recurrence than 
longitudinal tumour extent (Quirke 1986, Adam 1994, Martling 2003). Quirke and 
colleagues have shown that patients with positive microscopic margins have local 
recurrence rates as high as 83% (Quirke et al 1986). Local recurrence is debilitating 
and has a great impact of the quality of life of patients, therefore paramount attention 
has been given to the decision making enabling appropriate selection of patients for 
primary surgery or neo-adjuvant chemo-radiation prior to surgical resection. 
 
 
Therapeutic options for rectal cancer 
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Since the introduction of total mesorectal excision (TME) (Heald 1982), few surgeons 
doubt the advantages of performing rectal resection along with complete excision of 
the mesorectum. Standardised TME for patients with low or mid rectal cancer involves 
resection of the rectum along with the surrounding lymphatics, nodes, fatty tissue and 
mesorectal fascia sparing the pelvic splanchnic nerves and the parietal pelvic fascia. 
There is some debate whether this technique should be employed for high rectal 
cancers or whether rectal resection should be undertaken with 5cm of distal clearance.  
 
In any case, primary surgical treatment would be reserved for patients with early 
cancer (T1, T2 without nodal involvement) with the introduction of neo-adjuvant 
chemo-radiation to downstage locally advanced cancers (T3, T4) to facilitate curative 
resection and prevent local recurrence. In 1990, the National Institutes of Health 
Consensus Conference recommended that patients with locally invasive rectal tumours 
(T3, T4, TxN1-2) should receive neo-adjuvant treatment. This reflected the findings of 
the Swedish Rectal Cancer Trial (1997) showed that a short cycle of preoperative 
radiotherapy reduces the local recurrence rate from 27% to 11%. Kapiteijn et al (2001) 
further showed that local recurrences rates were lower also in patients who had both 
TME and neo-adjuvant radiotherapy compared to the TME only group.  
 
The complexity of decision making in the management of rectal cancer re-iterates the 
importance of accurate staging of rectal tumours to decide whether primary surgery or 
whether neo-adjuvant treatment should be employed. Within this context, it goes 
without saying that it is of paramount importance to avoid either over treating or 
undertreating patients. Three imaging techniques are now available for staging the 
primary tumour:  transrectal endoscopic ultrasound (TRUS), computerised tomography 
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(CT) and magnetic resonance imaging (MRI). There have been many studies reporting 
on imaging for rectal cancer and most focus on T and N stage with a few discussing 
the circumferential resection margin. 
 
1.2.2.2  Transrectal ultrasound (TRUS) 
Transrectal ultrasound was first introduced in clinical practice for local staging of 
rectal cancer in 1985 (Hildebrandt 1985) and the application of TRUS has expanded in 
the last decade. Since then, there have been several studies to determine the accuracy 
of TRUS and compare this to other imaging modalities. Skandarajah et al (2006) 
evaluated all the studies from 1984-2005 and discovered 867 articles in the medical 
literature. The most commonly used equipment in the literature is the rigid 7 MHz 
rotating endorectal probe providing a 2D image in a 360 degree axis with a focal 
length of 2-5cm (B&K ultrasound machine, Type 3535, Naerum , Denmark). The 
utilisation of the 7, 7.5 or 12 MHz endorectal ultrasound probe presents the bowel wall 
in five sonographic layers as a result of differing acoustic impedence (Figure 1.7). The 
ultrasound staging of tumour depth is prefixed by “u” but corresponds to the TNM 
staging (Table 1.4). 
 
Table 1.4  Ultrasound staging for depth of invasion of tumour 
ULTRASOUND  STAGING IN RECTAL CANCER 
   
uT1 Tumours confined to mucosa and submucosa  
uT2 Invasion into muscularis propria  
uT3 Invasion through and beyond muscularis propria into 
perirectal fat 
 
uT4 Adjacent structures involved  




A systematic review was conducted to identify the accuracy of transrectal ultrasound 
in the T and N staging of rectal tumours. Skandarajah et al (2006) conducted a similar 
review and identified 31 studies in the literature which contained more than 50 patients 
and also clearly compared TRUS to histological staging. The period included in their 
study span from 1984-2004. A further seven studies were identified with similar 
criteria after extending the search period to 2008.  
 
Accuracy of T staging 
The accuracy of T staging for rectal cancers using TRUS varies from 63.3% to 96%, 
with an overall accuracy of 83.8% for all stages. (Table 1.5) This series of different 
studies in the literature holds a total of 8357 patients. The accuracy of TRUS varies 
with stage with individual tumour accuracies being: T1-73.2% (40-100%); T2-70% 
(12-96%), T3-87.6% (56.8-100%); and T4- 75% (25-100%). Most of the studies have 
high accuracies but the overall result was influenced by 3 large studies (Ptok 2006, 
Garcia-Acguilar 2002, Marusch 2002) with large numbers of patients and accuracies of 
63.3, 69 and 65.8% respectively. 
 
Harewood et al (2002) prospectively evaluated 80 patients with rectal cancer using 
TRUS and reported T staging accuracy of 91%. The authors showed that the utilisation 
of transrectal ultrasound altered the management in nearly a third of the patients 
enabling upstaging of T stage and therefore neo-adjuvant treatment. In contrast, only 5 
out 33 patients with T3 stage were under staged and therefore went straight to surgery, 
all of whom required post-operative chemo-radiotherapy. Halefoglu and colleagues 
(2008) also showed high accuracy rates for T staging of rectal cancer with 85.3% 
accuracy in 34 patients. The sensitivity and specificity of TRUS was reported as 70.6% 
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and 90.2% respectively. However, in their smaller series, TRUS under staged 4 
patients with T3 tumours and over staged 5 T2 tumours as T3, thereby giving an 
overall accuracy of discriminating between pT1-pT2 and pT3-pT4 tumours of 76.5%, 
with a 87.5% sensitivity and 50% specificity. This is consistent with the staging errors 
seen in the literature with the most common being that of over staging T2 as T3. 
 
The discrepancies seen in the accuracy between the studies can be explained by several 
factors. Firstly, many of the earlier studies were done by inexperienced 
ultrasonographers and there is a recognizable learning curve with TRUS. Both 
Carmody et al (2000) and Lohert et al (2000) have independently shown that the 
ultrasonographers improved their accuracy rates from 58% to 95% over time, after 24 
patients in the first study and after 3 years’ experience in the second group. Secondly, 
morphology of the rectal tumour may hinder the examination as bulky tumours or 
those after biopsy, local excision and radiotherapy may provide inadequate images. 
Haemorrhage after biopsy or local excision can obliterate the layers seen on ultrasound 
and the desmoplastic reaction and hypervascularity after radiotherapy tend to lead to 
over staging of the tumours. Despite the discrepancies, one common fact is that T2 
tumours are regularly staged incorrectly. There is technical difficulty in differentiating 
between invasion into the muscularis propria and invasion through the muscularis 
propria into the perirectal fat. Thus, there is a tendency to overstage these tumours. The 
peritumoural inflammation changes the appearance of the rectal wall making an 
hyperechoeic layer look hypoechoeic. This would in turn lose the outer hypoechoeic 




TRUS has been shown to be more suitable for early tumours rather than advanced 
tumours as the modality is unable to visualise the mesorectal fascia and predict the 
circumferential margin due to the limited focal length. The focal length of a 7.5 MHz 
transducer reaches up to 5cm only, therefore tumour or lymph nodes further away than 
this distance cannot be visualised. Solomon et al (1993) in their metaanalysis showed 
that early tumours were staged more accurately than more advanced tumours. On the 
other hand, Puli and colleagues (2009), in their meta-analysis containing 5039 patients 
showed higher pooled sensitivity and specificity for the more advanced T stages of 
rectal cancers. For T1 stage, pooled sensitivity and specificity were 87.8% and 98.3% 
respectively; for T2 – 80.5% and 95.6%; for T3 – 96.4% and 90.6%; and for T4, 
TRUS had a pooled sensitivity and specificity of 95.4% and 98.3% respectively. 
Although there is great variation in the sensitivity of T staging in the literature, TRUS 
overall as a diagnostic staging test has a high diagnostic odds ratio especially for early 
T stages and therefore enables clinicians to offer surgical treatment alone with 
confidence to patients with early disease.    
 
Accuracy of N staging 
TRUS nodal staging is less accurate than that of T staging and accuracies range from 
50% to 86%. Table 1.6 shows the main studies from the literature and gives an overall 
accuracy of 71.4% in 3712 patients assessed for nodal disease. Such wide variations in 
accuracies exist in the literature as authors use variable criteria for defining nodal 
metastases. Historically, the main characteristics of malignant nodes include a round 




Beynon et al (1986) showed that nodes greater than 5mm have a 50-70% chance of 
harbouring metastases whereas nodes less than 4mm have only a 20% chance. 
Hildebrandt and colleagues (1986), on the other hand, did not use size as a criterion but 
relied only on echogeneicity relying on the observation that inflammatory nodes are 
hyperechoeic and malignant ones are hypoechoeic in nature. This statement holds 
independent of size as that is thought to be a poor indicator of malignancy. Katsura and 
colleagues (1992) showed that although 53.8% of nodes greater than 5mm were 
histologically cancerous, 72.3% of nodes with hypoechoeicity harboured metastases. 
Spinelli et al (1999) also showed that the sensitivity of TRUS was significantly lower 
once nodes were less than 5mm. Although TRUS can identify nodes as small as 3mm 
but it is unable to identify whether micrometastases are present at that size as the 
architecture of the nodes are not greatly altered (Kim 2000). Gleeson and colleagues 
(2009) felt that nodal echo features alone are often inadequate to establish the presence 
of loco regional metastatic disease and recommended further evaluation by fine needle 
aspiration of the nodes in question. Conventional ultrasound features of malignant 
nodes include 4 factors: smooth, round, hypoechoeic and greater than 10mm nodes. 
However, in their series only 68% of malignant nodes had more than 3 of these 
features. Non-conventional criteria were evaluated and short axis length >5 mm, in 
addition to the conventional hypoechoeic feature, were the only factors independently 
predictive of malignancy.  
 
Puli et al (2009) conducted a meta-analysis on the accuracy of transrectal ultrasound to 
diagnose nodal invasion by rectal cancers. They identified 35 relevant studies with 
2732 patients. The pooled sensitivity and specificity of diagnosing nodal involvement 
by transrectal ultrasound was 73.2% and 75.8% respectively. Interestingly, TRUS had 
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a low negative likelihood ratio of 0.42 and a higher positive likelihood ratio of 2.84 
which translates to TRUS performing better to exclude nodal invasion by rectal cancer 




Table 1.5  Accuracy of T staging using TRUS 
Author No. Patients T1 T2 T3 T4 Overall Accuracy 
(%) 





























Ptok 2006 3501 59 59.6 74.9 31.1 65.8 
Maor 2006 66 54.5 85.7 95 100 86 
Knaebel 2005 424 NR NR NR NR 81.8 
Knaebel 2005 332 NR NR NR NR 71.8 
Kauer 2004 458 52 59 86 36 69 
Mackay 2003 433 85.7 65.6 77 89.2 89 
Nesbakken 2002 81 40 81 80 25 74 
Garcia-Aquilar 2002 545 47 68 70 50 69 
Marusch 2002 422 50.8 58.3 73.5 44.4 63.3 
Harewood 2002 80 NR NR NR NR 91 
Akasu 2000 154 96.5 96 96 96 96 
Palacios 2000 120 100 44 96 100 90 
Kim 1999 89 100 50 87 71 81.1 
Massari 1998 75 86.6 88.8 91.4 100 90.7 
Fedyaev 1995 109 NR 94 87 93 95 
Hulsmans 1994 55 50 80 56.8 75 60 
Herzog 1993 111 86 65 99 100 89 
Katsura 1992 112 100 95 87 100 92 
Milsom 1992 67 NR NR NR NR 85 
Tarroni 1992 214 NR NR NR NR 94 
Tio 1991 61 72 47 97 50 80 
Glaser 1990 86 80 77 100 89 88 
Jochem 1990 50 76 76 92 92 80 
Orrom 1990 77 71 69 92 100 75 
Beynon 1989 100 NR NR NR NR 93 
Hildebrandt 1986 76 50 76 100 100 88 
Rifkin 1986 81 NR NR NR NR 84 
Saitoh 1986 88 93 93 92 75 90 
       
OVERALL 8357     83.8 
NR = not recorded 
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Table 1.6  Accuracy of N staging using TRUS 
 
Author No. Patients Overall accuracy 
(%) 
   
Jargenson 2011 83 63 
Ju 2009 78 64.1 
Halfoglu 2008 34 76.5 
Badger 2007 95 68.8 
Ptok 2006 NR NR 
Maor 2006 66 71 
Knaebel 2005 424 76 
Knaebel 2005 332 71 
Kauer 2004 NR NR 
Mackay 2003 263 66 
Nesbakken 2002 81 65 
Garcia-Aquilar 2002 545 72 
Marusch 2002 111 80 
Harewood 2002 80 82 
Akasu 2000 154 72 
Palacios 2000 120 70 
Kim 1999 89 63.5 
Massari 1998 75 76 
Fedyaev 1995 72 61.1 
Hulsmans 1994 54 52 
Herzog 1993 111 80.2 
Katsura 1992 98 61.2 
Milsom 1992 NR NR 
Tarroni 1992 84 84 
Tio 1991 214 70 
Glaser 1990 61 80 
Jochem 1990 73 72 
Orrom 1990 50 82 
Beynon 1989 75 83 
Hildebrandt 1986 27 50 
Rifkin 1986 81 86 
Saitoh 1986 71 73 
   
OVERALL 3712 71.4 




1.2.2.3  Magnetic Resonance Imaging (MRI) 
MRI has been used to evaluate rectal cancer since 1986 (Hodgman 1986, Butch 1986). 
Initially, the accuracy of T staging of rectal cancers was disappointing and similar to 
that of Computerised Tomography with accuracies reported between 59% to 74% 
(Butch 1986, Cova 1994, Zerhouni 1996). The main problem faced with conventional 
external body coil techniques is that it is difficult to differentiate the layers of the rectal 
wall accurately giving poor spatial resolution. Endorectal coils were therefore 
popularised and this imaging technique produced T staging accuracies comparable to 
that of TRUS with 80-90% accuracy stated in many studies (Chan 1991, Schnall 1994, 
Vogl 1997, Gualdi 2000). The high accuracy rates were the result of high resolution 
and differentiation of the layers of the rectal wall. However, this comes at the expense 
of several difficulties encountered when using the endorectal coils. They are often too 
large to pass beyond bulky tumours and stenotic lesions with appropriate positioning 
often being difficult (Matsuoka 2003). The balloon distension required may also distort 
the rectal wall (Bartram 2002). An important limitation is that the mesorectal fascia 
and the assessment of the circumferential margin is limited as there is a radial signal 
drop off giving a diminished field of view only a short distance from the endorectal 
coil (Beets Tan 2004). In addition, endorectal coils are not only limited in availability 
but also expensive being single use items.  
 
The new generation of external high resolution phased array surface coil systems has 
improved the local staging of rectal cancer. The combination of high resolution, 
improved signal to noise ratio and a large field of view allows detailed anatomical 
evaluation of the rectal wall and mesorectal fascia (Table 1.7). Despite these 
advantages, overall T staging accuracies of recent studies vary from 67-86% which is 
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disappointing (Bloomqvist 1997, Beets-Tan 2001, Gagliardi 2002, Poon 2005). These 
results can be attributed to the fact that MRI fairs worse at staging T1 and T2 tumours 
than more advanced cancers. Mathur et al (2003) showed that T1 and T2 tumours were 
staged to an accuracy of 46% whereas T3 tumours were at 76%. Similar observations 
were made by Drew et al (1999) and Hadfield and colleagues (1997). 
 
The majority of clinicians would now argue that the most important question relating 
to MR imaging and rectal cancer is the relationship of the tumour to the mesorectal 
fascia. This is of vital importance as the surgical resection in the form of TME would 
only be primarily undertaken if there is a clear margin between the tumour and the 
mesorectal fascia. The importance of predicting this tumour free circumferential 
resection margin (CRM) has been highlighted in recent MR studies using phased array 
surface coils. Beets-Tan et al. (2001) assessed 76 patients with rectal cancer using 
phased array coil MRI at 1.5 Tesla and predicted not only tumour stage but also 
distance from the tumour to the mesorectal fascia. On MR imaging the mesorectal 
fascia is a fine linear structure enveloping the mesorectum being hypointense on T2 
weighted and isointense on contrast enhanced T1 weighted images. They showed that 
the CRM can be predicted with high accuracy and consistency with 2 radiologists. 
Agreement between the 2 radiologists was 100% in T4 tumours, and 97% and 93% for 
the two radiologists in patients with tumours with a histological CRM of greater than 
10mm. For margins of 1-10mm, a tumour free CRM of 2mm was predicted with an 
accuracy of 97% if the distance between the tumour and the mesorectal fascia was at 
least 6mm. It is interesting to note that in this same study, the accuracy of MR staging 
of rectal cancer was only 67% for the first radiologist and 87% for the second. 
Furthermore, the accuracy for staging T1 and T2 tumours were markedly lower (38% 
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and 42%) than that of T3 and T4 tumours (95% and 100%). Certainly for the earlier 
stage tumours, there was no agreement between the two radiologists. The difficulties 
with staging T2 tumours for this group was thought to be poor distinction of 
speculation in the perirectal fat caused by fibrosis only (T2) from that caused by 
cancerous cells (T3). This is in complete contrast to the work by Brown and colleagues 
(1999) correctly staged 100% of rectal tumours and visualised the mesorectal fascia in 
all of their 25 patients. They felt that peritumoural fibrosis had a distinct lower signal 
intensity compared to that seen in cancerous margins.  
 
Although tumour staging using the T stage of the TNM classification is the traditional 
method of prognostically stratifying patients, this method has its limitations. In 
particular, the majority of rectal cancers at presentation are T3 tumours and the 
outcomes of these patients depend on the depth of extramural spread. The University 
of Erlangen group have published one of the largest series of rectal cancers (Merkel et 
al 2001) and showed that T3 tumours with extramural spread greater than 5mm were 
associated with a cancer specific 5 year survival of 54% compared with that of 85% 
seen in those T3 tumours with less than 5mm of extramural spread, regardless of 
whether lymph node involvement was present.  
 
The MERCURY (Magnetic Resonance Imaging and Rectal Cancer European 
Equivalence) Study group is a multidisciplinary collaboration formed in 2002 for the 
prospective evaluation of preoperative assessment in patients with rectal cancer. The 
group assessed the accuracy of preoperative staging of rectal cancer with MRI to 
predict surgical circumferential margins in 2006. The specificity for prediction of a 
clear margin by MRI was 92% with an accuracy of 91% and a negative predictive 
52 
 
value of 93% in patients undergoing primary surgery. In 2007, the group evaluated 
MRI versus the histopathological measurement of extramural depth of tumour 
invasion. Data was available for 295 patients of the 311 patients that underwent 
primary rectal cancer surgery. They demonstrated highly accurate measurement of the 
depth of extramural tumour spread as MR and histopathological assessments of tumour 
spread were equivalent to within 0.5mm. The same group have reported their 5 year 
follow up (Taylor et al 2011) and demonstrated that of the 374 patients who completed 
follow up, 33% were classified as good prognosis initially with either clear surgical 
circumferential margins or less than 5 mm spread from the muscularis propria. The 5 
year overall and disease free survival for this good prognosis group was 68% and 85% 
respectively . Furthermore, this group had a low local recurrence rate of only 3%. 
 
Several other authors have also shown good results with MRI and rectal cancer. Akasu 
and colleagues (2009) showed excellent agreement of T stage in 85 out of 101 rectal 
cancer patients (84%). This high accuracy was maintained across the T stages with 
96%, 88% and 99% for T2, T3 and T4 stages respectively. In addition, they showed 
96% accuracy for detection of mesorectal fascia involvement and 74% overall 
accuracy for detection of lymph node metastasis. Halefoglu et al. (2008) showed 
superior staging using MRI in 34 patients with rectal cancer. They achieved 89.7% 
accuracy in T staging of rectal cancers for MRI, with a sensitivity of 79.4% and a 
specificity of 93.1%. Equally, detection of lymph node metastases achieved an 
accuracy of 74.5%. Overall MRI had a 85.2% accuracy in discriminating between pT1-
pT2 and pT3-pT4 tumours, with MRI over staging 4 pT2 cases as T3 similar to the 






Table 1.7 Layers of the rectal wall as seen with MRI  
(Bartram and Brown 2002) 
 
 LAYERS OF THE RECTAL WALL ON MRI 
   
1 Mucosa: thin, low intensity signal  
2 Submucosa: thicker, higher intensity signal  
3 Muscularis Propria: low signal intensity  
4 Perirectal fat: high signal intensity  
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The identification of positive local lymph nodes in rectal tumours are the most 
challenging for an imaging modality as micrometastases can occur in normal size 
lymph nodes. Accurate staging is vital as the number of lymph nodes affect prognosis 
as well as the proximity of lymph nodes close to the mesorectal fascial envelope. The 
problems encountered with TRUS are also valid for MRI as size of lymph nodes is not 
an important criterion for metastatic disease. Brown et al (2003) showed that in lymph 
nodes greater than 3mm, factors such as an irregular border and mixed signal intensity 
are better than using size alone. Kim and colleagues (1999) re-iterated the importance 
of using multiple criteria to assess lymph nodes rather than size alone. The 
consequences of the difficulty in assessing nodes have given rise to the wide variation 







Table 1.8 Accuracy of N staging in rectal cancer using MRI 
Author No. Patients Overall accuracy 
(%) 
   
Hodgman 1986 34 39 
Butch 1986 16 37.5 
De Lange 1990 23 57 
Okizuka 1993 33 87 
Schnall 1994 36 81 
McNicholas 1994 20 95 
Thaler 1994 37 60 
Indinnimeo 1996 23 78.9 
Kwok 2000 4897* 65 
Halefoglu 2008 34 74.5 
Akasu 2009 101 74 
*systematic review 
 
Over the last few years, the use of ultrasmall superparamagnetic iron oxide (USPIO) 
has been suggested as a method of improving the nodal staging accuracy with MRI. 
The particles are phagocytosed by macrophages in lymph nodes and result in 
decreased signal intensity in normal nodes. This should in turn increase the detection 
of micrometastases. Koh et al. (2004) used USPIO-enhanced MRI and reported an 
association of lymph node enhancement with metastasis. Lahaye et al. also assessed 28 
rectal cancer patients with USPIO-enhanced MRI and compared accuracy of several 
criteria for predicting mesorectal node involvement, including border irregularity, 
short- and long-axis diameter, and estimated white region percentage.  They reported 
that estimated white region percentage to be reproducible, accurate and practical. This 
should be the basis of a future prospective study in a larger cohort. 
 
1.2.2.4  Computerised Tomography 
The advantage of CT is that it enables visualisation of the entire abdomen and pelvis 
and is valuable for detection of distant metastases. The initial reports of CT staging of 
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rectal cancer depth were promising in the literature with accuracy rates of 90% (Theoni 
1981, Zaunbauer 1981). However, the majority of these patients had advanced 
tumours. The more recent studies have T staging accuracies ranging from 47% to 75% 
(Freeny 1986, Bech-Shriver 1992). The main difficulty with CT imaging is that it is 
unable to differentiate the different layers of the rectal wall. Therefore, this makes it 
challenging to differentiate between T1 and T2 tumours and most of the studies with 
high accuracies have a small percentage of T1 tumours. In addition, it is also not 
possible to differentiate between inflammation and cancerous margins and the 
identification of the mesorectal fascia with good resolution which is vital to the 
management decisions in rectal cancer. Kwok et al (2000), in their metaanalysis of 78 
studies from 1980 and 1998 included 4897 patients and showed that the T staging 
accuracy with CT for rectal cancer was 73%. Conventional CT protocols with low 
spatial and contrast resolution with thick slice CT accounted for these poor results. The 
newer generation multi-slice CT scanners with reconstructions in multiple planes have 
produced more promising data. Kulinna and colleagues (2004) showed an accuracy of 
86% in a study of 92 patients. These achievements were confirmed by Fillipone et al 
(2004) who showed accuracy for T staging of 83% in 41 patients. 
 
Lymph nodes, when enlarged can be visualised by CT but it is not possible to 
differentiate between reactive or inflammatory nodes and those infiltrated by cancer. 
Some authors have tried to define malignant nodes with respect to their size but this 






1.2.2.5  Summary 
The review of the literature to date has shown that local staging of rectal cancer should 
be undertaken by TRUS and MRI. However, it seems that TRUS provides more 
accurate staging for early cancers (T1 and T2), whereas MRI is superior for more 
locally advanced tumours. Both imaging modalities offer similar accuracies in nodal 
staging. MRI has a clear advantage for predicting tumour free CRM as this is not 
clearly visualised by TRUS. CT imaging is not appropriate for local staging currently 
but studies with the new generation multi-slice scanners are eagerly awaited. 
 
1.2.3  Colonic Cancer 
1.2.3.1  Background 
Colorectal cancer is the third commonest cancer worldwide after lung and breast 
cancer with over two thirds of cancers occurring in developed nations. In excess of a 
million new cases of colorectal cancer were diagnosed worldwide accounting for 9% 
of cases. In the United Kingdom, 100 new cases are diagnosed each day. In 2005, there 
were 36766 new cases diagnosed with approximately two thirds in the colon (22748) 
and one third in rectum (14018) (Cancer Research UK). The distribution of cases in the 
colon and rectum show that nearly half of all cancers occur in the rectum and left colon 
(Figure 1.9). In 2006, there were 15975 deaths in the United Kingdom from colorectal 
cancer (10119 colon, 5838 rectum), making it the second leading cause of cancer death 
after lung cancer. 
 
The diagnosis of colon cancer is aided by the use of colonoscopy to localise the 
tumour and obtain histological confirmation of cancer. In addition, colonoscopic 
examination of the entire colon and rectum is crucial to exclude the presence of 
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synchronous tumours. Computed tomography is used routinely to screen the chest, 
abdomen and pelvis for the presence of metastatic disease. Once we have established 
the absence of disseminated disease and determined the suitability of the patient for 
surgery with regard to their fitness, surgical resection of the cancer offers the mainstay 
of primary treatment. Nearly, two thirds of patients will survive 5 years after curative 
resection, with recurrence being a rare phenomenon beyond four disease free years. 
Adjuvant chemotherapy is now being offered routinely to patients with high risk 
disease on histological examination.  
 
Local staging of colonic cancer is gaining increasing importance with the increase in 
colonoscopic mucosal resection techniques for early tumours. Especially with the 
introduction of the National Colorectal Cancer Screening programme, detection of 
colonic cancer may be at an earlier stage with more potential for local treatments. This 
highlights the importance of accurate local staging of colonic cancer by both 
colonoscopic and CT techniques. In addition, the possibility of neo-adjuvant 
chemotherapy being offered to patients with locally advanced cancers also re-iterates 
the importance of accurate local staging. Screening and neo-adjuvant chemotherapy 






Figure 1.9 Distribution of colorectal cancers in England 1997-2000  





1.2.3.2  Colorectal Cancer Screening 
The outcome of patients with colorectal cancer depends on the staging of the disease at 
the time of presentation. Historically, nearly 90% of symptomatic patients are not 
diagnosed until deeper penetration of the cancer into the bowel wall with local lymph 
node metastases (Gill 1978, Umpleby 1984, Stower 1985). The five year survival of 
patients with Dukes A cancer is favourable at 88% compared to those with advanced 
stage disease with metastases (7%) (Kievit 1995). It therefore follows that detection of 
cancer at an early stage is highly curable and this can be achieved by the screening of 
asymptomatic individuals. The majority of colon cancers arise from adenomatous 
polyps via the adenoma-carcinoma sequence discussed earlier (Peipins 1994), and 




Winawer and colleagues (1993) followed a cohort of 1418 patients whom had 
undergone colonoscopies and removal of one or more adenomata of the colon or 
rectum. They observed a lower than expected incidence of colorectal cancer in this 
group of patients followed for a mean of 5.9 years.  
 
There are a number of screening tests that have been employed for the detection of 
colorectal cancer all of which have been utilised for population based screening. 
 
Faecal Occult Blood Testing 
The guaiac smear test is the commonest test used for the detection of faecal occult 
blood. These are designed to detect blood losses over and above the normal 1.5ml/day 
of physiological blood loss. The presence of haem releases oxygen from peroxide 
thereby causing oxygenation of the guaiac chromogen into a blue product which is 
easily detected. Both rehydrated and dehydrated forms of the test are available with 
higher sensitivities and lower specificities being achieved with the rehydrated tests 
(Winawer 1997). Immunochemical tests are also available which utilise monoclonal 
antibodies against the globin chain of human haemoglobin.  
 
There have been four well designed randomised controlled trials in the United 
Kingdom (Scholefield 2002), Sweden (Jorgenson 2002), Denmark (Kronborg 2002) 
and United States (Mandel 1993). All of these have demonstrated a decrease in 
colorectal cancer mortality by 11-33%. A recent Cochrane Database review (Hewitson 
2007) combined the randomised controlled trials in a meta-analysis and showed a 
significant reduction in mortality of 15-33% (OR 0.85, CI 0.79-0.91). The American 
Study (Mandel 1993) further showed that mortality was reduced by 33% in the group 
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which underwent annual screening and this was significantly lower than that of the 
control group. Importantly, all of the randomised controlled trials (RCTs) 
demonstrated a favourable shift in disease stage with more Dukes A cancers than 
Dukes B or C. The FOBTs have commenced as a screening tool in the United 
Kingdom since April 2000 after the successful pilot studies in Fife, Grampian, 
Tayside, Coventry and Warwick. 
 
Other tools of screening exist but none of them have been through vigorous RCTs as 
the FOBT. These include flexible sigmoidoscopy, colonoscopy, computed tomography 
colonography and molecular markers in stool and serum.  
 
1.2.3.3 Chemotherapy for colon cancer 
 
Adjuvant chemotherapy 
The mainstay of adjuvant treatment for colon cancer is fluorouracil, which is a 
fluorinated pyrimidine that acts through the inhibition of the rate limiting enzyme in 
pyrimidine nucleotide synthesis, thymidylate synthetase (Sobrero 2000). There is 
considerable evidence related to adjuvant chemotherapy in colon cancer published 
over the last 20 years. Prior to 1990 however, there was insufficient evidence to 
advocate the routine use of chemotherapy in colorectal cancer. Buyse and colleagues 
(1988) published a meta-analysis of 25 studies and failed to show a significant survival 
benefit. 17 of these studies specifically examined the role of chemotherapy with 
control groups with a total of 6791 patients. Flurouracil containing regimes showed a 
small benefit in terms of overall survival with an odds ratio of 0.83 in favour of 
therapy (CI 0.70-0.98). Two hallmark studies in 1989 and 1990 changed the consensus 
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of chemotherapy in colorectal cancer. Laurie and colleagues (1989) randomised 401 
patients with Dukes B and C colorectal cancer to adjuvant chemotherapy (flurouracil 
alone or in combination with levamisole) and showed that both regimes showed a 
significant reduction in recurrence with only the combination regime significantly 
improving overall survival. Levamisole is an anti-helminthic and was examined in 
combination as an immunomodulating agent.  In addition, Moertel et al (1990), from 
the Mayo clinic, randomised 1296 patients with resected colon cancer either Dukes B 
or C to adjuvant chemotherapy with flurouracil and levamisole for one year or 
observation alone. The patients with Dukes C colon cancer could also be randomised 
to flurouracil alone or in combination with levamisole. They showed conclusively that 
patients with Dukes C cancer had a 41% reduction in cancer recurrence (p=0.005) with 
an overall reduction of death rate by 33% (p=0.006) when treated with the combination 
regime. Treatment with levamisole alone had no benefit, neither did the results with 
Dukes B patients draw any definite conclusions. Both of these studies therefore lead to 
the United States National Institute of Health consensus statements advocating the 
combination regime in patients with Dukes C colon cancer. 
 
Since the two initial pioneering studies, there have been several studies which have 
compared flurouracil based regimes against observation with significant improvements 
in 5 year overall survival in the region of 10%. (Table 1.9) Further queries relating to 
the length of treatment required, dosage of agent and combination therapy were the 
subject of several randomised studies. One such study termed the Quick and Simple 
and Reliable study (QUASAR 2000) recruited 5000 patients and compared high and 
low dose folinic acid with or without levamisole in addition to flurouracil. 
Interestingly, no significant differences were seen amongst the groups concluding that 
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levamisole is not necessary and that low dose folinic acid provided adequate 
modulation of fluorouracil. 
 
Interestingly, there have been no randomised clinical trials that have demonstrated 
significant survival benefit for adjuvant chemotherapy in patients with Stage II colon 
cancer. Gill and colleagues (2004) pooled the results of 7 studies and showed 81% 5 
year survival in patients who received fluorouracil regimes compared to 80% in the 
surgery alone group. Only marginal survival benefits have been shown by the 
QUASAR study (Gray et al 2004) only published in abstract form, and in subset 
analyses of the NSABP trials (Mamounas et al 2002). The American Society of 
Clinical Oncology (ASCO) (Figueredo et al 2004) and the National Comprehensive 
Cancer Network (NCCN) (Benson et al 2004) have both independently recommended 
against the routine use of adjuvant chemotherapy in Stage II colon cancer. There are 
subgroups of patients with Stage II cancer that may benefit from adjuvant 
chemotherapy and these include those with T4 stage, bowel perforation or bowel 
obstruction (Moertel 1995). 
 
The discussion of adjuvant chemotherapy has been concentrated to that of fluorouracil 
as the mainstay treatment regime. However, there is good randomised data from 
clinical trials advocating the use of other agents such as capecitabine. 
 (Hoff et al. 2001, Van Cutsem et al. 2001).
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Table 1.9 Randomised controlled trials of adjuvant flurouracil based 




5 year survival (%) 
  CHEMOTHERAPY OBSERVATION 
   
Moertel 1995 929 60 47 
    
Wolmark 1988 (NSABP-C01) 1166 67 60 
    
Francini 1994 239 79 65 
    
IMPACT 1 1995 1526 83 78 
    
O’Connell 1997 309 74 63 
 
NSABP: National Surgical Adjuvant Breast and Bowel Project Protocol C-01 (November 1977 and February 1983) 




The past decade has seen neoadjuvant chemotherapy become a routine aspect of 
oesophageal and rectal carcinomas. The response of the tumour tissue histologically to 
neoadjuvant chemotherapy and its correlation to clinical outcome has been thoroughly 
studied (Hiotis et al 2002, Schneider 2005). In contrast, the use of neoadjuvant 
chemotherapy in the management of advanced nonmetastatic colon cancer is not 
established in the literature. There are, however, increasing numbers of patients with 
metastatic colon cancer who are first treated with chemotherapy and later resection of 
the primary after adequate downstaging. This has identified a group of patients with 
locally advanced colon cancer who underwent aggressive downstaging after 




Karoui and colleagues (2008) characterised the histological effects of neoadjuvant 
chemotherapy on primary colonic cancers. 38 patients with Stage IV colon cancer 
underwent colonic resection either after chemotherapy or without. They demonstrated 
that chemotherapy induces a major histological regression in 70% of patients and this 
was comparable to that seen histologically with the liver metastases, and not observed 
in the control group. Tumour regression grade has been shown to be an important 
prognostic marker in other gastrointestinal tumours and therefore neoadjuvant 
chemotherapy may contribute to improved outcome in patients with colon carcinomas. 
The advantage of other gastrointestinal tumours such as oesophageal and rectal cancers 
is that clinical tumour and node staging has been evaluated extensively by endoscopic 
ultrasound, Computed Tomography and Magnetic Resonance Imaging and compared 
to pathological staging to assess downstaging after chemotherapy (Rodel 2005, Bosset 
2005). This has not been the case with colon cancer. 
 
The FOXTROT clinical trial in the United Kingdom (www.foxtrot.bham.ac.uk) has 
been designed to answer these questions related to the effects of neoadjuvant 
chemotherapy in patients with locally advanced colon cancer. This is a multicentre 
randomised controlled trial designed to determine whether neoadjuvant chemotherapy 
with or without panitumumab, followed by deferred surgery and completion of 
chemotherapy post operatively, can reduce 2 year recurrence and overall survival as 
compared to surgery without neoadjuvant chemotherapy. The neoadjuvant 
chemotherapy would be reserved for locally advanced colon cancers (T3 or T4) 
without distant metastases and therefore accurate pre-operative staging of colon cancer 
is a crucial aspect of this study to ensure that patients do not receive unnecessary 
treatment due to overstaging. Traditionally, Computed Tomography has been the 
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investigation of choice for local staging and is an integral part of the FOXTROT study. 
Patients will be selected on the results of the CT examination and poor prognostic 
indicators will include: T3 tumours with extension beyond 5mm; T4 tumours either 
involving the peritoneal surface, adjacent organs or perforated tumours (Dighe et al 
2008). Therefore all tumours which are T1 or T2 or have evidence of distant 
metastases will be excluded.  
 
1.2.3.4  Computed Tomography (CT) and local staging of colon cancer 
Conventional CT scans have been the investigation of choice in the evaluation of 
staging of colon cancer. Traditionally, the information available from the images have 
been limited to the site and size of the tumour, infiltration into surrounding structures 
and evidence of metastastic spread. The information provided has not been used to 
change the management of patients with colon cancer except in the light of colonic 
cancer metastases (Cohen 1992, Thoeni 1995, Isbister 1996). Classically, CT evaluates 
three major parameters in staging colon cancers: local extramural invasion, regional 
nodes either greater than 1cm or a cluster of 3 or more nodes each less than one 
centimetre, evidence of distant metastases and extension of the tumour into adjacent 
organs (Balthazar 1988). It has been difficult to compare different studies in the 
literature related to the accuracy of staging of colon cancer as there are great variations 
in the type of scanners used, the protocols and the methods of administering contrast 
agents. 
 
Early reports of the evaluation of CT as a staging investigation suggested that the local 
extent and regional spread of the tumour correlated well with the surgical and 
histopathological findings. Accuracy rates between 77% and 100% were quoted in the 
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literature (Dixon 1981, Zaunbauer 1981, Grabbe 1983, Van Waes 1983). However, 
majority of these studies focused on rectal cancer staging and reliable data of staging 
proximal to the recto-sigmoid junction is limited.  
 
There are several problems in drawing meaningful conclusions regarding the accuracy 
of CT in the local staging of colonic cancer. A review of the published literature 
identified only 20 papers dedicated to local CT staging of colonic cancer, three of 
which did not include any details regarding staging information, only descriptive terms 
(Mayes 1980, Meyer 1983, Gossios 1992) leaving only 17 papers for in depth analysis 
(Table 2). It is therefore not surprising that only a total of 1009 patients have been 
subject to involvement in a clinical study evaluating the local staging of colon cancer. 
Seven of the seventeen studies have combined patients with both colon and rectal 
cancer in their analyses (Thoeni 1981, Thompson 1986, Freeny 1986, Dux 1996, Laghi 
2002, Filippone 2004, Kanamoto 2007). The remaining ten studies in the literature, 
therefore, contribute only 604 patients as the complete number in the published 
literature on this subject.  
 
Utilisation of contrast in CT 
It is well known amongst radiologists that colonic opacification must be optimal, 
therefore the majority of the studies administered oral contrast either the night before 
or at least 30-60 minutes before cross sectional imaging. Three studies did not 
comment on any of the details of the CT scanning protocol (Keeney 1989, Chung 
2004, Smith 2007). Of the remaining 14 studies, 2 had no mention of the 
administration of oral contrast (Hundt 1999, Kanamoto 2007). All of them however, 
used intravenous contrast during imaging which is encouraging as the potential value 
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of the use of intravenous contrast to enhance the bowel was relatively recent. Amin 
and colleagues (Amin 1996, Harvey 1998), described the advantages of intravenous 
contrast and stated that the potential advantages were not only in providing images of 
the bowel wall but also of the extracolonic tissues and liver in one setting. This 
potentially has the benefit of aiding in the assessment of the depth of invasion of 
colonic cancers, including the identification of pericolic spread, lymph nodes and liver 
metastases. Contrast enhancement of colonic cancers was evaluated by Hundt and 
colleagues (1999). They assessed 37 patients with colorectal cancer (23 colonic, 14 
rectal) after intravenous contrast and spiral CT and showed that the accuracy of T 
staging of cancers was 81% in the arterial phase and only 64% in the venous phase, 
with T1 tumours not being detected in the venous phase. The authors claimed that 
normal colonic wall can be differentiated into three layers during the arterial phase 
with the inner layer corresponding to the mucosal layer, the middle low attenuation 
layer to the submucosal layer and the outer layer corresponding to the muscularis 
propria and serosa.  
 
Colorectal insufflation/enema 
Traditionally, CT has not been the investigation of choice in the evaluation of patients 
with suspected tumours of the colon. Early and subtle lesions involving the mucosa are 
difficult to detect, mainly because the colon is not distended (Thoeni 1981). This in 
additional to poor bowel preparation leaving faecal residue may give erroneous 
interpretations. Some authors have used water enemas to distend the colon and act as a 
contrast medium (Gazelle 1995, Dux 1996, Hundt 1999), whereas others have included 
the administration of rectal insufflation to toleration by the patient (Thoeni 1981, 
Balthazar 1988, Zerhouni 1996, Filippone 2004, Kanamoto 2007). However, there is 
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still a wide variation in clinical practice and this is illustrated in Table 2. With respect 
to water enemas, only 3 authors advocated its use as mentioned earlier, 3 did not 
mention it in their protocol (Keeney 1989, Chung 2004, Smith 2007) and 11 out of 17 
did not use it in their routine practice (Thoeini 1981, Thompson 1986, Freeny 1986, 
Balthazar 1988, Acunas 1990, Earls 1994, Zerhouni 1996, Laghi 2002, Filippone 
2004, Kanamoto 2007, Burton 2008). On the other hand, rectal insufflation was 
practised by 5 out 17 institutions, 3 did not mention it in their protocol (Keeney 1989, 
Chung 2004, Smith 2007) and 9 did not advocate its use (Thompson 1986, Freeny 
1986, Acunas 1990, Earls 1994, Gazelle 1995, Dux 1996, Hundt 1999, Laghi 2002, 
Burton 2008). 
 
Types of CT scanner 
Conventional CT imaging in the early 1980s (Thompson 1986, Freeny 1986) relied on 
staging colon cancer using images acquired at 10mm intervals. Both authors had 
similar CT protocols with the use of oral and intravenous contrast without rectal enema 
or insufflation. The accuracies of T staging of colon cancer by these authors vary from 
47.5% to 70%. Freeny et al (1986) evaluated 103 patients, 84 of whom had colon 
cancer using conventional CT at 10mm slices and obtained 47.5% accuracy for T 
staging with 61.2% sensitivity. They were only able to demonstrate an abnormality 
suggestive of a tumour in 85% of patients either as a circumferential thickening (34%) 
or as a discrete mass (66%).  In their patients, CT was unable to differentiate between 
tumour confined to the mucosa or that invading the muscularis propria. Thompson and 
colleagues demonstrated better accuracies of 70% for T staging in their 25 patients. 
However, the majority of their patients had rectal cancer (21 out of 25) which may 
account for this.  
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The development of CT technology with thinner slice image acquisition and spiral CT 
with image reconstruction in multiplanar reconfigurations, has led to improving 
accuracies in the local staging of colon cancer. It seems to be increasingly possible to 
identify depth of invasion and local nodal involvement. Kanamoto and colleagues 
(2007) used dual phase contrast enhanced multi-detector row CT at 1mm slice 
intervals and multiplanar reconstruction, to evaluate local invasion and lymph node 
metastasis in colorectal cancer. 51 patients were recruited with only 13 rectal cancer 
patients with an overall T staging accuracy of 94.1%. 
 
T stage 
Table 1.10 summarises the 17 studies to date in the literature which have evaluated 
local staging of colon cancer. This has identified a total of 1009 patients and CT 
imaging demonstrated a range of accuracies from 43.8% to 96.9%, with sensitivities of 
55%-77% and specificities of 57%-80.6%. Eight out of the seventeen studies, 
however, have included both rectal and colon cancer in their analysis (Thoeni 1981, 
Thompson 1986, Freeny 1986, Dux 1996, Hundt 1999, Laghi 2002, Filippone 2004, 
Kanamoto 2007), with two of them not specifying the exact number of colon cancers 
















 Acc Sen Spec Acc Sen Spec Acc Sen Spec Oral Rectal IV   
                  
Thoeni 1981 39 (16 colon) 5 92 - - - - - - - - √ √ √ χ √ χ 
                  
Thompson 1986 25 (4 colon) 10 70 77 57 35 22 75 - - - √ √ √ χ χ χ 
                  
Freeny 1986 103 (84 colon) 10 47.5 61.2 80.6 - 25.9 96 - 72.7 98.9 √ χ √ χ χ χ 
                  
Balthazar 1988 90 5 58 55 77 68 73 58 93 79 98 √ χ √ χ √ χ 
                  
Keeney 1989 14 - 57 78 - - 12 - - - - - - - - - - 
                  
Acunas 1990 28 8 71 60 67 75 75 75 93 87 95 √ √ √ χ χ χ 
                  
Earls 1994 29 10 72 - - 50 - - - - - √ χ √ χ χ χ 
                  
Gazelle 1995 30 - 76.7 - - - 60 79 - - - √ χ √ √ χ χ 
                  
Zerhouni 1996 237 4 72 68 70 62 56 71 85 62 97 √ χ √ χ √ χ 
                  
Dux 1996 74 * - 66 - - - 69 46 85 - - √ χ √ √ χ χ 
                  
Hundt 1999 37 (23 colon) 5 81 - - 81 84.3 60 - - - χ χ √ √ χ χ 
                  
Laghi 2002 35 * 1 96.9 - - - - - - - - √ χ √ χ χ χ 
                  
Filippone 2004 41(15 colon) 3 83 - - 80 90 77 - - - √ χ √ χ √ √ 
                  
Chung 2004 17 - 64.7 - - 70.6 - - - - - - - - - - - 
                  
Smith 2007 126 - 60.6† - - 52.6† - - - - - - - - - - - 
                  
Kanamoto 2007 51 (38 colon) 1 94.7 - - 80.5 86.9 79.6 - - - χ χ √ χ √ √ 
                  
Burton 2008 33 10 43.8† - - 59.3† - - - - - √ χ √ χ χ χ 
                  
 
 
Table 1.10: Accuracy of CT staging of colonic cancer 
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The most confusing aspect of colon cancer has been the histological staging of the 
disease and correlating this with CT staging. The original Dukes system was proposed 
for rectal cancer was simple and easy to use (Dukes 1938) (Table 1.11). However, this 
did not classify patients into prognostic groups accurately enough, so Kirklin and 
colleagues (1949) proposed a modification sub-dividing Stage B into: B1 where there 
is involvement of the muscularis propria but not through it; and B2 with tumour 
invasion through the muscularis propria. This sub-division was later extended to Stage 
C after suggestions from Astler and Coller (1954), with C1 involving nodes in the 
pericolic region and C2 involving the highest or apical node (Dukes and Bussey 1958). 
Finally, Turnbull and colleagues added another stage D for the presence of metastatic 
disease (Turnbull et al 1967). 
 
Table 1.11 Dukes Classification of rectal cancer 
Stage Description 
A Tumour limited to wall of rectum 
B Tumour spread by direct extension through extra-rectal tissues 
C Involvement of regional lymph nodes 
 
There are several variables that affect survival in colorectal cancer and the TNM 
classification was introduced to bring these together by the International Union 
Against Cancer (UICC, 1979) and the American Joint Committee for Cancer Staging 




Table 1.12 TNM classification for staging of colorectal cancer 
Stage Description 
Tumour(T)  
Tx Primary tumour unable to be assessed 
T0 No evidence of tumour 
Tis Carcinoma in situ 
T1 Tumour invasion into submucosa 
T2 Tumour invasion into muscularis propria  
T3 Tumour invasion through muscularis propria or non peritonealised 
pericolic/perirectal tissue 
T4 Tumour invades other organs or perforates visceral peritoneum 
Lymph nodes(N)  
Nx Loco-regional nodes cannot be assessed 
N0 No lymph node metastases 
N1 1-3 pericolic or perirectal lymph nodes involved 
N2 >4 pericolic or perirectal lymph nodes involved 
Metastases(M)  
Mx Distant metastases cannot be assessed 
M0 No distant metastases 




The published literature varies in the comparisons between histological staging and CT 
staging. Thoeni and colleagues (1981) correlated their findings to a modified Dukes 
system and found a high degree of correlation. Zaunbauer et al (1981) used the TNM 
staging, Van Waels (1983) used Thoeni’s modified system, Grabbe (1983) made 
comparisons with Dukes’, and Adalsteinsson (1985) utilised the Astler and Coller 
modification. Although, this variation exists, these authors concentrated mainly on 
rectal cancer with no precise data on colon cancer staging. The majority of authors 
comparing CT and colonic cancer staging have used a TNM based system of 
classification for interpretation.  
 
The initial studies in the 1980s and early 1990s using conventional CT identified colon 
cancer as either a discrete mass or focal wall thickening. Thoeni and colleagues (1995) 
stated that normal colonic wall thickness was less than 3mm, 3-6mm was deemed 
indeterminate and greater than 6mm was abnormal. They therefore described CT 
appearances of different stages of tumour. If the cancer was contained within the wall 
of the colon, the outer margins of the bowel wall appear smooth. Extension of the 
tumour beyond the colonic wall was visualised as a mass with irregular borders with or 
without strands of soft tissue extending from the colonic margin to the pericolonic fat. 
The authors felt that CT was unable to distinguish between the depths of invasion into 
the different layers of the colon and therefore their results could not be easily 
compared to the TNM staging as we know it nowadays. Their series could not 
distinguish between tumours confined to the mucosa and submucosa (T1N0M0) from 
those invading the muscularis propria but not going through to the serosa (T2N0M0). 
The high accuracy rates of 92% for T staging of 39 colorectal cancers (16 colonic) was 
mainly due to the fact that 24 of their patients had advanced disease at either Dukes 
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Stage C or D. CT frequently under stages patients with microinvasion of pericolonic 
fat. This accounts for the low accuracies in T staging shown by both Freeny (1986) and 
Balthazar (1988). They revealed accuracies of 47.5% and 58% respectively. However, 
it must be noted that in some these earlier studies, lymph node metastases were not 
analysed separately and low sensitivity of detecting lymph nodes (22%, Freeny 1986), 
lowers overall accuracy of staging.  
 
There have been three studies demonstrating T staging high accuracies above 90%. 
Thoeni et al (1981), as discussed, had an accuracy of 92% mainly due to the high 
proportion of advanced cancers. The other 2 studies by Laghi (2002) and Kanamoto 
(2007) demonstrated T staging accuracies of 96.9% and 94.7% respectively. Both 
studies adopted 1mm slice image acquisition with multi-detector CT using rectal 
insufflation and intravenous contrast. Kanamoto and colleagues (2007) showed high 
accuracy rates for all T1 and T2 tumours combined, T3 and T4 tumours demonstrating 
accuracy rates of 94.1%, 94.1% and 100% respectively. They used multiplanar 
reconstruction which they believed was superior to other techniques. Filippone et al 
(2004) also demonstrated that contrast enhanced multiplanar reconstruction was 
superior in local staging of cancers. In their cohort of 41 patients (15 colonic cancers), 
the overall accuracy of T staging was 73% when using the transverse images alone, 
and this rose to 83% when transverse and multiplanar reconstructed images were used 
in combination. The authors confirmed increasing accuracy for more advanced cases 
of colon cancer with 98% accuracy for T4 tumours compared to 93% for T1 and T2 
tumour combined. However, all three of  the above authors combined both colon and 
rectal cancers, therefore not giving a true reflection of colonic cancer staging alone. 
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There are 9 studies in the literature (Table 2) which purely focus on colon cancer 
staging without inclusion of rectal cancers in their analyses, giving a total of 604 
patients with T staging accuracies varying from 43.8% to 76.7% (Balthazar 1988, 
Keeney 1989, Acunas 1990, Earls 1994, Gazelle 1995, Zerhouni 1996, Chung 2004, 
Smith 2007, Burton 2008). These CT staging results have been compared to TNM 
classification without the exclusion of early colonic cancers and without the heavy 
weighting of advanced cancers in the series, both of which would account for higher 
accuracy rates in T staging of colonic cancers. Therefore, it may be interpreted that 
these provide more realistic accuracy rates for T staging of colonic cancers alone.  
 
Recently, it has been argued that T staging of colonic cancers stage may not be 
important and we should be concentrating our efforts on the identification of colonic 
cancers that have poor prognosis which may in the future be amenable to neo-adjuvant 
chemotherapy (Smith 2007, Burton 2008, Dighe 2008). Smith and colleagues reviewed 
126 patients with colonic cancer using conventional CT and divided patients into good 
and bad prognosis groups depending on their T stage. A favourable prognostic group 
included patients with T1, T2 and early T3 tumours with predicted extramural invasion 
of up to 5mm beyond the border of muscularis propria. The poor prognostic groups 
contained advanced T3 tumours with invasion more than 5mm beyond the border of 
muscularis propria and T4 tumours. The authors showed that 3 year disease free 
survival was 71% and 43% for CT-predicted good and poor groups respectively, which 
was similar to the 75% and 43% for histology- predicted good and poor groups. 
Although their overall T stage accuracy was only 60%, they showed high sensitivity 
(86-92%) for the identification of T3 and T4 tumours. Burton et al (2008) also showed 
high accuracies (82% for Radiologist 1, 70% for Radiologist 2) of conventional CT to 
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predict tumour invasion beyond muscularis propria when compared with histology. 
Although overall T staging accuracies were low for the 2 radiologists in this series 
(36% and 51.5%), however this was not as important as the prediction of poor 
prognostic features known to reduce disease free survival and overall survival in 
colonic cancers. 
 
Nodal stage  
The sensitivities of lymph node prediction by CT vary tremendously in the literature 
ranging from 22% to 90% (Thompson 1986, Freeny 1986, Balthazar 1988, Keeney 
1989, Acunas 1990, Gazelle 1995, Zerhouni 1996, Dux 1996, Hundt 1999, Filippone 
2004, Kanamoto 2007). Conventionally, size has been used as a criteria for detecting 
metastatic lymph nodes. The earlier studies by Thompson (1986) and Freeny (1986) 
used size greater than 1.5cm as abnormal and showed poor sensitivities for lymph node 
metastases of 22% and 25.9% respectively. Later, size greater than 1cm was deemed 
abnormal and Zerhouni and colleagues (1996) showed a sensitivity of 56% in 237 
patients with colonic cancer, being the largest colonic cancer staging series to date. In 
addition to size, abnormality was also detected if a cluster of nodes were seen on CT 
imaging. The difficulty with using size as the main criteria is that small nodes may 
harbour metastases and on the other hand, very large nodes may just as well be 
reactive in nature (Smith 2007). 
 
Lymph node sensitivities obtained using multi-dectector CT with contrast enhanced 
multiplanar reconstruction has been more promising. Filippone at al. showed 
sensitivity of detection of lymph node metastases of 90% in 41 patients. The authors 
compared CT findings to TNM classification and diagnosed N1 if a cluster of 3 nodes 
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were present or if fewer than 3 nodes were present with one being greater than 1cm; 
N2 if more than 3 nodes were identified; and N3 if enlarged retroperitoneal nodes were 
present and greater than 1cm. Similarly, Kanamoto (2007) showed sensitivities of 
86.9% in 51 patients by evaluating lymph nodes in both the long axis and the short 
axis diameter and stating that a ratio of 0.8 or greater (short/long axis diameter) was 
abnormal.  Although, both studies show promising results with regard to lymph node 
staging, both studies combine both colon and rectal cancers with total numbers of 
colon cancers from both studies totalling only 53 cases (Filippone 2004, n=15; 
Kanamoto 2007, n=38). 
 
The low sensitivities seen in the published literature (Table 2) with respect to lymph 
node staging is likely to reflect an inherent inability of CT to detect microscopic 
involvement as all published series use size as the main criterion and it remains 
difficult to stray away from this practice. Hundt and colleagues (1999) showed this as 
11 out their 34 cases underestimated the N stage due to microscopic involvement of 
the lymph nodes without enlargement, giving a CT sensitivity of 67.6%. 
 
Summary 
The published literature to date is limited with respect to local staging of colonic 
cancers. Accuracies of T staging in recent series with multidetector CT and contrast 
enhanced multiplanar reconstruction look promising but future studies focusing purely 
on colon cancer are needed. With respect to lymph node staging, CT offers poorer 
sensitivities and specificities when compared to T staging and is not the investigation 




1.2.3.5  Colonoscopic ultrasound 
 
High frequency mini probes have been referred to as catheter probes, high frequency 
ultrasound (HFUS) and endoscopic ultrasound probes in the literature (Schembre 
2005). Whatever their terminology, ultrasound in the colon using probes inserted 
through the working channel of the standard colonoscope have been shown to have 
clear advantages over standard endoscopic ultrasound. The probes are easier to use, 
they may be passed through tight strictures, examine proximal lesions as far as the 
standard colonoscope can reach during the index colonoscopy and give higher 
resolution images of the colonic wall (Maruta 1994). This latter fact has led to interest 
in using HFUS as an adjunct to endoscopic mucosal resection initially in the upper 
gastrointestinal tract (Takemoto 1992) and more recently in the colon (Hurlstone 2005, 
2007). 
 
High frequency ultrasound miniprobes are available in a variety of frequencies (12.5 
MHz, 20 MHz, 30 MHz, Olympus, Keymed, Southend-on-sea). The colonic wall 
visualised with a 12.5 MHz probe has been discussed (Fig 1.7). The wall is seen as a 
five layered structure alternating between hyperechoic and hypoechoic signals. The 
first hyperechoic layer is the interface between the water and mucosa. The second 
hypoechoic layer corresponds to the mucosa. The third hyperechoic is the submucosa, 
followed by a fourth hypoechoic muscularis propria and the outer hyperechoic serosa. 
Increasing the frequency to 20MHz scanning offers greater resolution of the colonic 
wall depicting the muscularis mucosae between the mucosa and the submucosa, and at 




Evidence from the literature regarding endoscopic ultrasound and staging of colonic 
cancer is limited. A systematic review was undertaken in order identify all published 
studies and identified 24 such publications with a total of 1627 patients (Table 1.13). 
Twelve of the studies combined data for both colon and rectal tumours (Shimuzu 1990, 
Cho 1993, Yoshida 1995, Hamada 1998, Tsuruta 1998, Tseng 1999, Norton 1999, 
Harada 2001, Tseng 2002, Hurlstone 2005, Hurlstone 2007). In addition, 7 studies did 
not use miniprobe ultrasound to stage colonic cancers and were limited to examine the 
recto-sigmoid, sigmoid or distal descending colon with a flexible echoendoscope 
(Shimuzu 1990, Tio 1991, Cho 1993, Kuntz 1997, Tseng 1999, Bhutani 2001, Konishi 
2003). Therefore, local staging of colonic cancer or determining depth of invasion 
using endoscopic ultrasound has been undertaken in only 1406 patients, 991 of whom 
have had assessment with mini probes alone. Nonetheless, the data clearly 
demonstrates that T staging of colonic cancer by endoscopic ultrasound is promising 
across a range a frequencies from 7.5 MHz to 20 MHz, with accuracies ranging from 
76-96%. Nodal staging on the other hand is more variable with accuracies ranging 







































†Accuracy for villous, non villous tumours 
Values in () indicate numbers with colon cancer only; * Values shown for Combined colon and rectal cancers; - missing values not quoted in paper 
Acc= Accuracy; Sen= Sensitivity; Spec= Specificity 




n Freq / Hz 
T stage (%) N stage (%) Miniprobe Acoustic 
coupling 
 
 Acc Sen Spec Acc Sen Spec   
            
Shimizu 1990 90* 7.5 84.9* - - 38.1 - - Y Balloon  
Tio 1991 30 7.5 93 - - 67 91 53 y Water  
Cho 1993 164* 7.5 83* - - - 68 70 N Balloon  
Yoshida 1995 51* 15 76* - - - - - Y Water  
Saitoh 1996 49 20 88 - - - - - Y Water  
Kuntz 1997 31 12 85 - - 90 - - N Balloon  
Hamada 1998 33* 15 82* - - 87 63 95 Y -  
Tsuruta 1998 45* 20 88.9* - - - - - Y Water  
Tseng 1999 73 (13)* 12 89* - - 77 77 76 N Balloon  
Norton 1999 121 (36)* 7.5,12 92* - - 65 83 53 Y -  
Hunerbein 2000 49 12.5 92 - - 85 - - Y Water  
Akahoshi 2001 83 12 89 - - 67 70 64 Y Water  
Bhutani 2001 26 7.5,12 85 - - 80 - - N Water/Balloon  
Harada 2001 35 (22)* 15 85.7* - - - - - Y Water  
Matsumoto 2002 50 12,20 91.8 89.9 90.3 24.1 50 19.2 Y Water  
Tseng 2002 86 (29)* 12 85* - - 73 74 71 Y Water/Balloon  
Zhou 2003 96* 12,20 82.7* - - - 55.4 68.8 Y Water  
Stergiou 2003 54 12 94 - - 84 56 90 Y Water  
Konishi 2003 65 7.5 80,96† - - - - - N Water  
Hunerbein 2004 88 12.5 87 - - 83 61 94 Y Water  
Hurlstone 2005 130 (102)* 12.5 96* - - 87 95 71 Y Water  
Hurlstone 2004 82 20 100% accuracy for detection of sm3 or above Y Water/Balloon  
Hurlstone 2005 (Gut) 62 (60) 12.5,20 sm1-100%; sm2-92%; sm3-93% Y Water/Balloon  
Hurlstone 2007 68 (62)* 12,20 sm1-100%; sm2-92%; sm3-92% Y Water/Balloon  
       





Depth of invasion of early colorectal cancers is important to determine accurately prior 
to embarking on treatment. Early colonic cancers include those that are confined to the 
mucosa and submucosa and are thereby classified as T1 on the TNM classification 
(Greene 2002). Intramucosal cancers have been reported not to harbour lymph node 
metastases and are therefore easily amenable to endoscopic mucosal resection (EMR) 
(Morson 1984, Fujimori 2001). On the other hand, cancers invading the submucosa are 
associated with lymph node metastases depending on the level of invasion. 
Nascimbeni and colleagues (2002) showed that the risk of lymph node metastases in 
cancers invading the upper third (sm1), middle third (sm2) and lower third (sm3) were 
2%, 9% and 35% respectively. Other series have shown that 6-12% of submucosal 
cancers have lymph node metastases (Cooper 1983, Kyzer 1992, Minamoto 1993). In 
any case, the prognosis of patients with colorectal cancer is dependent on the early 
detection of disease with 95% 5 year survivals achieved in T1 lesions and less than 
50% observed in patients with T3 and T4 disease (Berrino 2007). In addition, there is 
good data from both Japan and the United Kingdom regarding endoscopic mucosal 
resection and endoscopic submucosal dissection in the management of T1 tumours 
(Kudo 2000, Hurlstone 2004), re-iterating the importance of accurate local staging of 
colonic cancer. 
 
Hurlstone and colleagues (2004, 2005, 2007) have consistently shown high accuracy in 
determining depth of invasion of colonic polyps prior to endoscopic resection using 
12.5 and 20 MHz miniprobe ultrasound. In 2004, 82 lateral spreading tumours were 
subjected to HFUS and magnification chromoscopic colonoscopy, and all 15 of the 
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tumours invading the muscularis propria (T2 tumour) were accurately identified with 
20MHz ultrasound and therefore not subjected to endoscopic mucosal resection. In 
2005, the same Sheffield group showed 93% overall accuracy in determining depth of 
invasion in 62 patients with flat colorectal cancerous polyps using 20 MHz ultrasound. 
Furthermore, the accuracy for sm1, sm2 and sm3 lesions were 100%, 92% and 93% 
respectively. Similar accuracies were demonstrated in 2007 by the same group 
consistently showing the use of HFUS as an aide during endoscopic mucosal or 
submucosal dissection. High accuracies for depth of invasion for colonic polyps have 
also been shown using 7.5MHz probes by Konishi and colleagues (2003). They 
showed accuracies of 80% (12/15) in patients with colonic villous lesions and 96% in 
non-villous lesions (48/50). 
 
Local T staging of colonic cancers using 12 or 12.5 MHz mini probe ultrasound prior 
to surgery rather than endoscopic resection has also been undertaken (Hunerbein 2000, 
Akahoshi 2001, Matsumoto 2002, Stergiou 2003, Hurlstone 2005). Accuracies of T 
staging varied from 89-96% indicating that depth of invasion can be accurately 
determined. However, most of the patients in these series had an abundance of T1 and 
T3 lesions with small numbers of T2 and T4 tumours which may account for the 
variation in staging accuracies. Tseng and colleagues (2002) used 12 MHz minprobe in 
86 patients with colorectal cancer. They showed accuracies for T1, T2, T3 and T4 of 
100%, 78%, 93%, 71%. However, only 29 patients had colon cancer and the data 
reported are that for combined accuracies of colon and rectal cancers. Other groups 
have also shown varying accuracies for different stages of colonic cancers with a trend 
of lower accuracies for T2 tumours. Akahoshi et al (2001) showed T staging 
accuracies of 88% for T1 tumours, 64% for T2, 95% for T3 and 100% for T4 and an 
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overall accuracy of 89% for all T stages. However, their patient cohort had only one 
T4 and 11 T2 tumours.   Hunerbein and colleagues (2000) stated that they had 
difficulty in distinguishing T3 and T4 colonic cancers and therefore combined these in 
their analyses showing T staging accuracies of 91.7% (22/24 tumours). They stated 
that it was difficult to distinguish penetration into the free peritoneal cavity (T4) from 
penetration in the mesocolon (T3), as both are associated with complete disruption of 
the wall layers with irregular outer borders.  
 
Flexible echoendoscopes rather than miniprobes have been used with similar 
accuracies to miniprobes. Norton et al (1999), Bhutani et al (2001) and Tio et al (1991) 
showed T staging accuracies of 92%, 85% and 93% respectively. These authors used 
7.5 MHz scopes with water filled balloon plus water infiltration of the colon for 
acoustic coupling with success. The main reasons why they have fallen out of fashion 
is that there is a high cost of equipment requiring the use of 2 endoscopes, one for 
endoscopy and one for ultrasound. In addition, there is difficulty in manoeuvring 
around tight bends and stenotic tumours increasing the potential risk of perforation.  
 
N staging 
There has been ongoing discussion for ultrasound staging of lymph nodes in the 
gastrointestinal tract as to whether it is possible to detect benign from malignant nodes 
ever since computer analysis of echo patterns in lymph nodes have shown no 
difference between benign and malignant nodes (Heintz 1993). However, in the colon, 
11 studies have reported on nodal status accuracy ranging from 24.1% to 90% and 
sensitivities from 50% to 95% (Hamada 1998, Norton 1999, Hunerbein 2000, 
Akahoshi 2000, Matsumoto 2002, Tseng 2002, Stergiou 2003, Hunerbein 2004, 
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Hurlstone 2004, 2005 and 2007). The wide variation and some low accuracy in the 
literature may be explained by the fact that some lymph nodes may be too small to be 
visible and others may contain micrometastases within inflamed nodes, or some nodes 
may be out of reach of the miniprobe’s range (Hildebrandt 1994). Although there are 
certain characteristics such as size and hypoechoiecity with well-defined borders 
suggest malignancy, inflammatory nodes can have a similar appearance (Grimm 
1992). Despite this, some groups have shown high sensitivities of nodal staging. 
Hurlstone and colleagues (2005) demonstrated 87% accuracy and 95% sensitivity in 
130 patients with colorectal cancer (102 of who had colon cancer) using 12.5 MHz 
miniprobe ultrasound. On the other hand, Matsumoto (2002) showed overall nodal 
staging accuracy of only 24.1% in 50 patients with colonic cancer undergoing 12 and 
20 MHz ultrasound.  
 
Summary 
Colonoscopic miniprobe ultrasound has been shown to be a useful adjunct to 
endoscopic mucosal resection providing high accuracies in assessing depth of invasion 
of colon tumours. There seems to be good data supporting its use in early colonic 
cancer to assess mucosal and submucosal invasion, with small sample sizes denying us 
from drawing conclusions in advanced cancers. Nodal staging with mini probe 
ultrasound is variable and further research needs to be undertaken regarding this. There 
have no prospective comparative studies of CT staging and miniprobe ultrasound 
staging of colonic cancer to date. 
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1.2.4 Malignant polyps 
 
1.2.4.1  Overview 
Adenomatous polyps are benign neoplastic epithelium with a potential for 
transformation to malignancy. Adenomas may be classified into tubular (87%), 
tubulovillous (8%) and villous (5%) according to the World Health Organisation 
(WHO) (Castells et al. 2009). Only 5% of adenomas have the potential of malignancy 
with increasing probability with size greater than 1cm, villous component and in 
elderly patients (Liu et al 2005).  
 
The numbers of patients with polyps harbouring malignancy is increasing with the 
introduction of screening programmes for colorectal cancer. The prevalence of 
colonoscopically removed polyps with malignancy ranges between 0.2% and 11% 
(Netzer 1998; Volk 1999; Nusko 1997; Soetikno 2008). Often in clinical practice, the 
presence of a malignant polyp is an incidental and unexpected finding upon review of 
the histopathology after polypectomy. This may leave both the patient and the clinician 
is a therapeutic dilemma whether endoscopic treatment is sufficient or whether the 
patient needs to proceed to radical surgery. Although endoscopic removal is effective 
in removing polyps even down to the submucosal layer, it carries a risk of residual 
disease and does not provide assessment of the local lymph nodes. On the other hand, 
surgery allows both accurate staging and treatment of local and nodal disease, there is 
a certain morbidity and mortality associated with it especially in patients that are 
elderly or those who have initial rectal disease. Therefore, patients risk the presence of 
residual disease after polypectomy or may undergo unnecessary surgery after previous 
successful polypectomy. In order to reduce such risks for patients and inform them 
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appropriately, many endoscopic and histological variables have been evaluated to aid 
in the decision making process. However, official guidelines are still controversial and 
often cloud the decision making process (Eisen et al 2000). 
 
1.2.4.2  Histological risk factors of malignant polyps 
There have been large discrepancies in the terminology used for the diagnosis and 
evaluation of malignant polyps especially between Japanese and Western pathologists. 
For this reason, the Vienna Classification was adopted in 1998 offering a common 
worldwide terminology for gastrointestinal epithelial neoplasia (Table 1.14) 
(Schlemper et al. 2000). 
 
Table 1.14: Vienna classification of gastrointestinal epithelial neoplasia 
 
Category Description 
1 Negative for neoplasia/dysplasia 
2 Indefinite for neoplasia/dysplasia 
3 Non-invasive low grade neoplasia 
 (low grade adenoma/dysplasia) 
4 Non-invasive high grade  neoplasia 
 4.1 High grade adenoma/dysplasia 
4.2 Non-invasive carcinoma (carcinoma in situ)* 
4.3 Suspicion of invasive carcinoma 
5 Invasive neoplasia 
5.1 Intramucosal carcinoma† 
5.2 Submucosal carcinoma or beyond 
*Non-invasive indicates absence of evident invasion 




There are several factors that have been associated with a higher risk of residual 
disease after polypectomy of malignant polyps or indeed the development of recurrent 
carcinoma. These include morphology and size of polyp, type of endoscopic resection 
and margins obtained, stage of differentiation, level of invasion into the polyp, and 
lymphatic and vascular invasion. Hassan and colleagues (2005) examined 31 studies in 
the literature with 1900 patients with malignant polyps in order to identify the main 
histological risk factors and the occurrence of unfavourable outcomes. They concluded 
that a positive resection margin is predictive of local disease; the presence of poor 
differentiation associated with a higher cancer related mortality; and the vascular 
invasion associated with a higher rate of lymph node metastases. 
 
Polyp morphology 
Assessment of the polyp prior to the initial resection can alert the endoscopist as to the 
malignant potential. Sessile polyps have been reported to have a worse clinical 
outcome when compared to pedunculated lesions with more frequent local disease 
(9.9% versus 1.4%; Hassan 2005). Other features include size greater than 1 cm, 
presence of depression or ulceration, irregularity and deformity, a short immobile stalk 
and the inability to elevate a sessile polyp after submucosal injection. Kudo et al. 
(1996) described the pit pattern classification for colonic polyps after 
chromoendoscopy with indigo carmine and magnification colonoscopy (Table 1.15). 
They clearly demonstrated that the presence of Type 5 pit pattern correlates well with 














I Normal roundish pits (normal mucosa) 




Tubular or roundish pits smaller than normal  
(depressed type tumours) 
Tubular or roundish pits larger than normal 
(protruded type adenoma) 
IV Sulcus, branch or gyrus-like pits 
(villous adenoma) 
V Irregular or nonstructured pattern 
(submucosal or advanced cancers) 
 
 
Resection type and margin 
Endoscopic resection of polyps may be done piecemeal using a snare or en-bloc for 
smaller polyps or using techniques of endoscopic submucosal dissection (ESD). En 
bloc removal has been shown to be associated with lower recurrence rates than 
piecemeal resection. It also enables full histological evaluation of the specimen to 
evaluate the margins (Church 2003). A recent meta-analysis showed that ESD en bloc 
resection could be performed in 85% of lesions with clear vertical and lateral margins 




The resection margin needs histological evaluation if this is involved or less than 1mm, 
relapse rates can be as high as 21-33% (Cooper et al. 1995). Resection margins greater 
than 2 mm is considered safe as the risk of residual disease or recurrent cancer is 
extremely low (0-2%) (Netzer 1998; Volk 1995; Cooper 1995; Cunningham 1994). 
 
Stage of Differentiation 
Prognosis correlates with histological grade with Grade 3 or poorly differentiated 
carcinomas in polyps having a substantially higher risk of metastatic disease and 
cancer-related mortality (Hassan et al 2005). Grade 3 differentiation is seen in 5.7% to 
9.2% of patients with polyps and the risk of residual disease or relapse is between 36-
38% (Cooper 1995). 
 
Level of invasion into polyp 
Haggitt and colleagues (1985) suggested that the level of invasion of adenocarcinoma 
in a polyp is an independent risk factor of an adverse outcome. The authors assigned 
anatomical levels to each malignant polyp. Level 1 described adenocarcinoma limited 
to the head of the polyp; Level 2 involving the neck; level 3 the stalk; and level 4 
corresponding to the cells infiltrating the submucosa. These levels are more easily 
applied to pedunculated polyps and by definition invasive carcinoma in a sessile polyp 
indicated level 4 invasion.  
 
The degree of submucosal invasion can also be classified with sm1, sm2 and sm3 
corresponding to the upper, middle and lower thirds of the submucosa respectively. 
Histologically, sm1 corresponds to depth of invasion being less than 1mm or 1000µm 
from the muscularis mucosae (Paris classification 2002; Kikuchi et al 1995). The risk 
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of lymph node metastases increases substantially from 1-3%, 8% to 23% as you 
progress from sm1 to sm2 to sm3 respectively (Tytherleigh et al 2002). The Japanese 
have studied submucosal invasive in considerable detail and Kitajima and colleagues 
(2004) clarified the relationship between submucosal depth and the rate of lymph node 
metastases. Interestingly, they showed that in pedunculated polyps with submucosal 
invasion, the rate of lymph node metastases was 0% if the head was involved and also 
0% when the stalk was invaded less than 3mm or 3000µm. For these pedunculated 
polyps, Haggitt level 2 was used as the baseline for making measurements. 
Additionally, for non pedunculated polyps, the rate of lymph node metastases was also 
0% if the submucosal invasion was less than 1mm or 1000µm. 
 
Lymphatic invasion 
Lymphatic channels are usually present within the superficial submucosa and the 
muscularis mucosae with rare extensions into the lamina propria or mucosa. This near 
absence of lymphatics within the mucosa suggests that patients with intramucosal 
carcinoma do not have the potential for lymph node metastases. However, this view 
has been challenged with some studies have shown that there is proliferation of 
lymphatics in the stalk and mucosa of adenomas and early invasive cancers (Fogt et al 
2004; Walgenbach et al 2006). These authors used the antibody D2-40 which stains 
lymphatic endothelium to demonstrate this. Interestingly, there are no recognised 
guidelines for establishing the presence of lymphatic invasion with considerable inter 
and intra observer variability in the interpretation of samples. This often leads to 
diagnostic difficulties and most pathologists end up using a more cautious approach 




1.2.4.3  Imaging modalities 
We have seen that unfavourable histology is when the resection margin is less than 
2mm; there is piecemeal resection, in poorly differentiated carcinomas with lymphatic 
and vascular invasion. These histological parameters are often discussed after 
polypectomy with an incidental finding of carcinoma within the polyp, in order to 
provide the patient with an informed view prior to deciding whether to continue 
endoscopic surveillance or embark on surgical resection. For endoscopic surveillance 
in favourable circumstances, follow up colonoscopy is often carried out at 3 months 
after polypectomy and also at 1 year, 3 and 5 years (Alabi et al 2009).  
 
Endoscopic ultrasound is widely used to stage rectal tumours pre-operatively to aid 
decision making regarding local resection or radical surgery. There is limited data in 
the literature with only 2 studies investigating the use of this imaging modality to 
detect residual disease and local lymphadenopathy after polypectomy with an 
incidental finding of adenocarcinoma. Both of these studies examine rectal polyps with 
no data on endoscopic ultrasound in the colon (Kruskal 1999; Garcia-Aguilar 2005). 
 
 Kruskal and colleagues (1999) performed endorectal ultrasound in 18 patients whom 
had undergone polypectomy and found to have an incidental carcinoma, prior to 
surgical resection. They found that ultrasound was able to detect residual tumour after 
polypectomy with a sensitivity of 100%, specificity of 44%, positive predictive value 
of 64% and negative predictive value of 100%. However, in this small series, the 
precise T stage of the tumour was correctly predicted in only 44% of cases. In their 
series, they overstaged 7 cases and five of these did not show evidence of residual 
tumour after surgical resection. In each case, the ultrasonographic abnormality was 
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hypoechoeic and the authors were not confident in distinguishing this from residual 
tumour with their 7-10 MHz mechanical endoprobe. 
 
Garcia-Aguilar and colleagues (2005) also used utilised endorectal ultrasound (ERUS) 
in the management of patients with malignant rectal polyps. They followed 63 patients 
whom had undergone endoscopic polypectomy for malignant polyps with ERUS, 
either 7 or 10 MHz probe. The ERUS images at the polypectomy site were defined as 
normal when the 5 layer pattern was preserved, as cautery artefact when the layers 
were expanded but echoeic characteristics of the different layers were preserved. Any 
hypoechoiec image at the polypectomy site was defined as residual tumour. In their 
series, the accuracy of assessing the presence of residual tumour was 90 per cent. 
However, the negative predictive value was only 86 per cent indicating that a normal 









1.3 Diverticular disease 
 
1.3.1  Pathophysiology 
 
Diverticula were first reported in the early 18
th
 century by Littre and were originally 
thought not to cause any clinical symptoms, but were rather viewed as pathological 
curiosities (Finney et al. 1928). It wasn’t until 1849, when Cruvehiler described small 
herniations of the mucosa through the muscle layer of the sigmoid colon (Cruvehiler 
1849). Diverticular disease relates to the presence of diverticula in the colon and this 
may affect over half of the population in the United Kingdom over the age of 65. There 
has been an increased prevalence of diverticular disease, particularly in industrialised 
nations since the 20
th
 century. Although it is rare under the age of 30, more than 40% 
of individuals develop diverticulosis by the age of 60 and over 60% by the age of 80 
years or older (Almy et al. 1980; Jacobs et al. 2007). Diverticula tend to involve the 
sigmoid and left colon in more than 95% of cases in Western society with increasing 
right sided diverticula in elderly and Asian populations (Hughes 1969; Sugihara et al. 
1984). 
 
Colonic diverticula are pulsion or false diverticula containing only mucosa and 
muscularis mucosa and not all layers of the bowel wall. They appear macroscopically 
as saccular outpouchings acquired as a result of persistently raised intra-luminal 
pressures with penetration of the diverticula through areas of weakness of the circular 
muscular layer. This tends to be the point where the vasa recta penetrate the circular 
muscle layer with herniation’s therefore occurring at well-defined points around the 
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circumference of the colon along either side of the mesenteric taenia and on the 
mesenteric border of the 2 antimesenteric taenia (Slack 1962).  
 
The pathophysiology of the development of diverticular disease has resulted from a 
combination of disordered motility and generation of high intracolonic pressures (a 
process termed segmentation); role of dietary fibre and structural abnormalities of the 
colonic wall termed “elastosis”. Segmentation refers to the process of high intracolonic 
pressures being generated within individual colonic segments especially within the 
sigmoid colon which then probably leads to mucosal herniation and the development 
of diverticulosis (Painter et al. 1965). The early studies of diverticular disease 
compared populations of Africa and the United Kingdom and concluded that the 
higher incidence of diverticular disease in the UK was due to the lower quantities of 
fibre consumed. Indeed, Painter and Burkitt studied colonic transit times and stool 
weights in more than 1000 patients and discovered longer transit times and lower stool 
weights in the UK population as compared to their African counterparts (Painter and 
Burkitt 1971).  
 
Alternative theories to the low fibre hypothesis are related to colonic wall 
abnormalities. Early post mortem studies revealed an increased thickness of bowel 
wall in patients with diverticular disease (Slack 1962). This was initially thought to be 
due to muscle hypertrophy and hyperplasia but this was discounted by Whiteway and 
colleagues (1985) who proposed that the thickening was actually due to the elastin 
deposition within the taenia. The authors examined the muscularis propria in patients 
with diverticular disease and discovered that the taenia were thickened with greater 
than 200% increase of elastin in these patients as compared to controls. Furthermore, 
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the elastin deposition in a contracted form leading to bunching of the taenia and 
therefore shortening of the bowel. Therefore, in diverticular disease, the circular 
muscle which controls peristalsis becomes thicker and the longitudinal muscle 
condensing in taenia coli is shorter pulling the colon to a relatively short length. 
Interestingly, Wess and colleagues (1995) added that patients with diverticular disease 
have an abnormally high degree of collagen cross-linkage in the colonic wall which 
causes the tissues to become stiffer and less resistant to stretching. This subsequent 
loss of compliance of the colonic submucosa makes it more susceptible to tears when 
subject to segmentation and could therefore potentially lead to segmentation. 
 
The descriptions above show that the diverticula are the result of the secondary effect 
of the primary muscle abnormality, and therefore it seems likely that patients show a 
pre-diverticular phase of the disease. However, the majority of these patients are 
asymptomatic and therefore do not come to the attention of clinicians (Ming et al. 
1998; Silen 1995). Pathologists regularly recognise this muscular thickening on 
resected colonic specimens for other pathologies without the presence of diverticula 
(Ming 1998). Radiological studies have also shown that such pre-diverticular disease is 
the precursor of classic diverticular disease with formation of diverticula after several 
years (Feischner et al 1964).  
 
1.3.2  Imaging modalities 
 
Incidental asymptomatic diverticulosis is commonly seen on radiological imaging 
studies. However, diagnostic imaging specifically performed for diverticular disease is 
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essentially limited to imaging of suspected acute diverticulitis and complicated 
diverticular disease.  
 
With regard to diverticultis, plain film radiography is of little value and classical 
contrast enemas have been superseded by Computed Tomography with sensitivity 
rates of 80-92% and 99% respectively (Baker et al. 2008; Balthazar et al. 1990). 
Transabdominal ultrasound has also been shown to have sensitivities ranging from 77-
98% for diagnosis of diverticulitis, but is operator dependent and is not as accurate as 
CT for identifying alternative diagnoses (Lameris et al. 2008; Pradel et al. 1997; 
Schwerk et al. 1992). Magnetic resonance imaging (MRI) is comparable to CT in 
diagnosis and offers the advantage of no radiation exposure, but is seriously limited by 
the inability to drain intra-abdominal abscesses (Heverhagen et al. 2008; Ajaj et al. 
2005). 
 
Endoscopic assessment of diverticular disease is simply for assessment of the entire 
colon to exclude other diagnoses and confirm the diagnosis including absence or 
presence of colitis. There is no grading system in place for severity of disease and 
endoscopic assessment is purely of the mucosa rather than evaluation of the underlying 
layers of the bowel wall. Colonoscopic ultrasound using high frequency mini probes 
have been described earlier in the assessment of colorectal cancers and polyps. 
However, there is no data in the literature regarding assessment of the colonic wall in 
diverticular disease. In fact, there is limited data on mini probe ultrasound utilisation in 
benign disease. The normal colorectal wall can clearly be visualised as stated in 
previous chapters. This is as a five layered structure: the first corresponding to the echo 
of the overlying mucosa; second corresponds to the mucosa; third layer to the 
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submucosa; the fourth to the muscularis propria; and the fifth layer to the border echo 
of the serosa. Tsuga and colleagues (1998) used mini probe ultrasound to measure the 
colorectal wall thickness in ulcerative colitis and compared thickness with normal 
controls. They concluded that transmural assessment of the colorectal wall used in 
conjunction with clinical and endoscopic parameters may contribute to the diagnosis 
and treatment of ulcerative colitis. 
 
The utilisation of high frequency mini probe ultrasound for assessment of diverticular 
colonic wall thickness may provide additional diagnostic information in symptomatic 
diverticular disease which may prove useful especially in patients in the pre-



















2.1.1 Colonic cancer 
 
Colorectal cancer is the third commonest cancer worldwide after lung and breast 
cancer with over two thirds of cancers occurring in developed nations. In excess of one 
million new cases of colorectal cancer are diagnosed worldwide annually with almost 
40,000 new cases diagnosed in the UK (approximately two thirds in the colon and one 
third in rectum) (Cancer Research UK). 
 
The high incidence and substantial mortality of colorectal cancer have led to major 
developments in early detection and its treatment. With increased patient and clinician 
awareness of the diagnosis and a national colorectal cancer screening program in the 
UK, the proportion of patients with early colonic cancer may increase substantially. 
The most important prognostic factor is the stage of disease and it now apparent that 
local staging of the disease may play a major role in determining whether neo-adjuvant 
chemotherapy prior to surgery is indicated. There are a number of ways to stage the 
disease, each of which has their advantages and disadvantages and these have been 
outlined in the introduction. 
 
Local staging of colonic cancer has traditionally been evaluated by Computed 
Tomography (CT) but the information provided with CT has not transformed the 
management of colon cancer except in the case of distant cancer metastases. CT 
imaging has demonstrated a range of accuracies from 43.8% to 96.9%, with 
sensitivities of 55%-77% and specificities of 57%-80.6% for tumour (T) staging. The 
sensitivities of lymph node involvement predicted by CT vary tremendously in the 
literature ranging from 22% to 90% (Acunas 1990; Zerhouni 1996; Chung 2004). The 
main drawback with CT imaging is that it cannot differentiate between the different 





There has been increasing interest to stage colonic cancers using endoscopic 
ultrasound in a similar fashion as staging rectal cancers. However, it has not been 
technically feasible to stage tumours in the proximal colon via this modality due to 
bulky flexible endoscopes with ultrasound attachments. The introduction of mini probe 
ultrasound through the working channel of the colonoscope has made lesions in the 
proximal colon more accessible but evidence of superiority over current staging 
techniques from the literature is limited. 
 
2.1.2 Rectal tumours referred for Transanal Endoscopic Microscopic Surgery 
(TEMS) 
 
TEMS is indicated in certain patients with biopsy proven benign tubulovillous 
adenomas. However, surgical histopathology reveals post excision carcinoma is 21-
34% of such cases (Doornebosch 2008; Galanduick 1987; Taylor 1981). EUS may 
raise suspicion of malignancy in the presence of benign biopsies. There is some 
evidence that previous TEMS procedures may increase the morbidity of subsequent 
radical surgery (Baron 1995, Friel 2002, Hahnloser 2005). Therefore it is vital that 
accurate pre-operative staging is available for all patients undergoing local excision 
with TEMS. 
 
Traditional endorectal ultrasound offers accurate assessment of the depth of invasion in 
early rectal tumours with an overall accuracy of 87% and a sensitivity and specificity 
of 93% and 78%, respectively. This compares with MRI which offers 82%, 86% and 
77% corresponding values (Kwok 2000). Rigid transrectal ultrasound (7.5-12 MHz), 
however, is not feasible in all patients due to tumours being further proximal to the 
dentate line and stenosis. Ultrasound examination with mini probes would overcome 
these problems but there are limited studies address this in the literature. 
 
2.1.3 Malignant colorectal polyps 
 
Patients who have undergone snare polypectomy for malignant polyps are a 
management challenge. The decisions regarding further surgery or endoscopic 
surveillance are a balance between the assessments of risk of residual disease or 
involved local lymph nodes against the morbidity and mortality of surgical resection. 
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Malignant polyps confined to the mucosa are not thought to pose a risk of lymphatic or 
haematogenous spread due to the absence of lymphatics within the mucosal layer 
(Fenoglio 1973). However, increased risk of lymph node metastasis is proportional to 
the depth of invasion into the submucosa (Kikuchi 1995). 
 
Endorectal ultrasound has been utilised for risk assessment post polypectomy of 
malignant rectal polyps in relation to residual disease and local lymphadenopathy 
(Garcia-Aguilar 2005). The assessment of malignant polyps in the proximal colon 
using high frequency mini probes inserted through the working channel of the standard 
colonoscope is now possible (Maruta 1994). 
 
2.1.4 Diverticular disease 
 
Diverticular disease in an increasingly common benign disease of the colon, which 
causes significant morbidity and mortality.  
 
The colon in diverticular disease appears shortened with a thickened muscular wall, 
redundant mucosal folds, and diverticula disposed in two to four parallel longitudinal 
rows between the mesenteric and the antimesenteric teniae. The longitudinal and 
circular muscle in the teniae appears thickened (Whiteway and Morson 1985; M J Ford 
1995). The assessment of colonic wall thickness may be assessed by CT when patients 
are admitted with complications of diverticular disease such as diverticulitis. However, 
assessment of colonic wall thickness in symptomatic diverticular disease patients has 
not been undertaken routinely but has now become feasible with the development of 





2.2 HYPOTHESIS AND AIMS 
The central aim of this thesis was to investigate the feasibility of endoscopic high 
frequency mini probe ultrasound in the assessment of colorectal disease. This role was 
colonoscopic ultrasound was specific to 4 areas examined in this thesis: 
 
1. Investigate the role of colonoscopic high frequency ultrasound in the local 
staging of colonic cancers and compare this prospectively with the local staging 
undertaken by Computed Tomography (CT). 
2. Investigate the role of colonoscopic high frequency ultrasound in the 
assessment of rectal tumours referred for TEMS and in particular assess the 
depth of infiltration of rectal polyps in comparison to Magnetic Resonance 
Imaging. 
3. Investigate the role of colonoscopic high frequency mini probe ultrasound in 
the examination of the colon and rectum after excision of malignant polyps to 
assess for residual disease and local lymphadenopathy 
4. Investigate the feasibility of colonoscopic high frequency ultrasound in the 
assessment of diverticular disease and compare the thickness of colonic wall of 
symptomatic diverticular patients with normal subjects. 
  
 






2.3 EXPERIMENTAL DESIGN 
 
 
Approval was sought from the Kings College Hospital Committee on the Ethics of 
Human Research prior to the recruitment of patients.  Potential subjects were 
approached and written informed consent obtained.   
 
To address the first aim of the thesis, patients scheduled for elective surgery for 
curative resection of colonic cancer were approached and recruited after informed 
consent. All patients underwent CT of the abdomen and pelvis and colonosocopic high 
frequency ultrasound of the colonic tumour. A prospective comparison of the local 
staging of colonic cancer between CT and ultrasound was undertaken, and compared to 
the gold standard of post-operative histology. 
 
The second aim of the thesis was addressed by recruiting patients referred for TEMS. 
All patients underwent MRI of the pelvis for local staging of the tumour and in 
particular for evaluation of the depth of invasion of the rectal polyp. This was 
compared with the colonoscopic ultrasound findings for depth of invasion and 
compared to the gold standard of histopathology. 
 
To address the third aim, patients discovered to have a focus of incidental 
adenocarcinoma after endoscopic resection, were recruited after informed consent. 
These patients were evaluated with colonoscopic high frequency ultrasound to identify 
any residual disease or the presence of local lymphadenopathy, and followed up 
closely for detection of recurrent disease. 
 
Finally, symptomatic diverticular disease patients who were due to have colonoscopy 
were recruited. Colonoscopic high frequency ultrasound was used to measure the 
thickness of colonic wall in the mid sigmoid colon and this compared to thickness of 


















3.1 PROJECT SET-UP 
3.1.1 Ethical Approval 
The first step was to gain approval for the study from the King’s College Hospital 
Committees on the Ethics of Human Research.  This study began in 2008, after the 
introduction of the standardised Centralised Office for Research Ethics Committees 
(COREC) forms, which are now used nationwide for all applications to conduct 
research involving humans.  The relevant local application form was completed, along 
with the submission of a Patient Information Sheet and Patient Consent Form.  This 
application was considered by the King’s College Hospital Committees on the Ethics 
of Human Research and following some minor amendments to the Patient Information 
Sheet, ethical approval was granted. Four separate ethics applications were submitted 
for each of the four sub studies considered in this thesis.  
The summaries of the protocols and patient information leaflets, consent forms and 
letters to General Practitioners are outlined in Appendix 1. A summary of the proposed 
study protocols for each of the studies, along with the patient inclusion and exclusion 





Figure 3.1: Prospective comparison of Colonoscopic high frequency mini probe 
ultrasound and conventional Computed Tomography (CT) in the local staging of 
colonic cancers 
 
Figure 3.2: High frequency mini probe ultrasound in the assessment of rectal 
tumours deemed suitable for Transanal Endoscopic Microsurgery (TEMS) – A 





Figure 3.3: High frequency mini probe ultrasound as a useful adjunct in the 
management of patients with malignant colorectal polyps. 
 
 
Figure 3.4:  Utilisation of high frequency mini-probe ultrasound in the assessment 




3.1.2 Research and Development Approval 
Before patients could start being recruited for the study, approval was sought from the 
local Research and Development Committee at King’s College Hospital NHS Trust.  
This process also entailed ensuring that the study met the demands of the Data 
Protection Act (1998), with respect to the plans made for storing patient information; 
all data was kept on a password-protected computer database, within a double locked 
office.  Furthermore a coding system was employed, making it impossible to link 
experimental results with patient identifiers. 
 
3.1.3 Patient Recruitment 
Potential eligible study subjects were identified with the help of the colorectal cancer 
nurse specialist and the committee members of the Colorectal Multidisciplinary Team 
(MDT), and approached either as an outpatient or whilst an in-patient on the ward, 
prior to surgery.  Following a clear and thorough explanation to both the patient, and 
any relatives present, regarding the nature, aims and demands of the study, an 
information sheet was offered and a short period of time left for deliberation.  If the 
patient was willing to participate in the study, then any final queries were addressed, 
and they were asked to complete and sign a consent form.  There were some special 
circumstances for each of the individual sub studies and these are addressed 
individually 
 
3.1.3.1  Colonic tumours 
Prospective comparison of Colonoscopic high frequency mini probe ultrasound 
and conventional Computed Tomography (CT) in the local staging of colonic 
cancers 
 
The patients diagnosed with colorectal cancer in the hospital are all discussed in the 
Colorectal Multidisciplinary Meeting (MDM) prior to any treatment or management 
decisions. Therefore, recruitment of patients was primarily from the MDM or with 
assistance from the Colorectal Nurse Specialists. Patients with rectal cancer were 
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excluded from the study as were patients not eligible for curative surgical resection. 
This was defined as tumours within 15 cm from the anal verge or below the peritoneal 
reflection on CT and MRI. Therefore, any tumours offered neo-adjuvant radiotherapy 
fitted into this category. Some patients were recruited directly from endoscopy or from 
the outpatient clinic and consented prior to their colonoscopy explaining to patients 
that they would only be recruited into the study if a colonic cancer was discovered. In 
this manner, unnecessary additional colonoscopic examinations were avoided. 
 
3.1.3.2  Rectal tumours 
High frequency mini probe ultrasound in the assessment of rectal tumours 
deemed suitable for Transanal Endoscopic Microsurgery (TEMS)  
 
King’s College Hospital offers a tertiary referral service for TEMS. All patients are 
referred to one Consultant Surgeon and these patients are all discussed in the 
Colorectal MDM. Recruitment was via this meeting and patients were approached in 
the Colorectal Outpatient department or in the Endoscopy Unit prior to their routine 
flexible sigmoidoscopy.  
 
3.1.3.3  Malignant polyps 
High frequency mini probe ultrasound as a useful adjunct in the management of 
patients with malignant colorectal polyps. 
The recruitment was via the Colorectal MDM with assistance from the Colorectal 





3.1.3.4  Diverticular Disease 
Utilisation of high frequency mini-probe ultrasound in the assessment of colonic 
wall thickness in patients with diverticular disease. 
Within the trust, all patients with diverticular disease are referred to a specialist 
outpatient clinic with support from a Specialist Nurse dedicated to this disease. 
Asymptomatic patients who had incidental diverticular disease on routine colonoscopy 
were excluded. Symptomatic patients were approached in the Diverticular Disease 
Clinic. Normal subjects without diverticular disease, on the other hand, were identified 
from the Endoscopy Unit. Only patients with no lower gastrointestinal symptoms were 
included and these were either patients within the colorectal cancer screening program 
or asymptomatic patients with previous colorectal polyps undergoing colonoscopy 




3.2 Endoscopic ultrasound  
3.2.1 Equipment 
The colonoscopic ultrasound scans undertaken within our unit for the purposes of this 
thesis were undertaken by the author using both 12 and 20 MHz catheter mini probes 
(UM-2R and UM-3R Olympus, Japan) inserted through standard colonoscopes used 
for routine endoscopy. The miniprobe connected to a drive unit and processor attached 
to a television monitor to display radial ultrasound images. All of the images were 
captured using plain Sony photographic paper and stored for further analyses if 
necessary. 
Acoustic coupling for ultrasound imaging was achieved by the use of a water jet pump 
delivered through the “ERBE diathermy” machine and water delivered through the 
working channel of the colonoscope upon depression of a foot pedal. In addition, water 




Patients were recruited into the study after informed written consent for research and 
also for colonoscopic examination of their bowel. Patients received sedation and 
analgesia for colonoscopy as per the department protocol which advocates the use of 
2mg midazolam and 25 micrograms of Fentanyl routinely. Patients were placed in the 
left lateral position to start with and moved to supine or right lateral positions if 
necessary during the examination. The colonsocope was inserted in the standard 
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fashion to examine the entire length of colon. Once the pathology was encountered, 
adequate lavage of the area was undertaken to ensure that no faeculent material was 
present as this would obscure and create artefact for ultrasound imaging. Excessive air 
was suctioned from the bowel to prevent air artefact for ultrasound and air insufflation 
was reduced to a minimum or even switched off if views were adequate. Water was 
instilled via the working channel of the colonoscope to completely submerge the area 
in question, tilting the patient or changing their position to allow gravity to aide this 
process. The mini probes were then introduced through the working channel of the 
colonoscope after lubrication with aquagel and the probe advanced until the ultrasound 
probe could be seen to lie adjacent to the pathology. Ultrasound imaging was 
conducted with the probe completely submerged in water and approximately 0.5-1cm 
from the pathology. The whole area was imaged sequentially and representative 
images captured on photographic paper. The colon was then suctioned to drain the 
excess water and air insufflation re-started in order to withdraw the colonoscope safely 
from the bowel. 
 
Ultrasound imaging using 12 MHz mini probe ultrasound produces a 5 layered image 
of the colorectal wall (Figure 3.5). This is seen as a series of concentric rings of 
differing echogeneicity. The first 2 layers are hypoechoic which corresponds to the 
mucosa and muscularis mucosae. The 12 MHz ultrasound does not differentiate 
between these 2 layers as they are both hypoechoeic. The third layer is hyperechoeic 
and is the submucosa. The echoeic layers alternate as you traverse through the gut wall 
thereby demonstrating the fourth layer as hypoechoeic (muscularis propria) and the 




Figure 3.5 The layers of the gut wall on radial 12 MHz endoscopic ultrasound 
 

















The ultrasound examinations were carried out by the author and although other 
medical personnel were present during the examinations, the final image interpretation 
of the pathology in question was conducted by the author himself. Therefore there was 
no inter-observer variability that needed to be taken into account. The author was 
familiar with endorectal ultrasound and had performed over than 100 procedures prior 
to undertaken colonoscopic mini probe examination and therefore it was felt that the 
learning curve for the procedure was short. Initially, there were some technical 
difficulties with achieving acoustic coupling. It was noted that if air insufflation was 
used during colonoscopy then it was imperative to terminate the air insufflation once 
the pathology was encountered, excess air suctioned and then the colon irrigated with 
normal saline (0.9%) completely so that the pathology was submerged with fluid. 
Patients needed to be moved into various positions including left and right lateral, 
supine and prone, head up and head down in order for gravity to assist with the 
pathology being submerged in fluid prior to ultrasound examination. Bowel 
preparation should also be optimal as any faecal residue particles would create an 
artificact for the ultrasound. 
 
The depth of invasion of colorectal tumours were carefully evaluated by the mini probe 
ultrasound by ensuring sequential imaging of the entire surface of the tumour under 
direct endoscopic examination. In this manner, the tumour was identified as 
hypoechoeic in nature traversing through the layers of the colorectum and this was 
assigned a tumour (T) stage.  
 
Examination for local lymphadenopathy was undertaken with the same protocol for 
every case. Sequentially scanning in a radial fashion was undertaken after acoustic 
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coupling was achieved 10cm above and below the tumour in question using both 
frequencies of miniprobes. This identified lymph nodes of any size as well defined 
hypoechoeic oval or round lesions with the 5 cm focal length of the ultrasound probes. 
It was not possible to identify the exact anatomical location of the nodes and these 
were either pericolic or mesenteric nodes.  
 
The thicknesses of the colonic wall measurements were undertaken using the higher 
frequency probe. The mini probes need to be placed perpendicular to the colonic wall 
being evaluated otherwise this would give false readings. This is described in more 




3.3 STATISTICAL ANALYSIS 
 
Statistical analyses were conducted after importing data from Microsoft Excel 2007 
and analysed using Graphpad Prism version 5 and STATA (v9). All results were 
summarised using descriptive statistics. Normally distributed data was presented as 
mean values with s.e.m. (in parenthesis).  
Weighted Kappa coefficients were calculated to assess the accuracy of each imaging 
modality against the pathological assessment (gold standard). Ordinal logistic 
regression models were used to compare the imaging modalities while assessing other 
factors that may have influenced accuracy (i.e. age, gender and location). The 
sensitivity, specificity, positive predictive value, negative predictive value, accuracy 
and kappa coefficients of each imaging modality were also calculated against the 






























Colorectal cancer is the third commonest cancer worldwide after lung and breast 
cancer with over two thirds of cancers occurring in developed nations. In the United 
Kingdom, 100 new cases are diagnosed on average each day, with a third being 
localised to the rectum and two thirds more proximally in the colon. 
Accurate local staging of colonic cancer is increasingly important. Increased awareness 
of the diagnosis and a national colorectal cancer screening program may increase the 
detection rates of early colonic cancer with increased potential for local treatment. The 
possibility of neo-adjuvant chemotherapy prior to surgery is dependent on accurate 
local staging, which historically has been assessed by CT. 
Computed Tomography (CT) is presently the investigation of choice in the evaluation 
of staging of colon cancer. This technique aims to provide assessment of the site and 
size of the tumour, infiltration into surrounding structures and metastatic spread. At 
present, neo-adjuvant therapy is offered to patients with demonstrable metastatic 
disease on the staging CT scan (Cohen 1992; Isbister 1996; Thoeni 1995). Current 
evidence based CT guidelines recommend assessing for local extramural invasion as a 
sign of T3, regional nodes either greater than 1cm or a cluster of 3 or more nodes (each 
less than one centimetre) as a sign of involvement, and distant metastases and / or 
extension of the tumour into adjacent organs as a sign of T4 disease (Balthazar 1988). 
Recently, there has more interest in the evaluation of CT for local staging of colon 
cancer (Burton 2008; Smith 2007) especially in the detection of locally advanced 
tumours as these may be a group amenable for neo-adjuvant chemotherapy and there is 
an on-going national randomized trial on the potential role of neo-adjuvant 
chemotherapy in advanced colonic cancer (www.foxtrot.bham.ac.uk).  
Ultrasound in the colon using high frequency mini probes inserted through the working 
channel of the standard colonoscope is of particular interest because of its ease of use, 
its ability to assess lesions proximal to the rectum (outside the range of conventional 
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endoscopic ultrasound) and with the advent of higher frequency probes, its potentially 
increased sensitivity in predicting mural invasion due to high resolution images 
(Maruta 1994) (Figures 4.1). 
 





To date, there are no studies comparing local staging of colonic cancers by modern CT 
with high frequency mini probe ultrasound. We compared conventional CT and high 






Consecutive patients listed for surgical resection for colon cancer from March 2008 
and November 2009 were entered into the study after informed written consent.  All 
patients underwent diagnostic colonoscopy and biopsy for histological confirmation of 
malignancy. In addition, both 12 and 20 MHz (Olympus Keymed UM-3R, Japan) mini 
probe high frequency ultrasound was performed in a back to back design either during 
the index colonoscopy or on table during general anaesthesia prior to laparoscopic or 
open colonic resection. If colonoscopy was undertaken in the operating theatre, 
insufflation was always using carbon dioxide as this is readily absorbed and would not 
cause untoward colonic distention making laparoscopic surgery hazardous. 
Acoustic coupling was achieved during colonoscopic ultrasonography by suctioning of 
excess air and water instillation in the colon to submerge the tumour completely. The 
patient’s position was changed frequently to allow gravity to aid in submerging the 
tumour completely with water without the presence of large air bubbles. Water was 
instilled either by the use of a syringe through the working channel of the colonoscope 
or the utilisation of water pump with continuous irrigation of fluid through the working 
channel controlled by a foot pedal. The entire tumour was sequentially scanned under 
endoscopic vision and the depth of invasion recorded as the Tumour (T) stage of the 
hyperechoeic lesion traversing the layers of the colonic wall. Local lymphadenopathy 
was noted as well defined hypoechoeic lesions either in the pericolic or mesenteric 
distribution. The colon was submerged with fluid in order allow sequential scanning 
10 cm above and below the tumour.  
Images were captured on Sony photographic paper and also real time ultrasound 
recorded onto super VHS format to enable further review if necessary. Two authors 
were present during ultrasound examination. However, the main author was 
responsible for staging the colonic cancer alone and only he was blind to the results of 
the CT local staging. As 2 authors did not independently stage the cancers, inter-
observer variability was not explored. The time taken to perform the colonoscopic 
ultrasound was recorded both for 12 and 20 MHz examinations. This was defined as 
the time between initial insertion of the mini probe through the working channel and 
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the time of withdrawal from the same channel at the end of the procedure. The main 
author was responsible to collect all the data. 
All patients underwent 64 slice CT of the chest/abdomen and pelvis using intravenous 
and oral contrast with multiplanar reconstruction (MPR) using 2 millimetres slices. No 
bowel preparation was administered pre procedure and the colon was not distended. 
All patients were scanned after a 70 second delay in the portal venous phase. 100mls 
of iohexol was injected at a rate of 2-3ml/sec. Images were evaluated by an 
experienced colorectal radiologist with 13 years of abdominal radiology experience. 
All images were evaluated in axial images alone, and then axial combined with MPR 
reformat. Lesions were classified as T1 or T2, if no tumour was demonstrated to 
breach the muscularis propria; T3, if the tumour demonstrated a nodular pushing edge 
that breached the muscularis propria; and T4, if the tumour was demonstrated to 
directly involve adjacent organs. 
 
Nodal metastases or positivity on CT was defined as either a single node greater than 1 
cm or a cluster of 3 nodes each greater than 3 mm. With respect to high frequency 
ultrasound, size was not a criterion and well defined hypoechoeic nodes were taken as 
positive. 
 
The local staging of colonic cancers by the two imaging modalities were compared to 
the standard histological T (tumour) and N (nodal) stage after colonic resection. 
Histological analysis was conducted in a standardised protocol by a single experienced 
Colorectal Pathologist as per guidelines issued by the Royal College of Pathologists in 
order to collect the minimum dataset.  
 
Statistics 
Weighted Kappa coefficients were calculated to assess the accuracy of each imaging 
modality against the pathological assessment (gold standard). This comparison was 
done using weighted kappa coefficients where weights of 0.7 to 0.8 were given to 
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penalize disagreements of one level in either direction and weights of zero were given 
to penalize disagreements of more than one level in any direction. 
Ordinal logistic regression models were used to compare the three imaging modalities 
while assessing other factors that may have influenced accuracy (i.e. age, gender and 
location). The sensitivity, specificity, positive predictive value, negative predictive 
value of nodal involvement was also calculated. 
 
All data was collected prospectively onto Microsoft Excel and the statistical packages 






38 patients were recruited into the study after informed written consent. Of these, 22 
patients (58%) were female. The mean age was 65 (SD 13.2, range 38-89). Location of 
colonic cancers were sigmoid (n=20), caecum (n=7), descending (n=5), ascending 
colon (n=2), splenic flexure (n=2), transverse colon (n=1) and hepatic flexure (n=1) 
(Table 4.1). All patients underwent surgical resection, 21 undergoing laparoscopic 
surgery and 17 open colorectal resections. 
 
 




 Acoustic coupling was achieved in all 38 patients (100%) using 12 MHz ultrasound 
and in 34/38 patients (89%) using 20 MHz ultrasound. The reasons for the failure 
included artefact secondary to excess air in the colon (n=2) and failure to completely 
submerge in the tumour with water despite position changes of the patients (n=2). 
Mean procedural time for 12 and 20 MHz scanning was 8.5 (SD 3.4, range 5-22) and 
7.7 (SD 2.2, range 5-15) minutes respectively. This was in addition to the time taken 
for routine colonoscopy.  CT was able to visualise the tumour in all cases both in axial 
and reformatted multiplanar images. 
 
Location of  
tumour in colon 
Number 
of cases 
Mean distance from 
anal verge (cm) range in 
parentheses 
Proportion of total 
(%) 
    
Sigmoid 20 18.25 (15-40) 52.6 
Descending 5 51 (45-65) 13.2 
Splenic flexure 2 72.5 (70-75) 5.3 
Transverse colon 1 50 2.6 
Hepatic flexure 1 70 2.6 
Ascending colon 2 77 (74-80) 5.3 
Caecum 7 87 (76-95) 18.4 
    




Histopathological examination of the resection specimen revealed 7 T1, 4 T2, 25 T3 
and 2 T4 cancers. 
 











Overall, imaging agreement with histology was observed in 82% (31/38) and 82% 
(28/34) using ultrasound at 12 MHz or 20 MHz ultrasound respectively, while for CT 
was only observed in 42% (16/38) of the patients. Some of the observed agreement 
may have been due to chance alone. Hence, agreement of measure was evaluated in 
terms of the weighted Kappa coefficients for the 4 level diagnostic tests (Table 4.9). 
These are calculated by first measuring the percentage of agreement between any two 
diagnostic methods and then adjusting these values, discounting the amount of 
agreement that could be expected due to chance alone. The weights take into account 
the ordered nature of the classification and the fact that a misclassification by one level 
is less severe than one by two or more levels. The p-values reported test the null 
hypothesis that the Kappa coefficient is zero.  
 
In relation to the histopathological results (Tables 4.3-4.4 and Figures 4.4, 4.5a & 3b, 
4.6a-4c), CT  
 Incorrectly classified all the 7 T1-tumours, overstaging 6 as T2 and 1 as T3.  
 Correctly classified only one of the 4 T2-tumours, under-staging 1 as T1 and 
over-staging 2 as T3.  
T stage Number 
of cases 
Proportion of total (%) 
   
T1 7 18.4 
T2 4 10.5 
T3 25 65.8 
T4 2 5.3 
   
Total 38 100 
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 Correctly classified 15 of the 25 T3 tumours, under-staging 7 as T2 and over-
staging 1 as T4 and 2 as T1. This yields a sensitivity of 60% and specificity of 
62% for this classification. 
 Incorrectly classified the 2 T4 tumours under-staging them both as T3.  
The weighted Kappa coefficient for CT in relation to the gold standard, 
histopathology, was 0.36 (SE=0.14). 
 
 















Table 4.4: Overall accuracies of CT for individual T stages of colonic cancer 
 
 
95% confidence intervals in (parentheses) 
PPV=positive predictive value 
NPV=negative predictive value 
 
 cT1 cT2 cT3 cT4 Total 
pT1 0 6 1 0 7 
pT2 1 1 2 0 4 
pT3 2 7 15 1 25 
pT4 0 0 2 0 2 
Total 3 14 20 1 38 
 Sensitivity Specificity PPV NPV 
T1 0 (0-0.41) 0.90 (0.74-0.98) 0(0-0.71) 0.80 (0.63-0.92) 
T2 0.25 (0.01-0.81) 0.62(0.44-0.78) 0.07 (0-0.34) 0.88 (0.68-0.97) 
T3 0.60 (0.39-0.79) 0.62 (0.32-0.86) 0.75 (0.51-0.91) 0.44 (0.22-0.69) 















































T1 tumour infiltrating the submucosa but not extending 
to muscularis propria (arrows) 
T2 tumour abutting the muscularis propria (arrows) but 
not extending through this layer 
T3 tumour infiltrating through 




In relation to the histopathological results (Tables 4.5-4.6), 12 MHz ultrasound,  
 correctly classified 5 of the 7 T1-tumours, over-staging two: 1 as T2 and one as 
T3; 
 correctly classified 2 of the 4 T2-tumours; 
 Correctly classified 24 of the 25 T3-tumours, under-staging 1 as T2. This 
offered 96% sensitivity and 69% specificity;  
 incorrectly classified the 2 T4-tumours, under-staging them both as T3. 
 
The weighted Kappa coefficient for ultrasound 12 MHz in relation to the gold standard 




Table 4.5: Agreement between 12 MHz mini probe ultrasound and histopathology for 
T staging of colonic cancers 
 
 
 uT1 uT2 uT3 uT4 Total 
pT1 5 1 1 0 7 
pT2 1 2 1 0 4 
pT3 0 1 24 0 25 
pT4 0 0 2 0 2 








Table 4.6: Overall accuracies of 12 MHz mini probe ultrasound for individual T stages 




 Sensitivity Specificity PPV NPV 
T1 0.71(0.29-0.96) 0.97(0.83-0.99) 0.83(0.36-0.99) 0.94(0.79-0.99) 
T2 0.50(0.07-0.93) 0.94(0.80-0.99) 0.5(0.07-0.93) 0.94(0.80-0.99) 
T3 0.96(0.80-0.99) 0.69(0.39-0.91) 0.86(0.67-0.96) 0.90(0.56-0.99) 
T4 - - - - 
 
95% confidence intervals in (parentheses) 
PPV=positive predictive value 
NPV=negative predictive value 
 
In relation to the histopathological results (Tables 4.7-4.8), 20 MHz ultrasound:  
 correctly classified 4 of the 6 T1-tumours, over-staging two: 1 as T2 and 1 as 
T3; 
 correctly classified 2 of the 4 T2-tumours; 
 correctly classified all of the 22 T3-tumours. This offered 100% sensitivity and 
67% specificity; 
 incorrectly classified the 2 T4-tumours, under-staging them both as T3. 
 
The weighted Kappa coefficient for ultrasound 20 MHz in relation to the gold standard 
was 0.81 (SE=0.17). 
 
 
Table 4.7: Agreement between 20 MHz mini probe ultrasound and histopathology for 
T staging of colonic cancers 
 
 
 uT1 uT2 uT3 uT4 Total 
pT1 4 1 1 0 6 
pT2 1 2 1 0 4 
pT3 0 0 22 0 22 
pT4 0 0 2 0 2 
Total 5 3 26 0 34 
 





Table 4.8: Overall accuracies of 20 MHz mini probe ultrasound for individual T stages 
of colonic cancer 
 
 
 Sensitivity Specificity PPV NPV 
T1 0.67(0.22-0.96) 0.96(0.82-0.99) 0.80(0.28-0.99) 0.93(0.77-0.99) 
T2 0.5(0.07-0.93) 0.96(0.72-0.99) 0.67(0.07-0.93) 0.92(0.72-0.99) 
T3 1.0(0.85-1.0) 0.67(0.35-0.90) 0.85(0.65-0.99) 1.0(0.63-1.0) 
T4 - - - - 
 
95% confidence intervals in (parentheses) 
PPV=positive predictive value 
NPV=negative predictive value 
 
 
On a multivariate ordinal logistic regression, CT and both ultrasounds at 12 and 20 
MHz showed a highly significant association with the pathology classification while 
age (P=0.89), gender (P=0.71) and location (sigmoid versus other P=0.25) were not 
significant either as a main effect or in interaction with any of the diagnostic methods 
(P=0.80). The odds of a higher level in the pathology result were significantly higher 
for higher level classification in the ultrasound 12 MHz and 20 MHz (P=<0.001) 
 15-fold higher for CT=T1-T2 in relation to CT=T3-T4 (P=0.002). 
 81-fold higher for US-12 MHz=T3 in relation to US-12 MHz=T1-T2 
(P=<0.001) 














Z P value 
CT 81.0 71.1 0.36 0.14 2.6 0.01 
12 MHz 94.2 69.6 0.81 0.16 5.1 <0.0001 




Histopathological examination demonstrated 15 out of 38 patients to be node positive 
with respect to metastases (39.5%). CT offered 80% sensitivity and 48% specificity for 
detection of node positive disease with an overall accuracy of 61%. 20 MHz 
ultrasound offered an overall accuracy of 65% with 23% sensitivity and 90% 
specificity.  However, 12 MHz ultrasound was significantly better than both CT and 20 
MHz with 80% sensitivity, 83% specificity and an overall accuracy of 82% (p=<0.001) 
(Tables 4.10-4.13). 
 
Table 4.10: Agreement between CT and histopathology for nodal status in colonic 
cancer 
 
 CT node positive CT node negative Total 
Histology node positive 12 3 15 
Histology node negative 12 11 23 




Table 4.11: Agreement between 12 MHz ultrasound and histopathology for nodal 
status in colonic cancer 
 
 12 MHz node 
positive 
12 MHz node 
negative 
Total 
Histology node positive 12 3 15 
Histology node negative 4 19 23 






Table 4.12: Agreement between 20 MHz ultrasound and histopathology for nodal 
status in colonic cancer 
 
 20 MHz node 
positive 
20 MHz node 
negative 
Total 
Histology node positive 3 10 13 
Histology node negative 2 19 21 






Table 4.13: Overall accuracies of CT, 12 and 20 MHz ultrasound for assessment of 






Sensitivity Specificity PPV NPV Kappa 
(SE) 






































This initial pilot feasibility study demonstrates that high frequency mini probe 
ultrasound out performs CT for local staging of colorectal cancer. CT scan is currently 
used primarily for staging distal metastases of solid organs but its value in local 
staging of colonic tumours is yet unproven. The 12 and 20 MHz mini-probe ultrasound 
did not differ in their overall accuracies of staging both offering 82% accuracy.  The 
paucity of T2 (n=4) and T4 (n=2) tumours may influence these results and further 
patients need to be evaluated in order to draw firm conclusions in the assessment of 
these T stages. The largest group of 25 patients with T3 tumours were accurately 
staged with both 12 and 20 MHz offering sensitivities of 96% and 100% respectively, 
with good agreement showing high kappa values at 0.81 for both frequencies of 
ultrasound. This contrasts with conventional CT which demonstrated significantly less 
sensitivity (60%) and specificity (62%) for this group. 
 
Evidence from the literature regarding endoscopic mini probe ultrasound and staging 
of colonic cancer is limited (Akahoshi 2001; Hunerbein 2000; Hurlstone 2005; 
Matsumoto 2002; Stergiou 2003). Nonetheless, our accuracy for T staging of 82% for 
12 MHz US is similar to that quoted which vary from 89-96% using 12 or 12.5 MHz 
US. Most of the patients in the published series have an abundance of T1 and T3 
lesions with small numbers of T2 and T4 tumours, as was in our material. Tseng and 
colleagues (2002) used 12 MHz miniprobe in 86 patients with colorectal cancer. They 
showed accuracies for T1, T2, T3 and T4 of 100%, 78%, 93% and 71%, respectively. 
However, only 29 patients had colon as opposed to rectal cancer. Other groups have 
also shown varying accuracies for different stages of colonic cancers with a trend of 
lower accuracies for T2 tumours. For instance Akahoshi et al (2001) showed T staging 
accuracies of 88% for T1 tumours, 64% for T2, 95% for T3 and 100% for T4 and an 
overall accuracy of 89% for all T stages. However, their patient cohort had only one 




Our CT accuracy of 42% is difficult to compare with previous studies as there are great 
variations in the type of scanners used, the protocols and the methods of administering 
contrast agents. Early reports of the evaluation of CT as a staging investigation 
suggested that the local extent and regional spread of the tumour correlated well with 
the surgical and histopathological findings. Accuracy rates between 77% and 100% 
were widely quoted (Dixon 1981; Grabbe 1983; van Waes 1983; Zaunbauer 1981). 
However, majority of these studies focused on rectal cancer staging and data of staging 
of proximal lesions are limited.  In addition, all of the studies with increased overall 
sensitivity define T4 as direct organ invasion only, and not peritoneal fat invasion, 
which falsely increase the accuracy rates. This does not apply to our findings but in 
part explains their higher rates. 
 
Laghi et al (2002) and Kanamoto et al (2007) demonstrated T staging accuracies of 
97% and 95%, respectively. Both studies adopted 1mm slices image acquisition with 
multi-detector CT using rectal insufflation and intravenous contrast. Combining T1 
and T2 tumours and T3 and T4 tumours suggested accuracy of 94% and 100%, 
respectively (Kanamoto 2007). This study used multiplanar reconstruction which they 
believed was superior to other techniques. This is contrary to our findings and also to 
the findings of other authors. It should be stated that we did not use bowel preparation 
or rectal insufflation for obtaining CT images and this may account for our low 
accuracy of 42%. Combining T1 and T2 tumours as one group and T3 and T4 tumours 
as another  gave CT a slightly better accuracy of 68% (26/38 correctly identified) in 
the T staging of colonic cancers, but still not comparable to that achieved by Laghi 
(2002) and Kanamoto (2007). Some of the apparent discrepancies in the literature may 
be due to the failure to separate rectal from colonic cancers (Balthazar 1988; Burton 
2008; Smith 2007; Acunas 1990; Chung 2004; Earls 1994; Gazelle 1995; Keeney 
1989; Zerhouni 1996).  
 
 Dighe and colleagues (2010) summarized the literature regarding local staging of 
colonic cancer by CT in a recent metanalysis of 19 studies. The sensitivity and 
specificity for differentiating between T1/T2 and T3/T4 tumours was reported as 86% 
and 78% respectively. In a subgroup analysis they showed that the best results were 
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obtained in studies that used axial slices of 5 mm or less and those that used rectal 
insufflation with air or water during imaging. Furthermore, it is interesting to note that 
the 13 studies which used spiral or multidetector CT had better pooled sensitivity and 
specificity of 93% and 81% respectively. With regard to nodal status, the pooled 
analysis showed a sensitivity of 70% and specificity of 78% with once again best 
results being obtained using multidetector CT. 
 
In our series, the relative small number of node positive patients tempers the 
interpretation of results. Never the less, 12 MHz US (which has a higher tissue 
penetration than the higher frequency probe) was significantly superior with overall 
accuracy of 82% compared to 61% and 65% offered by CT and 20 MHz US, 
respectively. 11 studies have reported on nodal status accuracy for colonic cancer 
ranging from 24% to 90% and sensitivities from 50% to 95% (Akahoshi 2000/2001; 
Hunerbein 2000; Hurlstone 2005; Matsumoto 2002; Stergiou 2003; Tseng 2002; 
Hamada 1998; Hurlstone 2005; Norton 1999). Hurlstone and colleagues (2005) 
demonstrated 87% accuracy and 95% sensitivity in 130 patients with colorectal cancer 
(102 of who had colon cancer) using 12.5 MHz miniprobe ultrasound. The wide 
variation and some low accuracies in the literature  are almost certainly due to the fact 
that  histological micrometastases are impossible to differentiate from inflamed nodes, 
and indeed some nodes may be out of reach of the miniprobe’s range (Hildebrandt 
1986). The latter is thought to be the reason for lower accuracies seen with the higher 
frequency 20 MHz probe.  
 
Lymph node staging using our mini probe technique will always have one crucial flaw. 
Some may argue that the method of examining for lymphadenopathy is somewhat 
arbitrary as the whole length of the colon 10 cm above and below the tumour is 
sequentially scanned. This is likely to under stage the extent of disease as the focal 
length of the probes is no more than 5 cm and therefore it is unlikely to identify nodes 
further away from the tumour which are crucial to the nodal staging of the patient. 
Furthermore, with our technique it is impossible to be certain that the “abnormal” 
lymph node identified on ultrasound is the identical abnormal lymph node isolated on 
histopathological specimen. It is also not possible on ultrasound to be accurate in 
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identifying the anatomical region of the lymphadenopathy such as pericolic or 
mesenteric. 
 
The initial review of the literature with respect to both T and N staging of colonic 
cancers have shown great variability of the results which are in part due to the 
technical nature of the staging technique with a learning curve. In this study, the main 
author was trained in endorectal ultrasound using the rigid probe and utilized his 
knowledge of staging rectal cancers to that using mini probes for staging of colonic 
cancers with the assumption that as he was trained and over the learning curve in 
transrectal ultrasound, and that this would be similar for colonoscopic mini probe 
examinations. There is some evidence of the existence of a learning curve in 
transrectal ultrasound but the literature is poor with respect mini probe ultrasound. 
Carmody et al (2000) compared local staging of rectal cancer in 36 patients performed 
by a single surgeon who was inexperienced in performing the procedures. The 
accuracy of staging improved over the study period with a 58.5% accuracy in the 
initial 12 examinations to 87.5% accuracy in the remaining 24 patients. Orrom et al 
(1990) also showed a steady improvement in rectal cancer staging accuracy over a 31 
month period with improvements from 58% to 95% from a single surgeon. Interesting 
Li et al (2010) did not show any improvement with respect to T stage but marked 
change with nodal staging. They reported on 50 patients whom underwent transrectal 
ultrasound over a 2 year period. The overall accuracy for T staging was 86% and this 
did not change significantly from the early period (84%) to the later group (88%). On 
the other hand, accuracy for lymph node staging improved in the same time period 
from 52% to 80% with overall N staging of 66%. The authors stated that experience 
was particularly important for nodal staging and felt that the learning curve was 
overcome between 25-40 cases. For the purposes of my study, it was assumed that 
experience with previous transrectal ultrasound was transferable to colonoscopic 
ultrasound and this is largely true as the colonic images are very similar. However, this 
may have affected the results of nodal staging and it would be interest to evaluate this 
further with larger numbers in the study. Interestingly, Siridawana et al (2009) felt that 
colonoscopic ultrasound was still associated with a learning phenomenon despite 
experience with a transrectal rigid probe with poor sensitivity of colonic ultrasound at 
61% in local staging of 44 rectal cancer patients. However, they used a colonoscopic 
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ultrasound 7.5 MHz flexible echoendoscope for the purposes of their study. Although 
there is no data regarding learning curve for mini probe ultrasound, my personal 
experience suggests that once the technical aspects of the acoustic coupling are 
overcome, image interpretation skills are transferable from the transrectal ultrasound 
experience. 
 
The reported sensitivities of lymph node prediction by CT vary substantially ranging 
from 22% to 90% (Balthazar 1988; Kanamoto 2007; Acunas 1990; Gazelle 1995; 
Keeney 1989; Zerhouni 1996; Dux 1996; Filippone 2004; Freeny 1986; Hundt 1999; 
Thompson 1986). Our sensitivity of 80% for CT at the expense of low specificity of 
48% and poor agreement with kappa coefficient of only 0.31 is in keeping with 
previous studies. Lymph node sensitivities obtained using multi-detector CT with 
contrast enhanced multiplanar reconstruction has been more promising. Filippone at al. 
(2004) showed a sensitivity of detection of lymph node metastases of 90% in 41 
patients and by comparison, Kanamoto (2007) 87% in 51 patients. However the use of 
size as the main criterion for diagnosis will remain problematic. This is emphasised by 
Hundt and colleagues (1999) who showed that 11 out their 34 cases underestimated the 
N stage due to microscopic involvement of the lymph nodes without enlargement, 
giving a CT sensitivity of 68%. 
 
CT scan was not originally utilised to provide information regarding local staging of 
colonic tumours. CT scan has technique-related limitations that make the distinction 
between T1 and T2 tumours difficult and in future studies they may be needed to be 
looked together as a joint T1-T2 group. Dighe and colleagues (2010) evaluated the 
accuracy of multidectector CT in stratifying patients with colon cancer in good and 
poor prognostic groups. Low risk groups included patients with T1/T2 tumours and 
also T3 tumours with extramural depth of less than 5 mm. High risk groups included 
T3 tumours with extramural depth greater than 5 mm and T4 tumours (The cut off of 
5mm for extramural depth had been shown previously by Smith and colleagues (2007) 
to be a good distinction between good and poor prognosis according to histopathology 
and disease free survival). The authors reviewed CT scans of 84 patients and showed 
an accuracy of 74% for T staging of colon cancer with sensitivity of 78% and 
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specificity of 67%. Furthermore they noted worse accuracy for detection of malignant 
lymph node at 58%. Overall, agreement for assigning patients into either a good or 
poor prognosis group was moderate with kappa value of 0.54. The authors argued for a 
role of preoperative CT in the identification of patients suitable for recruitment for the 
UK national FOxTROT trial entitling patients with poor prognosis features neo-
adjuvant chemotherapy. With this in mind, it is of some concern to note that in their 
series, 10 out of 30 tumours with favourable eventual histological features were 
deemed to be radiologically poor prognosis and thus would potentially over treated 
with neo-adjuvant chemotherapy. On the other hand, 12 out of 54 tumours with a poor 
prognosis on histology were judged to be of good prognosis radiologically.  
 
Leufkens at al (2011) also conducted a systematic review of the accuracy of colon 
cancer staging by Computed Tomography. They excluded all studies with rectal cancer 
staging and those that did not have a separate analysis for colon cancer staging. Only 
11 studies were included in the review with 753 patients in total. Sample-size-
weighted sensitivity, specificity and accuracy for T-staging was 77%, 3% and 67%, 
respectively; and for N-staging 76%, 55% and 69%, respectively. The specificity for T 
staging was considerably low and probably related to the difficulty of CT interpreting 
individual layers of the colonic wall particularly in the presence of poor preparation 
and absence of rectal insufflation. Limitations of this review are that the number of 
included studies was small, reviewing radiologists were aware of the diagnosis or 
information on blinding was not stated in the study, and 5 of the 11 studies were 
retrospective in design. There is much heterogeneity in the CT protocol used for local 
staging of colonic cancers and in this review, only a third of the studies offered CT 
axial imaging at 5mm slices. Another additional technical aspect is that if multiplanar 
reconstruction is not used routinely to locally stage the tumour, then true axial images 
must be obtained which are through the tumour and perpendicular to its long axis.  
Anderson and colleagues (2011) assessed the effect of true axial imaging on the 
accuracy of colonic cancer staging. 50 consecutive datasets were consecutively 
assessed by 3 radiologists. The images were read as standard axial CT initially and 
then re-read 6 weeks later but with true axial slices through the tumour and 
perpendicular to the long axis. The overall accuracy for tumour (T) staging was 56% 
for Radiologist 1, 48% for Radiologist 2 and 64% for Radiologist 3 for standard axial 
CT imaging. This improved to 72% (p=0.012), 66% (p=0.012) and 80% (p=0.021) 
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when the true axial images were added. Similarly, for nodal staging, overall accuracy 
improved from 56% to 70% (p=0.065) for Radiologist 1, 58% to 76% (p=0.012) for 
Radiologist 2 and 60% to 76% (p=0.021) for Radiologist 3 when true axial images 
were used. 
 
In our study, only one radiologist was responsible for the interpretation of CT images 
which limited our analysis. This was a prospective study, therefore all images were 
analysed pre-operatively removing biased which may have been imposed on a 
retrospective analysis. For subsequent analyses of future CT images, we have assigned 
2 radiologists to interpret the images independently and we plan to compare the inter-
observer variability of local staging.  
 
Currently, local staging of colonic cancer does not affect the treatment outcome in 
patients as all patients deemed fit for surgery are offered segmental resection based on 
the absence of distant metastases rather than local staging. However, the possibility of 
neo-adjuvant chemotherapy for advanced colonic cancers may increase the importance 
of accurate local staging and with this in mind; we embarked on this prospective study. 
In the future, distinction between T3 and T4 tumours from T1 and T2 tumours may 
have more importance and both colonoscopic high frequency ultrasound and CT 
should be able to offer this. It would be interesting to apply colonoscopic high 
frequency ultrasound as an additional staging arm to FOxTROT as our initial results 
are somewhat promising and  this may play a role in the future in the local staging of 










Accurate pre-operative staging of colonic cancer is important for optimising treatment. 
Local staging of tumours has been shown to be important in rectal cancer, currently in 
colonic cancer the focus is on CT staging of distal metastases. There is a possibility 
that the role of neo-adjuvant chemotherapy might expand to include colonic cancer. 
Also the introduction of laparoscopic surgery for colonic resections increases the 
significance of local staging since T1 and T2 tumours are more suitable for 
laparoscopic surgery. We have shown in this small prospective comparison that high 
frequency mini probe endoscopic ultrasound is feasible in the local staging of colonic 
cancers. This study comparing conventional CT and high frequency ultrasound for 
local staging of colonic cancer shows that both 12 and 20 MHz ultrasound are 
significantly better for T staging of colonic cancer, with 12 MHz only being advocated 
for detection of nodal disease. These findings need to be evaluated further and 

























In the last decade, ERUS has become increasingly available and accepted as a tool for 
staging rectal cancers. The technique has in the past been less utilised as the modality 
as it requires a significant learning curve for orientation and identification of 
ultrasound images and planes. Intraluminal examination of the rectum by ultrasound 
can be done using a rigid probe or a flexible echoendoscope. High frequency mini 
probes are also now available which can advanced through the working channel of 
standard colonsocopes and image tumours under direct endoscopic vision. 
 
The accuracy of ERUS for assessing depth of invasion of rectal cancer (T stage) ranges 
from 80-85%, compared to 65-75% for CT and 75-85% for MRI (Gleeson 2009). A 
recent meta-analysis pooling studies from 1980 to 2008 (Puli et al 2010) showed that 
sensitivity and specificity of ERUS to diagnose T1 cancers were 87.8% and 98.3% 
respectively. Results for the other stages for sensitivity and specificity were 80.5% and 
95.6% for T2 tumours; 96.4% and 90.6% for T3; and 95.4% and 98.3% for T4 
tumours. ERUS has been shown to be particularly accurate for staging superficial 
tumours. Zorcolo and colleagues (2009) found that ERUS differentiated early and 
advanced rectal cancers with 96% sensitivity, 85% specificity and 94% accuracy. 
 
Local excision of rectal tubulovillous adenomas at colonoscopy is often difficult as 
these tumours are broad based and the completeness of resection is problematic. 
Additionally there has been some concern regarding local recurrence after piecemeal 
endoscopic resection. However these issues have been minimised with the introduction 
of Transanal Endoscopic Microsurgery (TEMS) (Buess et al. 1988). The advantage of 
local as opposed to radical surgery is that it reduces patient morbidity and improves 
functional outcome. TEMS may be a suitable alternative operation for patients with 
comorbidities and high peri-operative risk. Local excision using TEMS may also be 
used with curative intent in patients with early rectal cancers. However, risk of local 
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recurrence and lymph node metastases increases with increasing depth of invasion 
varying from 0-18% in T1 tumours and 17-47% for T2 tumours (Kim 2000). Kikuchi 
et al (1995) elaborated on this and demonstrated that local lymph node involvement 
rates varied from 0%, 5% and 25% for sm1, sm2 and sm3 lesions respectively. 
 
TEMS is indicated in certain patients with biopsy proven benign tubulovillous 
adenomas. However, surgical histopathology reveals post excision carcinoma in 21-
34% of such cases (Doornebosch et al. 2008; Galandiuk 1987; Taylor 1981). EUS may 
raise suspicion of malignancy in the presence of benign biopsies. There is some 
evidence that previous TEMS procedures may increase the morbidity of subsequent 
radical surgery Baron 1995; Friel 2002; Hahnloser 2005). Therefore it is vital that 
accurate pre-operative staging is available for all patients undergoing local excision 
with TEMS. 
 
The assessment of nodal metastases is less accurate with ERUS than for tumour depth. 
Puli et al (2010) combined 35 studies with 2700 patients and showed that the 
sensitivity and specificity of ERUS for diagnosing nodal involvement was 73.2% and 
75.8% respectively. There is wide variation in the literature and this is partly due to the 
variable criteria used for defining nodal metastases. Small nodes are not always easily 
observed with ultrasound and 18% of lymph nodes less than 5mm harbour metastatic 
disease (Skandarajah 2006). Recently, Gleeson and colleagues used ERUS with fine 
needle aspiration to identify suspicious nodal characteristics. They identified that nodal 
hypoechogenicity and short axis greater than 5mm were independent factors for 
malignancy. In addition, a long axis greater than 9mm was 95% specific for the 
presence of malignancy. 
 
Traditional endorectal ultrasound offers accurate assessment of the depth of invasion in 
early rectal tumours with an overall accuracy of 87% and a sensitivity and specificity 
of 93% and 78%, respectively. This compares with MRI which offers 82%, 86% and 
77% corresponding values (Kwok 2000). Rigid transrectal ultrasound (7.5-12 MHz), 
however, is not feasible in all patients due to tumours being further proximal to the 
dentate line and stenosis. In addition, this involves a further procedure to the 
diagnostic endoscopy. The potential advantage of high frequency miniprobe ultrasound 
is that this can be performed at the index endoscopy (by inserting the probe through 
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the working channel of colonoscope) and avoids the need to arrange an additional 
procedure. The higher frequency (20MHz) may provide superior imaging offering 











1-mucosa; 2- muscularis mucosae; 3- submucosa; 4- muscularis propria; 5-serosa 
 
 
The purpose of this study was to determine the feasibility and accuracy of 20MHz mini 
probe ultrasound in the assessment of rectal wall penetration of tumours deemed 












Consecutive patients with rectal tumours deemed suitable for TEMS were included in 
the study from Feb 2008 to Nov 2009 after informed written consent. Pre-operative 
investigations in all patients included colonoscopy and biopsy, MRI of the anorectum 
and pelvis and 20 MHz mini probe ultrasound.  
 
MRI was performed using 1.5T full body scanner with the patient in the supine 
position using a phased array surface coil centred on the pelvis. Bowel preparation and 
air insufflation were not used. Axial T1 weighted conventional spin echo images of the 
pelvis were first obtained with 4mm section thickness using a 24cm field of view. Both 
axial and sagittal T2 weighted fast spin echo images were then obtained in the same 
region using 5mm section thickness. These T1 and T2 images were then utilised to 
plan T2 weighted 3mm section thickness transverse oblique true axial imaging through 
the rectal tumour and mesorectum. The images were interpreted by an experienced 
colorectal radiologist pre-operatively, blind to both the ultrasound and 
histopathological staging. 
 
20 MHz mini probe ultrasound examinations were performed at the index colonoscopy 
and during the TEMS resection by inserting the probe through the working channel of 
the operating scope (Figure 5.2). A 5mm laparoscopic port was used for insertion of 
the miniprobe to provide an air tight seal. Acoustic coupling was achieved by 
suctioning of excess air in the rectum and instillation of water to submerge the tumour. 
The main author was responsible for performing and interpreting the ultrasound 
images and was unaware of the results of the MRI. Images were captured on 
photographic paper and SVHS for further review if necessary. Another surgeon carried 
out all of the TEMS procedures and the specimen was resected en bloc and sent for 






Figure 5.2: Mini probe ultrasound inserted through working channel of operating 












Staging by ultrasound and MRI were compared to the postoperative histological 
resection specimen. Graph Pad Prism (Version 5) and SPSS (Version 16.0) were used 
to calculate the sensitivity, specificity, positive predictive value, negative predictive 
value, accuracy and kappa coefficients of each imaging modality against the 
histopathological gold standard.  
 
Weighted kappa coefficient were used to quantify the level of agreement between the 
different methods with the gold standard (histopathology) in order to penalise for the 
amount of the disagreement observed and to allow for particular combinations of 
ratings not being observed.  The kappa coefficient was used to quantify the level of 
agreement between the different methods with the gold standard (histopathology). The 
kappa coefficient used weights of 1, 0.5 and 0 to penalise for the amount of the 
disagreement observed and it also allowed for particular combinations of ratings not 






Thirty four patients were recruited for the study, with higher proportion of males to 
females (20M: 14F) and mean age of 69 years (SD 14, 27-89 years). Mean Body Mass 
Index of the group was 26.4 (SD 5.2, range 17.6-41.6). The size of the rectal lesions 
ranged from 10-60 mm with a mean of 30 mm and occupied 5-55% of the rectal 
circumference. All lesions were below the peritoneal reflection, 5-15 cm (mean 10 cm, 
SD 2.6) from the anal verge. 
 
Post-operative histology identified 21 benign tubulovillous adenomas (9 high grade 
dysplasia, 12 low grade dysplasia) and 13 lesions with a focus of adenocarcinoma 
(38%). The latter group included 3 mucosal, 7 submucosal, 2 T2 and 1 T3 tumour. In 
terms of T stage, there were 21 T0, 3 T1m, 7 T1sm, 2 T2 and 1T3 tumour. Therefore, 
24 lesions in total were confined to the mucosa.  
 
MRI was completed in 30/34 patients (88%) as 4 patients were unable to tolerate the 
investigation. MRI only identified one of the mucosal lesions, therefore these were 
grouped together with T1 tumours for further analysis (Tables 1-3) (Figure 5.2). There 
were 27 T0/T1 tumours, of which MRI correctly staged 10 (37%), over-staging 10 as 
T2 and 7 as T3. In addition, 4 out 10 (40%) T1 tumours were correctly staged, over-
staging 5 as T2 and 1 as T3. Only two T2 tumours were present, one of which was 
correctly staged by MRI. In the comparison of MRI with the gold standard 
(histopathology) the observed agreement was 86.3%, only slightly above 84.9%, the 
expected chance agreement. The weighted kappa coefficient was 9% (SE=5%). No 
significant difference from zero was detected (P=0.23). Following Landis and Koch's 




Table 5.1: Agreement between MRI and histopathology for T staging of rectal 
tumours deemed suitable for TEMS 
 
p = pathological staging 





Table 5.2: Agreement between MRI and histopathology for T staging of rectal 








p = pathological staging 









95% confidence intervals in (parentheses) 
PPV=positive predictive value 




Acoustic coupling was achieved in all 34 patients (100%) during 20 MHz ultrasound. 
All 31 T0/T1 patients were correctly identified by ultrasound (100%). Within this 
 mT0 mT1 mT2 mT3 Total 
pT0 1 5 5 6 17 
pT1 0 4 5 1 10 
pT2 0 0 1 1 2 
pT3 0                      0                     0                      1    1 
Total 1 9 11 9 30 
 mT0/T1 mT2 mT3 Total 
pT0/TI 10 10 7 27 
pT2 0 1 1 2 
pT3 0                      0                     1 1 
Total 10 11 9 30 
 Sensitivity Specificity PPV NPV Kappa 












group, there were 24 mucosal lesions, 23 (96%) of which were correctly determined, 
over-staging 1 as a submucosal lesion. Additionally, 6 out of the 7 (86%) submucosal 
lesions were correctly identified, under-staging 1 as a mucosal lesion. 20 MHz 
ultrasound offered 96% sensitivity, 80% specificity and a likelihood ratio of 4.8 in 
differentiating between mucosal and submucosal rectal tumours. Only 2 T2 and 1 T3 
tumour were present in this cohort, 2 of which were under-staged by ultrasound 
(Tables 4-6). In the comparison of 20MHz with the gold standard (histopathology) the 
observed agreement was 91.2%, well above 56.7% the expected chance agreement. 
The weighted kappa coefficient was 79.6% (SE=14%). This kappa coefficient was 
significant different from zero (95% c.i. 34% to 62%; P=0.0004). Following Landis 








Table 5.4: Agreement between 20 MHz ultrasound and histopathology for determining 
depth of rectal wall penetration in tumours deemed suitable for TEMS 
 
 
 uMucosal uSubmucosal uT2 uT3 Total 
pMucosal 23 1 0 0 24 
pSubmucosal 1 6 0 0 7 
pT2 1 0 1 0 2 
pT3 0 0 1 0 1 
Total 24 7 2 0 34 
 
p = pathological staging 







Table 5.5: Agreement between 20 MHz ultrasound and histopathology for T staging of 




 uT0/T1 uT2 uT3 Total 
pT0/T1 31 0 0 31 
pT2 1 1 0 2 
pT3 0 1 0 1 
Total 32 2 0 34 
 
p = pathological staging 





Table 5.6: Overall accuracies of 20 MHz ultrasound in T staging of rectal tumours 




95% confidence intervals in (parentheses) 
PPV=positive predictive value 





Overall, 20 MHz ultrasound was significantly more accurate (32/34, 94%) than MRI 
(12/30, 40%) in determining the rectal wall penetration for rectal tumours deemed 
suitable for TEMS (p<0.0001). 
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Surgical excision of rectal cancers consists of either transanal excision, transanal 
endoscopic microsurgery (TEMS) or total mesorectal excision (TME). The choice of 
procedure depends on the stage of rectal cancer on pre-operative imaging which is of 
paramount importance as generally cancers staged as TI or lower are treated by local 
excision whereas TME is reserved for more advanced stages. The usual scenario for 
referral for TEMS is such that a patient is discovered to have a rectal tumour with 
biopsies suggestive of tubulovillous adenoma with high grade dysplasia without 
confirmation of underlying malignancy. In our institution, we assessed these patients 
with both MRI and high frequency 20 MHz mini probe ultrasound to assess depth of 
invasion of these polyps prior to TEMS procedure. Assessment of nodal status was not 
assessed as the primary end point as we have previously shown that 20 MHz 
ultrasound is poor at assessing lymph node status and would as such made a poor 
comparison to MRI. Furthermore, all patients included in this study were those 
referred for TEMS procedure and therefore depth of infiltration of the polyp was 
important to ascertain as this would guide management. 
 
MRI was utilised as a comparison to high frequency mini probe ultrasound because in 
our tertiary referral practice for TEMS, MRI has been used as the imaging modality of 
choice for the assessment of rectal tumours referred for potential TEMS. This may be 
an unfair comparison as the patients in this cohort were more likely to have an earlier 
stage of rectal tumour and MRI fairs poorly in this aspect of staging. Nonetheless as 
this is the current practice offered in the region, we felt that any new imaging modality 
should be compared against the best current practice. However, it may have been more 
interesting to also compare the staging of these rectal tumours with traditional rigid 
endorectal ultrasound. 
 
Although MRI is widely used to stage rectal tumours we show that its overall accuracy 
(40%) at assessing early T0 and T1 tumours compares unfavourably with that of 
miniprobe ultrasound which was 100% sensitive. As this cohort of patients had 
presumed benign tubulovillous tumours destined for TEMS procedure there is a lack of 
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patients with the more advanced T stages. Patients destined for TEMS were 
deliberately selected for this study as all of these patients would have imaging for local 
staging of tumour and also all patients would undergo en-bloc full excision of the 
tumour. Therefore, we were able to evaluate the accuracy of high frequency mini probe 
ultrasound in assessing depth of invasion, and compare this to MRI.  
 
Traditionally, the ultrasonographic assessment of rectal tumours is usually undertaken 
by a rigid probe using frequencies between 7.5 and 12 MHz. There have been many 
studies that have compared the accuracy of diagnostic imaging modalities for the 
staging of rectal cancer but it is difficult to draw conclusions from the literature with 
studies varying in sample size, patient population, study design, imaging technique and 
results. Nonetheless, there have two well conducted meta-analyses and a systematic 
review of the literature (Bipat 2004; Lahaye 2005; Skandarajah 2006) all of which 
point to EUS being more accurate at characterising early rectal tumours and perirectal 
tissue invasion, and MRI more useful in advanced disease as it was clearer in 
determining the anatomical planes corresponding to the mesorectal fascia (Skandarajah 
2006). However, it must be emphasised that the advantages of EUS depend heavily on 
operator experience and transrectal EUS may be less accurate than MRI in stenotic and 
proximal tumours (Kulinna 2004). There is also a learning curve with operator 
variability. Orrom and colleagues (1990) reported an increase in diagnostic accuracy 
from 59.3% to 95% over a 3 year period. Some studies suggest a learning curve of 50 
cases for T staging and more than 75 cases for nodal assessments (Marusch at al 2002). 
In our study, the author was above his learning curve for transrectal ultrasound using a 
rigid probe but this is our first experience of mini probe ultrasound which suggests that 
the skillset is easily transferable across the different probes. 
 
Puli and colleagues (2010) performed a systematic review and meta-analysis of the T 
staging of early rectal tumours using endoscopic ultrasound. Patients with early rectal 
cancers (T0) have a high 5 year survival of greater than 95% (US National Institute of 
Health data 1975-2004), whereas 5 year survival for Stage II, III and IV disease are 
considerably worse at 65%, 35% and 9% respectively. This variation in survival makes 
the local staging of rectal cancer important for prognosis and treatment. The authors 
showed that pooled sensitivity and specificity of EUS for T0 tumour invasion was 97% 
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thereby allowing physicians and surgeons to correctly identify patients suitable for 
endoscopic treatment.  
 
The experience of mini probes in assessing depth of invasion is limited in the 
literature. We determined the depth of mural invasion using 20 MHz mini probe 
through the working channel of the colonoscope and differentiation between mucosal 
from submucosal lesions was possible with an accuracy of 96%, something which is 
highly problematic using 12 MHz (Glancy et al. 2005). Hurlstone and colleagues 
(Atkinson 2007; Hurlstone 2005; Hurlstone 2005) have consistently shown high 
accuracy in assessing depth of invasion of colorectal polyps prior to endoscopic 
resection using 12.5 and 20 MHz miniprobe ultrasound. They subjected 82 lateral 
spreading tumours to high frequency miniprobe ultrasound and magnification 
chromoscopic colonoscopy. All 15 of the tumours invading the muscularis propria (T2 
tumour) were accurately identified with 20MHz ultrasound and therefore not subjected 
to endoscopic mucosal resection. The same Sheffield group showed 93% overall 
accuracy in determining depth of invasion in 62 patients with flat colorectal cancerous 
polyps using 20 MHz ultrasound. Furthermore, the accuracy for sm1, sm2 and sm3 
lesions were 100%, 92% and 93%, respectively and this group is the only group that 
have been able to differentiate sm1-3 lesions in the literature. Overall, their data are 
similar to our results of 96% sensitivity in differentiating between mucosal and 
submucosal lesions. We did not sub classify the tumours with submucosal invasion 
into ultrasonographic sm1, sm2 and sm3 but only utilized the mini probe to 
differentiate between mucosal and submucosal lesions. My personal experience 
regarding submucosal invasion is that it is extremely difficult to obtain reproducible 
images of the submucosal layer in order to be confident in diagnosing sm1, sm3 and 
sm3 lesions with 20 MHz probes. My personal opinion is that you are able to identify 
lesions into the upper half of the submucosal layer and those in the lower half of the 
layer which could potentially guide you to make decisions regarding endoscopic 
treatment or colorectal resection.  
 
The new generation MRI of external high resolution phased array surface coil systems 
has improved the local staging of rectal cancer. The combination of high resolution, 
improved signal to noise ratio and a large field of view allows detailed anatomical 
evaluation of the rectal wall and mesorectal fascia. Despite these advantages, overall T 
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staging accuracies are only 67-86% (Beets-Tan 2001; Blomqvist 1997; Gagliardi 2002; 
Poon 2005). These results can be attributed to the fact that MRI fairs worse at staging 
T1 and T2 tumours than more advanced cancers.  Mathur et al (2003) showed that T1 
and T2 tumours were staged to an accuracy of 46% whereas T3 tumours were at 76%, 
which was also confirmed by others (Drew 1999, Hadfield 1997). These results are 
similar to ours with poor agreement of MRI with histology for T0/T1 lesions, leading 
to overstaging of these tumours. 
 
The decision for undertaking TEMS is relatively straightforward in the case of an 
endoscopically diagnosed tubulo-villous adenoma with benign histology. However, if 
the biopsy reveals a focus of malignancy, over-staging to T3 by MRI of early T1 
lesions confined to the mucosa or just invading sm1 level may subject these patients to 
potentially unnecessary neo-adjuvant treatment rather than primary local surgery. The 
addition of endoscopic ultrasound to evaluate these lesions has great potential as part 
of the accurate and routine pre-operative assessment. Rigid endorectal ultrasound has 
been shown to be very effective in staging early rectal tumours prior to endoscopic 
surgery. Puli and colleagues (2009) reviewed the literature for all studies utilizing 
TRUS to stage lesions confined to the mucosa (T0) all of whom had endoscopic 
surgery. They identified 11 relevant studies with 1791 patients. The pooled sensitivity 
and specificity of TRUS in diagnosing T0 involvement was 97.3% and 96.3% 
respectively. Furthermore, TRUS had a high positive likelihood ratio and a low 
negative likelihood ratio which indicates that TRUS was superior in excluding as well 
as diagnosing the correct histological stage. Despite these impressive results, many 
authors have stated that it is challenging to distinguish between T0 and T1 lesions 
using the rigid probe. Zorcolo and colleagues (2009) reported on 81 patients whom had 
undergone TRUS and subsequent TEMS. They grouped the T0 and T1 lesions together 
for their analysis and showed that TRUS had an overall accuracy of 94%. However, 
differentiation between T0 and T1 lesions was challenging with 57.6% of adenomas 
and 30.7% of carcinoma in situ being staged as uT1. Furthermore, almost half of the 
pT1 tumours were staged as uT0. The authors felt that this was not clinically relevant 
as in their practice all patients with T0 and T1 tumours were offered local excision by 




The advantage of high frequency mini probes is that the entire lesion can be 
sequentially scanned under endoscopic vision of the probe ensuring that no part of the 
tumour is left un-staged and that it does offer the differentiation between mucosal and 
submucosal lesions. We cannot conclude that high frequency ultrasound should be a 
replacement to MRI but simply that this is feasible in the rectum with promising initial 
results. Therefore, it may a useful adjunct to the assessment of rectal polyps referred 
for TEMS excision. Furthermore, the high accuracy in differentiating mucosal from 
submucosal lesions may prove useful in assessing polyps throughout the colon and 
rectum prior to embarking on endoscopic resection. 
 
For future studies, it would be useful to compare colonoscopic mini probe ultrasound 
with traditional endorectal ultrasound using a rigid probe to determine whether mini 
probes could be used as an alternative staging tool, thereby providing this imaging 






Our results indicate that high frequency mini probe ultrasound is feasible in the rectum 
to evaluate tumours referred for TEMS. The accuracy of 20 MHz ultrasound is clearly 
superior to that of MRI in assessing depth of rectal wall penetration for T0 and T1 
tumours. Ultrasound can raise suspicion of malignancy in the case of pre-operative 
benign biopsies. If the high diagnostic accuracy of this method is confirmed for T3 
tumours then there may be a role for more accurate selection of patients with rectal 
cancer for pre-operative radiotherapy. Further studies are indicated especially in 
























Patients who have undergone snare polypectomy for malignant polyps are a 
management challenge. The decisions regarding further surgery or endoscopic 
surveillance are a balance between the assessments of risk of residual disease or 
involved local lymph nodes against the morbidity and mortality of surgical resection. 
Malignant polyps confined to the mucosa are not thought to pose a risk of lymphatic or 
haematogenous spread due to the absence of lymphatics within the mucosal layer 
(Fenoglio 1973) 
1
. However, increased risk of lymph node metastasis is proportional to 
the depth of invasion into the submucosa (Kikuchi 1995)
2
. Hassan and colleagues 
(Hassan 2005)
3
 pooled data from 31 studies in the literature with 1900 patients and 
showed that different histological factors were linked to distinct clinical outcomes. The 
presence of a positive resection margin post polypectomy is predictive of local disease; 
poorly differentiated carcinomas are associated with higher mortality, and vascular 
invasion with a higher risk of lymph node disease. 
 
Endorectal ultrasound has been utilised for risk assessment post polypectomy of 
malignant rectal polyps in relation to residual disease and local lymphadenopathy 
(Garcia-Aguilar 2005)
4
. The assessment of malignant polyps in the proximal colon 
using high frequency mini probes inserted through the working channel of the standard 
colonoscope is now possible (Maruta 1994)
5
. The colonic wall is seen as a five layered 
structure alternating between hyperechoic and hypoechoic signals with 12 MHz 
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ultrasound (Figure 1.7). The first hyperechoic layer is the interface between the water 
and mucosa. The second hypoechoic layer corresponds to the mucosa. The third 
hyperechoic is the submucosa, followed by a fourth hypoechoic muscularis propria and 
the outer hyperechoic serosa. Increasing the frequency to 20MHz scanning offers 
greater resolution of the colonic wall depicting the muscularis mucosae between the 
mucosa and the submucosa, and at the same time offering detailed views of the 
submucosa. 
 
We offered colonoscopic high frequency mini probe ultrasound post polypectomy for 
malignant polyps in the colon and rectum. Here we report our initial results using such 






Consecutive patients identified as having a focus of malignancy post endoscopic snare 
polypectomy from March 2008 and November 2009 were entered into the study after 
informed written consent. The endoscopy department in our institution has a protocol 
to state that all polyps greater than 1 cm that have undergone endoscopic treatment 
should be tattooed with ink in the vicinity so that future treatment may be undertaken 
if deemed necessary.  All patients underwent repeat diagnostic colonoscopy within 3 
months of the index colonoscopy for endoscopic ultrasound assessment. Both 12 and 
20 MHz (Olympus Keymed UM-3R, Japan) mini probe high frequency ultrasound was 
performed in a back to back design to check for local recurrence and local 
lymphadenopathy. Acoustic coupling was achieved during colonoscopic 
ultrasonography by suctioning of excess air, and water instillation in the colon to 
submerge the area of interest completely. Images were captured and real time 
ultrasound recorded onto SVHS to enable further review if necessary. During 
colonsocopic examination, the presence of residual abnormality was noted and 
biopsies were taken from any macroscopically abnormal area. Ultrasound 
examinations were undertaken in all patients in the vicinity of the previously tattooed 
area, and residual abnormalities were defined as mucosal, submucosal or invading into 
muscularis propria. In addition, the colonic wall layers were noted either to be intact or 
disrupted. 
 
All patients underwent 64 slice CT of the chest/abdomen and pelvis using intravenous 
and oral contrast with multiplanar reconstruction conducted by an experienced 
Colorectal Radiologist. The purpose of the examination was to detect the presence of 
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local mesenteric lymphadenopathy and distant metastases. Nodal metastases or 
positivity on CT was defined as either a single node greater than 1 cm or a cluster of 3 
nodes each greater than 3 mm. With respect to high frequency ultrasound, size was not 
a criterion and well defined hypoechoeic nodes were taken as positive. The colorectum 
was scanned sequentially in the vicinity of the previously tattooed area and 10 cm 
above and below this region to evaluate for local lymphadenopathy. 
 
The follow up protocol for all patients consisted of clinical assessment in the colorectal 
cancer follow up clinic at 3, 6 and 12 months. History, clinical examination, serum 
carcinoembryonic antigen levels were performed at each visit. Repeat colonoscopy 
was performed at 6 and 12 months. Further 64 slice CT of the abdomen/pelvis and 
chest was performed at 12 months. Thereafter, patients were followed up in the 
colorectal cancer follow up clinic with 6 monthly clinical visits, a further CT scan at 








Twenty one patients were recruited into the study with a mean age of 67 (SD 13.7, 
range 27-86). The male to female ratio was 15M: 6F. The location of polyps in the 
colorectum included rectum (n=8), sigmoid (n=10), transverse colon (n=1), ascending 
colon (n=1), and caecum (n=1). There were 6 pedunculated and 15 sessile polyps. The 
mean size of the polyps was 26mm (SD 12, range 12-50 mm). (Table 6.1) 
 
All patients had a focus of adenocarcinoma within the polyp: 12 of these were well 
differentiated adenocarcinomas confined to the mucosa; and 9 infiltrated into the 
submucosa (7 within the sm1 layer and 2 into sm2). All patients had successful 
endoscopic polypectomy without complications with complete histological margins in 
12 cases, incomplete in a further 4 and uncertain margins in the remaining 5 cases due 
to diathermy artifact.  
 
12 and 20 MHz colonoscopic high frequency ultrasound was undertaken in all twenty 
one patients with successful acoustic coupling. Macroscopic endoscopic residual 
abnormality at the previous polypectomy site was seen in 8 patients. 20 MHz 
ultrasound revealed all 8 of these abnormalities to be contained within the mucosa as 
mucosal irregularity with intact normal colonic wall layers (Figure 6.1 and 6.2). The 
remaining 13 patients had normal 20 MHz ultrasound. None of the patients were 





Figure 6.1a-c: Endoscopic and ultrasonographic images of a post polypectomy 
site showing scar tissue endoscopically and intact normal colonic wall layers on 12 














Figure 6.2a-c: Endoscopic and ultrasonographic images of a post polypectomy 









a. Endoscopic view showing 
polypectomy scar 
b. High frequency ultrasound probe 
through working channel of 
colonoscope 
c. 20 MHz ultrasound image showing 
intact colonic wall layers with no 












Tv=tubulovillous; T=tubular; sm1/2 = Kikuchi level for depth of submucosa invasion to upper 1/3 and middle 1/3 respectively 
Incomplete resection margin defined as within 1mm of the edge of the tumour; Uncertain margin related to diathermy artifact 
Patient 
No. 












          
             
1 76 RECTUM 20  TV  intramucosal  Well INCOMPLETE  No 
2 59 SIGMOID 17  TV  intramucosal  Well COMPLETE  No 
3 67 TRANSVERSE 15  TV  sm1  Well COMPLETE  No 
4 79 SIGMOID 40  T  intramucosal  Well INCOMPLETE  No 
5 77 RECTUM 14  TV  sm1  Well UNCERTAIN  Yes 
6 58 RECTUM 30  TV  intramucosal  Well INCOMPLETE  Yes 
7 79 SIGMOID 25  T  intramucosal  Well UNCERTAIN  No 
8 52 SIGMOID 15  T  intramucosal  Well COMPLETE  No 
9 78 CAECUM 20  TV  sm1  Well INCOMPLETE  Yes 
10 70 SIGMOID 25  T  intramucosal  Well COMPLETE  No 
11 51 SIGMOID 35  T  intramucosal  Well COMPLETE  No 
12 67 SIGMOID 40  TV  intramucosal  Well COMPLETE  No 
13 27 RECTUM 50  T  sm1  Well UNCERTAIN  Yes 
14 79 RECTUM 50  TV  intramucosal  Well COMPLETE  No 
15 72 RECTUM 15  TV  sm2  Well UNCERTAIN  No 
16 76 ASCENDING 30  TV  intramucosal  Well COMPLETE  No 
17 69 RECTUM 24  TV  intramucosal  Moderate UNCERTAIN  Yes 
18 68 SIGMOID 12  TV  sm2  Well COMPLETE  Yes 
19 50 SIGMOID 20  TV  sm1  Well COMPLETE  No 
20 61 RECTUM 40  TV  sm1  Well COMPLETE  No 
21 86 SIGMOID 15  TV  sm1  Well COMPLETE  No 
        





The eight patients with a macroscopic abnormality endoscopically had biopsies taken 
from this site, all of which were deemed to be hypertrophic scar tissue on histological 
analysis.  
Mean follow up for patients in this cohort was 44 months (1-59 months). All patients 
had normal CT imaging of their abdomen/pelvis and chest. 15 out of 21 (72%) patients 
were managed conservatively and did not undergo surgery after an informed 
discussion with the patients. All of these patients have remained disease free with 
normal subsequent colonoscopy and CT.  6 out of 21 (28%) patients underwent further 
colorectal resection (Table 6.2). All 6 of these patients had normal follow up 
endoscopy, 12 and 20 MHz ultrasound and normal CT imaging. Examination of the 
resected surgical specimen histologically revealed absence of cancer. Two of these 
patients had protracted length of stay due to post-operative complications, the first 
developing multi-organ failure secondary to sepsis and the second developed acute 
respiratory distress syndrome secondary to lower lobe pneumonia. 
 
 
Table 6.2: Outcome of patients with malignant polyps scheduled for surgery  
 
 








Surgery LOS / 
days 
1 77 Rectum 14 Sm1 Uncertain TEMS 1 
2 78 Caecum 20 Sm1 Incomplete RH 9 
3 28 Rectum 50 Sm1 Uncertain AR 37 
4 58 Rectum 30 Mucosal Incomplete TEMS 1 
5 69 Rectum 24 Mucosal Uncertain TEMS 1 
6 68 Sigmoid 12 Sm2 Complete SC 97 
 
Sm1/2=submucosal invasion, Kikuchi level1/2 
TEMS= Transanal endoscopic microsurgery 
RH= Right hemicolectomy 
AR= Anterior Resection 
SC= Sigmoid colectomy 




Figure 6.3: Flow chart to demonstrate outcome of patients with malignant polyps 
 
21 patients post polypectomy 
of malignant lesions 
Colonoscopic examination of 
tattooed region within 3 
months  
Normal colonoscopy (n=13) 
Residual endoscopic 
abnormality (n=8) 
Normal colonoscopic 12 and 
20 MHz ultrasound with intact 
colonic wall layers and no 
lymphadenopathy (n=21) 
Surgical resection in 6 patients  
Endoscopic surveillance and 
clinical follow up (n=15) 
No cancer in surgical specimen 
in all 6 cases 
No local or systemic 






Our initial experience indicates that most patients with apparent local malignant 
colorectal polyps can be managed after endoscopic polypectomy without the need for 
major surgery. This is suggested by the observation that all patients within this cohort 
did not show evidence of local or systemic recurrence. The 6 patients who underwent 
radical surgery after an informed consent process did not have any evidence of residual 
disease in the resected surgical specimen. Radical surgery is not without 
complications, especially that for rectal resection (Grumann 2001; Karanjia 1992; 
Lewis 1992) and autonomic nerve injury and sexual and urinary dysfunction is 
common (Havenga 1996). Therefore, the decision for radical surgery after endoscopic 
treatment of malignant polyps should be with caution. 
 
Traditionally, assessment of malignant polyps for prediction of residual disease and 
local lymphadenopathy has been by histology. Histological parameters such as positive 
resection margin, poorly differentiated adenocarcinoma and vascular invasion are all 
associated with poorer outcome in terms of local recurrence and lymph node 
metastases (Hassan 2005). Histological margins are often difficult to assess especially 
after piecemeal polypectomy of sessile polyps (Colacchio 1981; Haggitt 1985; Morson 
1984). The level of confidence having clear margins range from 82-100% in different 
series (Colacchio 1981; Morson 1984; Haggitt 1985). Endoscopic ultrasound has 
therefore been used as an aid to assess for the presence of residual disease and local 
lymphadenopathy. All previous studies have been in the rectum. Kruskal and 
colleagues (1999) reported a sensitivity of 100% and specificity of 44% for endorectal 
ultrasound in detecting residual cancer in 13 patients whom had undergone 
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polypectomy for rectal malignant polyps. Garcia-Aguilar et al (2005) showed an 
accuracy of 90% in the assessment of residual disease at the polypectomy site. 
However, the negative predictive value was 86% indicating that a normal ultrasound 
does not exclude the possibility of residual cancer in the surgical specimen. We 
showed normal 12 and 20 MHz ultrasound at the polypectomy site in all 21 patients. 
Although, none of these patients have developed local recurrence, 6 of them underwent 
surgery allowing direct comparison with histological assessment of the resected 
specimen. In our initial experience, a macroscopic abnormality on endoscopic view 
was frequently detected and these could be evaluated further with ultrasound. The 
abnormalities were limited to the mucosa with maintenance of the colonic layers 
suggesting that this was related to previous resection artifact rather than residual 
disease. The ultrasound images of surgical scar, diathermy artifact and residual disease 
need to be evaluated further in a series with a larger sample size in order for us to 
come to some definite conclusions. Nonetheless, we have shown that high frequency 
mini probe ultrasound is feasible in the colon and rectum and may be a promising 








High frequency mini probe ultrasound is feasible in the colon and rectum for the 
assessment of the polypectomy site post endoscopic resection of malignant polyps. 
Definitive management of these polyps cannot be exclusively based on the ultrasound 
findings but this may act as a useful adjunct to histology in providing a more complete 


























Diverticular disease is characterised by outpouchings of the colonic wall through areas 
of natural weakness affecting over half of the population of the United Kingdom, 
ranking it as one of the most common bowel disorders of the Western world. The 
majority of patients remain asymptomatic but a minority of individuals may develop 
associated morbidities ranging from excessive flatulence through to diverticulits 
(Eggenberger 1999). Diverticultitis may lead to further complications such as abscess 
formation, colonic perforation and large bowel obstruction in up to 25 % of patients 
(Kang et al. 2004). Prevalence in Northern Europe ranges from approximately 13% in 
patients up to the age of 54 to 40-50% in elderly patients over 75 years (Eide 1979, 
Parks 1982). The age standardised mortality has not changed considerably in the 
United Kingdom over the last 3 decades ( Kang et al 2003) but as this is an age related 
disease, the burden on society will increase as the life expectancy increases in our 
population (UK Office for Statistics 2007).  
The mechanical features of the bowel are maintained via circular and longitudinal 
muscular layers. The circular muscle is responsible for peristalsis and the longitudinal 
muscles condense in thick bands which pull the colon into a relatively short length.  In 
diverticular disease the circular muscle is thicker and the longitudinal muscle in shorter 
(Eggenberger 1999). This muscle thickening is not due to hypertrophy (Haber et al. 
2000), but to deposition of collagen and elastin (Whiteway 1985; Golder et al 2007; 
Eastwood 2003).  Interestingly, the pre-diverticular state is thought to consist of the 
muscle abnormality alone, even without the presence of diverticula and the 
identification of such colonic abnormalities may explain symptoms in some patients. 
Assessment of diverticular disease is conventionally performed using colonoscopy 
with cross sectional imaging reserved for assessment of diverticular complications. 
Colonoscopic assessment can identify the number of diverticula in the colon and also 
evaluate the superficial changes in the bowel mucosa. Recent advances in 
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colonoscopic ultrasound have made it possible to evaluate the colorectal wall in detail. 
High frequency (20 MHz) mini probe ultrasound has been used to evaluate the 
colorectal wall in patients with Ulcerative Colits (Tsuga et al. 1998), but this has not 
been evaluated in patients with diverticular disease. The aim of this study was to 
determine the feasibility of high frequency ultrasound in the assessment of diverticular 
disease, in particular to assess the colonic wall thickness in symptomatic diverticular 








Patients were recruited from the Colorectal Outpatient department in our institution. 
These were patients that were referred to a Specialist Diverticular disease clinic who 
were assumed to have symptomatic uncomplicated diverticular disease. Symptoms of 
these patients included lower abdominal pain and bloating, rectal bleeding and 
tendency to pass small pellet type stools per rectum. All patients with complicated 
diverticular disease were excluded such as those with previous confirmed localised 
perforation, diverticular stricture or fistula, previous pericolic or pelvic abscess or 
patients who had undergone previous surgery for diverticular disease. In addition, 
patients who simply had the presence of diverticula and whom were asymptomatic 
were also excluded from the study. 
After initial informed consent, all patients underwent diagnostic colonoscopy and 20 
MHz (Olympus Keymed UM-3R, Japan) mini probe high frequency ultrasound was 
performed during the same procedure if sigmoid diverticular disease was encountered.  
Demographic data, severity and distribution of diverticular disease, and high frequency 
ultrasound findings were collected for all patients in the study.  Only patients with 
isolated sigmoid diverticula were included in the study. The severity of diverticular 
disease was divided into mild, moderate and severe depending on the number of 
populated diverticula, less than 10, 10-25, and greater than 25 respectively. The 
thickness of the colonic wall was measured in the mid sigmoid colon for all patients 
using 20 MHz high frequency ultrasound (Figure 7.1). The mini probe was introduced 
through the working channel of the colonoscope to measure the thickness of the 
colonic wall.  The mini probe was applied perpendicular to the colonic wall in order to 
take accurate measurements of the different layers of the colon. Acoustic coupling was 
achieved during colonoscopic ultrasonography by suctioning of excess air, and water 
instillation in the colon to submerge the area of interest completely. Images were 






Figure 7.1  20 MHz colonoscopic ultrasound showing the layers of the colonic 




1-mucosa; 2- muscularis mucosae; 3- submucosa; 4- muscularis propria; 5-serosa 
 
 
The structure of the colonic wall was evaluated with reference to the total wall 
thickness, mucosa, submucosa and muscularis propria. The ultrasound images were 
captured as still frames and measurements of the individual layers of the colonic wall 
were taken in millimetres (mm) using the EUM 30 processor twin point “on screen” 
callipers (Keymed). The 20 MHz UM-3R catheter probe (Olympus, Keymed) provides 








proximal tip axis. Similar data was sought from normal control patients who were 
undergoing colonoscopy either for screening or asymptomatic patients undergoing 
follow up colonoscopy for polyps. Only patients with normal colonoscopic findings 
were included in the control group (Figure 7.2) 
 
Figure 7.2  20 MHz ultrasound image showing an example of measurement of 
thickness of muscularis propria in patients with diverticular disease 







Patients in both groups had biopsies of the colon in the region of the ultrasound 
measurements to exclude other diagnoses which could confound the measurements. 
The time taken (mins) to perform the ultrasound examination was recorded from the 
insertion of the probe to its withdrawal from the working channel of the colonoscope. 
In addition, for both groups of patients, quality of life data was measured using two 
different health survey instruments. An institution specific “Bowel disease 
questionnaire” (see Appendix 2) was utilised to assess the impact of the symptoms (if 
any) on the patients’ lifestyles and perceptions of their general health. There were 32 
questions which evaluated four different areas: bowel symptoms, systemic symptoms, 
emotional and social function. Patients were asked to categorise the impact on a scale 
from 1 (severely affecting their life) to 7 (normal or minimal affect).  The second 
survey was the Short Form 36 (SF-36) questionnaire (see Appendix 1) which is a self-
completed questionnaire covering broad aspects of health. There questions on 
functional status, emotional and social well -being. The overall evaluation of health are 
categorised in eight groups: physical function; role-physical; body pain; general health; 
vitality; social functioning; role-emotional; and mental health reported health. These 
eight are then clustered to form two higher-order scales, the physical and mental health 
summary scores. In comparison with other generic health indices, the SF-36 has been 
shown to discriminate better between populations with varying quality of life (QOL) 
(Chrispin 1997, Heyland 1998). 
Statistical analyses were carried out using SPSS version 15 and Graphpad Prism 
version 5. The thicknesses of the colonic wall were compared between the two groups 
of patients using two sample t test and linear regression analysis adjusted for age and 
sex. Similar comparisons were of QOL between the two groups. For the latter, we used 
linear regressions to model the effect of different factors on the response total score 
SF36.  The multivariate linear regression model, used to assess the difference between 
the normal and DD groups while adjusting for the concurrent effect of potential 
influential variables and possible interactions. Those variables with significance below 
0.20 in the univariate models were fitted in the multivariate model in a stepwise 
manner, with final significance assessed at the usual 5% level. Differences between the 





There were a total of 36 patients, 17 in the normal group and 19 in the DD group. The 
mean age overall was 59 (SD=13; range 32 to 82). The mean age in the normal group 
was 56 (32-76) whereas it was 61 (43-81) in the DD group. There was no significant 
difference in the two groups (p=0.27).  Of the patients in the DD group, 6 (32%) had 
mild, 4(21%) moderate and 9(47%) severe diverticular disease in terms of the number 
of populated diverticula in the sigmoid colon. 
The thickness of colonic wall at the level of the mid sigmoid colon for mucosal (M), 
submucosal (SM), muscularis propria (MP) and total colonic wall thickness (TCWT) 
are shown in Table 7.1-7.3. At all levels, the thicknesses of colonic wall was 
significantly greater in diverticular disease patients than in normal controls which was 
especially predominant in the muscularis propria and total colonic wall thickness 
(p=<0.0001). 
 
Table 7.1 Thickness of the sigmoid colon in diverticular disease patients 
during colonoscopic ultrasound using 20 MHz mini probe 
Colonic wall 
layers 
Mean/mm Range SD 
+/- 
SE 95% CI 
Mucosa 0.83 0.5-1.2 0.19 0.04 0.73-0.92 
Submucosa 1.25 0.6-2.2 0.38 0.09 1.07-1.44 
Muscularis Propria 2.81 0.9-4.6 1.01 0.23 2.33-3.30 
Total wall 5.52 2.4-8.9 1.80 0.41 4.65-6.39 
 
 
Table 7.2 Thickness of the sigmoid colon in normal patients during 




Mean/mm Range SD 
+/- 
SE 95% CI 
Mucosa 0.52 0.2-1.0 0.21 0.05 0.41-0.62 
Submucosa 0.77 0.4-1.4 0.28 0.07 0.63-0.92 
Muscularis Propria 0.86 0.6-1.5 0.26 0.06 0.73-0.99 
Total wall 2.66 2.0-3.8 0.54 0.13 2.38-2.94 
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Table 7.3 Comparison of mean colonic wall thickness in normal and 









Mucosa 0.52 +/- 0.05 0.83 +/- 0.04 0.0002 
Submucosa 0.77 +/- 0.07 1.25 +/- 0.09 0.0003 
Muscularis Propria 0.86 +/- 0.06 2.81 +/- 0.23 <0.0001 




All patients completed both a bowel disease questionnaire which was institution 
specific and also the SF-36 questionnaire (Appendix 2). There was no significant 
difference found between the normal and DD groups in terms of symptoms (Table 7.4) 
using the institution specific bowel disease questionnaire. These results remained after 
comparisons were adjusted by age and gender; significance for multivariate is shown 
in the last column of Table 7.4.   
 
Table 7.4 Results of the two-sample t-test comparing the Normal and DD 
groups by different symptoms using the Institution specific bowel disease 
questionnaire 
*Adjusted for age and gender 
 
Table 7.5 shows the univariate regressions and Table 7.6 shows the final multivariate 
regression model for the total SF36 scores. We observed that in the univariate model, 
although the DD had on average 9.2 more in the total SF36 score, this difference did 
not reach statistical significance (P=0.37) and only gender and the bowel, systemic and 
emotional symptoms showed significance. 
Questionnaire 
section 
Difference 95% C.I for 
difference 
P value P value 
(adjusted*) 
Bowel -6.5 -23.8-10.9 0.45 0.50 
Systemic -4.8 -11.0-1.5 0.13 0.18 
Emotional functions -10.5 -28.1-7.1 0.23 0.27 
Social functions -5.0 -14.6-4.5 0.29  0.29 
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Furthermore, only gender and the systemic symptoms score retained statistical 
significance in the multivariate model and after adjusting for these effects the 
difference between the groups was better defined (Table 7.6). Men had, on average, 
17.3 more in the SF36 score (95% ci 4.7 to 29.8; P=0.01). A reduction of 2.2 was 
observed in the mean SF36 for each unit increase in the score for systemic symptoms 
(coef=2.2; 95% ci 1.2 to 3.2; P<0.0001). The significant effects observed by bowel 
symptoms and emotional functions in the univariate model were lost in the presence of 
gender and systemic symptoms. After adjusting for these effects, a significant effect of 
group is observed. The DD group had, on average, 13.8 more in the SF36 score in 
relation to the normal group (coeff=13.8; 95% ci 1.1 to 26.5; P=0.04). 
 

























Gender 22.85 5.22-40.48 0.01 
Severity of DD   0.22 
Mild vs normal -8.1 -35.5-19.2 0.54 
Moderate vs normal 15.6 -19.8-50.9 0.37 
Severe vs normal 17.3 -5.8-40.5 0.13 
Group DD vs normal 9.2 -11.7-30 0.37 
Bowel symptoms 0.52 -0.09-1.14 0.09 
Systemic symptoms 2.35 1.10-3.59 0.001 
Emotional functions 0.70 0.17-1.23 0.01 
Social functions 0.47 -0.65-1.59 0.39 
 









Group DD vs Normal 13.8 1.1-26.5 0.04 
Systemic 
 





This is a pilot study which demonstrates the feasibility of colonoscopic ultrasound to 
measure the colonic wall thickness in patients with diverticular disease and their 
normal controls. The study clearly shows that it is feasible to measure the individual 
colonic wall layers with high frequency 20 MHz mini probe ultrasound. The thickness 
of the colonic wall is thicker in patients with diverticular disease than in their normal 
controls with especially marked difference in the thickness of the muscularis propria 
layer. This is consistent with the pathological findings in diverticular disease described 
by Morson in 1963 with shortening and thickening of the muscularis propria causing it 
to behave like a myostatic contracture. Autopsy studies have also described similar 
increases in the thickness of colonic wall in diverticular disease (Slack 1962). 
 
The utilisation of high frequency colonoscopic ultrasound to assess colonic wall 
thickness is diverticular disease is original. Traditionally, thickness of colonic wall 
measurements were only applied to patients with acute diverticulitis with Computed 
Tomography used to classify severity of diverticulits. Ambrosetti and colleagues 
(1993) utilised colonic wall thickness greater than 5 mm in combination with pericolic 
fat stranding, abscess, extraluminal air and contrast as criteria to predict severity of 
disease and also to predict which patients were more likely to undergo operative 
intervention. Patients with severe CT findings underwent operative intervention more 
frequently than those patients with mild findings (33% versus 15%). In addition, 
patients younger than 50 years of age with severe CT findings were also more likely to 
have recurrences or complications (Ambrosetti 1994).  
 
There is no current imaging modality used to assess severity of diverticular disease 
without diverticulitis or complications and there is no evidence which correlates 
anatomical findings in diverticular disease with symptoms, as patients with severely 
populated diverticula may have relatively few symptoms whereas those with minimal 
diverticula may have severe abdominal pain, bloating and change in bowel habit. 
Furthermore, there is no data correlating thickness of colonic wall in patients with 
diverticular disease with symptoms. Although, this study did show worsening quality 
of life SF-36 scores in patients with DD compared with controls, the number in the 
diverticular group were too small to draw conclusions regarding the thickness of 
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colonic wall and SF-36 scores within the diverticular group itself. Future studies could 
look at correlating the thickness of colonic wall to symptoms and one could 
hypothesise that symptoms of diverticular disease may be attributed in part to the 
colonic wall thickness especially in the muscularis propria layer. This may also be 
useful in the future to assess colonic wall structure in patients with symptoms 
suggestive of diverticular disease but with no populated diverticula. Perhaps, we may 
be able to assess and diagnose the pre-diverticular state which may prove useful in 
managing these patients and instigating medical treatment early to perhaps improve 
symptoms and reduce rates of complications. 
 
There have been randomised controlled trials in the literature which have evaluated the 
role of medical therapy to prevent complications of diverticular disease. In 2002, Tursi 
and colleagues randomised 218 patients with recurrent diverticulitis to rifaximin and 
mesalazine versus rifaximin alone. They showed that severity of symptoms and bowel 
habits improved significantly in the mesalazine group with a lower recurrence of 
diverticulitis at 2.7% versus 18% in the non mesalazine group. There have also been 
studies in the literature that have used mesalazine in patients with symptomatic 
uncomplicated diverticular disease rather than those with previous diverticulitis. All of 
these studies have shown some benefit in improving symptoms and bowel habits 
(Tursi et al. 2006; Di Mario et al. 2005; Comparato et al 2007). The rationale for using 
mesalazine in the treatment of diverticular disease has taken recent research interest. 
Pathological evidence shows that patients with symptomatic diverticular disease often 
exhibit microscopic inflammation of the mucosa close to diverticula. During 
colonoscopy, it is sometimes noted that there is diverticular inflammation without 
clinical evidence of acute diverticulitis (Ghorai et al 2003). In some cases, there may 
even be extensive inflammation, which is defined as diverticular colitis (Makapugay et 
al 1996). The pathogenesis of diverticular colitis is unknown and its relation to the 
diverticula is unclear. However, there are several hypotheses which include mucosal 
prolapse, relative ischemia, bacterial overgrowth, and increased exposure to 
intraluminal toxins and antigens secondary to faecal stasis (Shepherd 1996; Peppercorn 
2004). The rationale for the use of mesalazine in the treatment of diverticular disease 
involves its anti-inflammatory activity such as acting as an inhibitor of 
cyclooxygenase, platelet activating factor synthetase and thromboxane synthetase), 
which inhibit the production of interleukin (IL)-1 and free radicals (Eliakim 1992; 
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Grisham 1994; Wood 1996). The findings of these mesalazine studies are now the 
subject of international multicentre randomised blinded placebo controlled trials which 
may offer more insight into this aspect as medical care. 
 
 
Dughera et al (2004) evaluated the role of probiotics. They randomised 83 patients, 
whom had had previous diverticulitis treated with rifaximin, to an oral polybacterial 
lysate suspension containing Escherichia coli and Proteus vulgaris or control group, 
and showed the recurrence rate was lower in the probiotic group at 4.6% compared to 
12.5% in the control group. 
 
There was no difference noted in diverticular and normal patients’ perception of 
quality of life using the institution specific bowel disease questionnaire in contrast to 
the SF-36. This may question the validation of the institution specific questionnaire as 
the SF-36 is a well-established tool used in Quality of Life studies internationally. A 
larger sample size would be needed to validate the former questionnaire formally. The 
SF-36 scores in the diverticular patients were clearly worse than those in the normal 
group which confirms that the diverticular patients were all symptomatic and in 
particular clearly demonstrated anatomical differences in terms of colonic wall 
thickness compared to their counterparts. 
 
This initial pilot feasibility study lends a platform to future research in this field. The 
two groups were chosen as such with symptomatic diverticular disease and normal 
subjects in order to ascertain feasibility of the technique rather than to state bold 
conclusions. It would be interesting to evaluate several groups of patients using the 
same methodology: a group with diverticulosis who are asymptomatic; symptomatic 
uncomplicated diverticular disease group; complicated diverticular disease group 
within the previous 24 months; normal patients similar to our controls and patients 
with a diagnosis of irritable bowel syndrome (IBS). This would then enable us to 
evaluate a spectrum of colonic wall thicknesses ranging from normal, through IBS, 
diverticulosis and complicated diverticular disease. Currently, an endoscopic 
diverticular score does not exist which takes into account the number of populated 
diverticular and colonic wall thickness and it may be interesting to propose such an 




In our current thinking, measurement of colonic wall thickness is not clinically useful 
as it does not alter management of patients with diverticular disease. However, this 
may offer us a better understanding of patient symptoms and might define groups of 
patients amenable to future treatments such as that in the prevention of complications 
of diverticular disease. This initial study does have several limitations which include 
small sample size and not including patients with a spread of severity of diverticular 
symptoms in order to evaluate and correlate their anatomical details and symptoms 
scores. Nonetheless, this has developed future research in this field which may offer us 






Colonoscopic high frequency mini probe ultrasound is feasible in the colon to measure 
colonic wall thickness in patients with diverticular disease. There seems to be 
increased colonic wall thickness across all levels especially that of the muscular 
propria layer. This may be useful in the future to provide us with more anatomical 
information in order to better understand the relationship between pathology of 




































This thesis has evaluated the role of high frequency mini probe ultrasound in the 
assessment of different aspects of colorectal disease. It has clearly shown that mini 
probe ultrasound is feasible in the colon and rectum with minimal technical problems 
and without any undue complications. However, the various studies are only pilot in 
nature and further prospective research needs to continue with larger sample sizes in 
order to make more robust conclusions. This is a modality that involves some technical 
skill and is therefore subject to operator dependence and biases. Future studies should 
also include more than one ultrasound examiner with evaluation of inter-observer 
agreement keeping the blinded aspect of the study design. High frequency mini probes 
have been available for use for over 2 decades in the United Kingdom primarily in the 
upper gastrointestinal tract. It has not been adopted for routine use in the colon for a 
variety of reasons. The procedure is time consuming and on average each mini probe 
examination adds an additional 10 minutes to the colonoscopic examination. In 
addition, the examination requires deflating the colon of air and the instillation of 
water in the colon in order to achieve ultrasound coupling. The patient position may 
need to be altered from supine to right or left lateral or prone in order to allow for 
complete submersion of the pathology being scanned.  Furthermore, utilisation of local 
staging of colonic pathology has not altered the course of patient management and 
there has therefore been slow uptake. Additionally, the ultrasound machine is 
expensive and the mini probes semi-disposable wearing on repeated use and rarely 
lasting more than 40 procedures. Each mini probe does have a cost attached to it and 
for this current thesis each mini probe was purchased at cost of £5000. This would add 
an additional £125 to each procedure if the probe lasted for 40 procedures. It is 
important to take care when handling the probes as they are mechanical radial probes 
which if bent or knocked may not function adequately. There are newer machines and 
probes on the market currently that cost the same, but last for several hundred 
procedures which is likely to be more cost effective (Fujinon variable frequency probe 
7.5 MHz – 25 MHz). The added advantage of this later system is that all the probes are 
of variable frequency and therefore this saves time over changing probes regularly for 





Despite these observations, both 12 and 20 MHz ultrasound was superior to cross 
sectional imaging in local staging of colonic cancers and also more accurate than MRI 
in evaluation of the depth of invasion of rectal polyps. Although, local staging of 
colonic cancers is not currently an important aspect in the management of patients with 
resectable disease, this may gain more importance in the future if neo-adjuvant 
chemotherapy is adopted for locally advanced T3 and T4 tumours. This may gain 
further interest if the results of the UK FoXTROT study report in favour of 
neoadjuvant treatment. Interestingly, the 20 MHz ultrasound was able to detect 
subtleties such as invasion into the mucosa or submucosa with high accuracies of over 
90%. 20 MHz ultrasound was utilised to assess rectal polyps prior to TEMS resection 
as all patients underwent surgery thereby providing histological comparison to the 
ultrasound staging. Further work is currently being undertaken within the department 
in the assessment of the depth of colonic polyps, potentially making this a suitable 
imaging modality to alter management of colorectal polyps as to whether they undergo 
endoscopic resection or standard surgical resection in the future 
 
The assessment of the resection site after polypectomy of malignant lesions was shown 
to be feasible in the colon with evaluation of the presence of residual polyp and local 
lymphadenopathy. The direct comparison of ultrasonographic findings to 
histopatholgy was not feasible in all cases as only 6 patients underwent surgery. 
Nonetheless, all of the patients with normal ultrasound findings had normal histology 
with no presence of residual cancer in the specimen. This poses the question of 
whether ultrasound could be used in the future to guide us with management of 
malignant polyps. This question may have been better answered if sample size had 
been larger and all of the patients in the cohort had undergone surgery so direct 
comparison with histopatholgy could be made. Although the assessment of mesorectal 
nodes with ultrasound has been established in rectal tumours, there is no data regarding 
the assessment local lymph nodes after polypectomy in the colon. The ultrasound 
examination would be better suited prior to colonoscopic polypectomy but often the 
imaging is not available and incidental malignancy is often only noted after 
polypectomy on histology. Ultrasound criteria for positive lymph nodes also vary 
greatly from different units and often size is utilised as defining characteristic. 
However, all of this is subject to operator expertise and this is the main reason for such 
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variation in results. Nonetheless, it is worth pursuing as there is no clear consensus in 
the management of such patients and additional ultrasound information may help in the 
future to guide management. 
 
Staging for local lymphadenopathy for colonic cancers or even in patients with 
malignant polyps has several limitations. Firstly, we are unable to predict the 
anatomical location of lymph nodes whether there are pericolic or mesenteric and also 
whether the nodes seen on ultrasound that are positive are indeed the same nodes that 
are deemed positive on histological examination. There is no method of confirming 
this unless you were able to mark or dye the node in endoscopically using ultrasound 
and then visualise the same staining on histopathology which seems rather far-fetched. 
There are 2 techniques which may be worth exploring in order to improve the 
diagnostic accuracy of local lymphadenopathy; ultrasound contrast agents and 
elastography. 
 
The concept of ultrasound contrast agents was introduced by Gramiak and Shah (1967) 
who observed strong echo signals in blood after injection of indocyanine green as a 
result of air bubbles that were coadministrated during the bolus injection. Since then 
the basis of ultrasound contrast agents is the intentional creation of air or gas bubbles.  
Contrast enhanced transabdominal ultrasound has been in place for over 10 years and 
has been shown to differentiate between benign and malignant liver tumours. The 
application of contrast agents to endoscopic ultrasound is relatively recent and this 
application is primarily to image the pancreas. Criteria for differentiation of pancreatic 
masses have been published (Dietrich 2008; Rickes 2002, 2004, 2007; DÓnofrio 
2007). Adenocarcinomas are usually poorly vascularised whereas hypervascularisation 
after injection of a contrast agent is the characteristic sign of a neuroendocrine tumour 
and metastatic renal cell carcinomas. Studies evaluating this technology for the 
assessment of lymph nodes are few. There are only two studies in the literature which 
were performed to evaluate whether lymph nodes were benign or malignant (Kanamori 
2006; Hocke 2008). The results were varied with sensitivity and specificity that ranged 
from 50% to 1005 and from 71.8% to 81.8% respectively. Contrast enhanced 
colonoscopic ultrasound is an interesting concept and would be valuable in particular 
for assessment of lymph nodes in the follow up of patients having endoscopic 
surveillance for malignant polyps. 
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Elastography performed real time generates a visual scale of relative tissue hardness 
using a colour coded map superimposed on a B mode endorectal ultrasound image. 
The resulting elastogram is a product of a complex algorithm that states how tissues 
deform when pressure is applied rhythmically using a water filled balloon surrounding 
an ultrasound probe. Most real time elastography strain-ratio measurements provide 
semiquantitative data on relative tissue strain (Thomas 2010; Zhi 2008). Waage and 
colleagues (2010) have used endorectal elastography in the evaluation of rectal 
tumours. They obtained adequate elastography images in 66 out of their 69 patients in 
their series and identified an optimal strain ratio cut off value of 1.25 to discriminate 
between benign and malignant tumours, giving them a sensitivity, specificity and 
accuracy of 93%, 96% and 94% respectively. This technology could also be applied to 
assessment of lymph nodes and like contrast ultrasound may prove to be useful in 
assessing patients with malignant polyps. The greatest challenge, however, would be to 
apply this technology to the colon rather than just to the rectum. 
 
Finally, the colonic wall thickness can be evaluated using 20 MHz ultrasound with 
consistently increased thickness of mucosa, submucosa and muscularis propria seen in 
patients with diverticular disease when compared with controls. This was particularly 
apparent for the muscularis propria with marked increase in thickness seen in 
diverticular disease patients. Further research needs to be focused in this area to 
determine whether there is any significance in the correlation of anatomical changes in 
diverticular disease with patient symptoms, in particular whether marked changes in 
thickness are present in symptomatic patients without  many diverticula which may 
signify the ‘pre-diverticular state'.  
 
This thesis has outlined many of the advantages and some of the disadvantages of 
colonoscopic mini probe examination. Despite this, there has not been widespread 
uptake in this technique, the reasons of which have been discussed. The future of this 
technique lies in specialist tertiary referral centres in the assessment of colorectal 
polyps prior to endoscopic resection. Currently magnification colonoscopy is not 
widely available and mini probe ultrasound may be useful in identifying colorectal 
lesions that are mucosal and in the early submucosa which would be suitable for 
endoscopic mucosal resection and endoscopic submucosal dissection; and those that 
invade the deep submucosa which would be better treated with colorectal resection.  
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Mini probe ultrasound may take a limited role in the local staging of colonic cancers 
especially if the results of the FoXTROT study are favourable towards offering 
neoadjuvant chemotherapy for locally advanced colonic cancers. Although we have 
shown that local staging is superior with ultrasound compared to CT, ultrasound 
technology is likely to only be available in tertiary level centres and I suspect that 
emerging CT technology will provide better results which can easily applied across a 
national scale. We are still at earlier stages in the follow up of malignant polyps with 
colonoscopic ultrasound and there needs to be a larger study with longer follow up, but 
I suspect that this will receive much interest as it is often a surgical dilemma with 
regards to endoscopic surveillance versus surgery. 
 
There are further developments in technology which may determine whether this will 
be adapted for assessment of lymph nodes such as Doppler, elastography and three 
dimensional ultrasound, the latter of which has just been developed but not been 
clinically assessed using mini probes. 
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 Colorectal cancer is the third commonest cause of cancer related death in the 
United Kingdom and around 100 new cases of colorectal cancer are diagnosed each 
day in the United Kingdom. This amounts to nearly 17000 deaths (Cancer Research 
UK) per year. Current guidelines suggest that pre-operative staging of colonic cancers 
should include full imaging of the colon by way of a colonoscopy to confirm the 
tumour and exclude other synchronous lesions and also obtain biopsies for histological 
confirmation. Local and systemic pre-operative staging of the cancer is achieved by a 
Computerised Tomography (CT) scan of the abdomen, pelvis and chest. 
MRI and endoscopic ultrasound are being used routinely to assess the local spread of 
rectal cancers but have not found a place in colonic tumours.  
 
Chemotherapy has an increasing role in the management of colorectal cancer and is 
currently offered in an adjuvant setting (post surgery) for colonic cancers that meet the 
criteria and as both a neo-adjuvant (pre-surgery) and adjuvant treatment for rectal 
cancers that meet the criteria. There is however much debate as to the role of neo-
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adjuvant chemotherapy in the management of locally advanced colonic cancers. 
Currently, the FOXTROT national clinical trial has been designed to offer us more 
insight into this aspect of management of colonic tumours. The current assessment of 
locally advanced colonic cancers is by way of CT scan which is poor at assessing local 
disease and presence of local lymph nodes.  
 
Endoscopic ultrasound has become the standard for pre-operative staging of cancers of 
the oesophagus, stomach and rectum but has not been used routinely for cancers of the 
colon. This has been due to the fact that up until now accurate pre-operative local 
staging information has not changed the management of patients with colonic tumours. 
However, with the introduction of endoscopic procedures for resection of early colonic 
cancers and the use of neo-adjuvant chemotherapy for locally advanced cancers, 
accurate local staging information is crucial in the pre-operative period similar to that 
with rectal cancers. 
 
Endoscopic ultrasound is incorporated with the colonoscope to assess the tumour size, 
depth of infiltration and the presence or absence of local lymph nodes in the colonic 
mesentery. This has been shown to be 84-94% accurate in assessing depth of 
infiltration and 77-90% accurate in the assessment of local lymph nodes. However, the 
accuracy of endoscopic ultrasound as compared to conventional imaging using CT and 
histopathological analysis has not been prospectively evaluated in the literature. 
 
This study will compare the local staging of colonic cancers by CT and endoscopic 
ultrasound using histopathological analysis of the resected specimen as the gold 
standard. The patients will undergo only their scheduled colonoscopy and shall have 
endoscopic ultrasound assessment of the colonic tumour during the same procedure. 
During the colonoscopy, if a colonic polyp is discovered, endoscopic ultrasound shall 
be used to assess the depth of invasion and lymph node status. Therefore, all patients 
scheduled for colonoscopy will be offered the opportunity to participate in the study. 
 
Another arm of the study will examine staging of colonic malignant polyps which have 
been resected endoscopically and it is not known whether there is regional lymph 
nodes involvement. CT scan is an innacurate investigation for evaluation of mesenteric 
lymph nodes and it is hoped that endoscopic ultrasound might offer better chance for 
detection. The detection of regional lymph nodes is essential to make a decision on 
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 To compare the accuracy of local staging of colonic tumours by CT scan and 
by colonoscopic ultrasound using histopathologic assessment of the specimen as gold 
standard 
 
5. Materials and Method 
 
5.1 Study population and Method 
 
All patients who are offered colonoscopy at Kings College Hospital London will be 
invited to participate. Information leaflets shall be given to patients to take home at the 
time of the decision to book for endoscopy in the outpatient clinic. Informed consent 
will be taken for the procedure at the same time as consent for endoscopy on the day of 
procedure in only those patients who have received and read the information leaflets. 
In addition, patients discovered to have cancer within an excised colonic polyp will be 
identified from the Colorectal Multidisciplinary meetings and offered the opportunity 
to undergo an endoscopic ultrasound at their next scheduled colonoscopy. 
 
Colonoscopic ultrasound shall only be performed in those patients in whom a colonic 
tumour or polyp is discovered. The ultrasound examination will take place during the 
same endoscopy using endoscopic ultrasound equipment already available within the 
department. The ultrasound image is obtained after instilling a small amount of water 
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in the colon similar to the water used to flush away debris in routine colonoscopy. The 
size of the tumour, depth of infiltration (T stage) and the presence of lymph nodes will 
be noted. Lymph nodes of all sizes shall be noted and measured. The ultrasound 
examination will increase the colonoscopy time by 5-10 minutes. 
 
The management algorithm will not be affected by the ultrasound findings. Those 
patients who are discovered to have cancer of the colon will undergo their routine pre-
operative investigations including CT scan of the abdomen / pelvis and chest. The 
diagnostic accuracy of the ultrasound will then be compared with CT and also with the 
pathological analysis of the resected specimen. 
 
The CT scan will be assessed by a single Consultant Radiologist and the histological 
specimen will be analysed in the routine manner by the Colorectal Histopathologist at 
Kings College Hospital and discussed within the Colorectal multidisciplinary team. 
 
The accuracy of local staging of colonic neoplasms by endoscopic ultrasound shall be 
compared with conventional CT with the pathological analysis of the resected 
specimen as the gold standard.  
 
 
5.2 Exclusion criteria 
 Patients from vulnerable groups (groups of patients in question A24 of COREC 
form3) 
 
5.3 Study period 
Recruitment for the study will be from October 2007. The study period will be 
for a period of 2 years. 
 
5.4 Data Protection 
The data will consist of documents and computer files. Documents will be 
stored in a locked office in the Department of Colorectal Surgery. Computer 
files will be password protected and exist on a computer in the same office. 




5.5 Data Analysis 
All data will be expressed as mean ± standard deviation or percentage. 
Student’s t-test and chi-squared test will be used for statistical analysis, with 






The results of the study will aim to assess the accuracy of local staging of 
colonic polyps and tumours by colonoscopic ultrasound, conventional CT and 
compare these to the histological examinations of the resected specimens. We 










CONSENT FORM (Version 1.1 (12/08/2007)) 
 
Title of project: The use of colonoscopic ultrasound to assess colonic tumours 
 
Investigators: Mr Savvas Papagrigoriadis, Mr Amyn Haji, Dr Suzanne Ryan 
 Dr John Devlin, Dr David Reffitt, Professor Ingvar Bjarnason 
 
Researcher obtaining consent:  
 
Name …………………………………   Signature ………………………………….. 
 
 
To be completed by the volunteer     Circle as Necessary 
 
1. Have you read the information sheet about this study?   YES/ NO 
2. Have you had the opportunity to ask questions and discuss the study?   YES/ NO 
3. Have you received satisfactory answers to all your questions?   YES/ NO 
4. Have you received enough information about this study?     YES/ NO 
5. Do you understand that you are free to withdraw from this study and ask for your   
 information to be destroyed? 
 *at any time 
 *without giving a reason 
 *without affecting your future medical care or legal rights   YES/ NO 
 
6. Do you agree to your General Practitioner being informed about your participation in this 
study?          YES/ NO 
 
7. I understand that relevant sections of my medical notes and data collected during the study 
may be looked at by the research investigators and that the data will be confidential and used 
only for research purposes       YES/ NO 
8.   Do you agree to take part in this study?     YES/ NO 
 
…………………………….  …………….  ………………………….. 
Name of patient    Date   Signature 
 
 









PATIENT INFORMATION SHEET - Version 1.1 (12/08/2007) 
 
 
Title of project: The use of colonoscopic ultrasound to assess colonic tumours 
 
Investigators: Mr Savvas Papagrigoriadis, Mr Amyn Haji 
 Dr John Devlin, Dr Suzanne Ryan 
 
As a patient of Kings College Hospital we invite you to participate in this research 
study. Before you decide you need to understand why the research is being done and 
what it would involve for you. Please take time to read the following information 
carefully. 
You do not have to take part in this study if you do not want to.  If you decide to 
take part you may withdraw at any time without giving a reason.  Your decision 
whether to take part or not will not affect your care and management in any way. 
 
Introduction 
This information sheet is being given to all patients who have been advised by their 
doctor to have a form of bowel investigation called Colonoscopy. This investigation 
involves a camera that looks at the inner lining of the large bowel. The leaflet will 
explain about the research project and provide information to help you make up your 
mind about participation. Detailed information about colonoscopy is also included 
separately in the pack.  
 
Colorectal cancer is the third commonest cause of cancer related death in the United 
Kingdom and around 100 new cases of colorectal cancer are diagnosed each day in the 
United Kingdom. Currently, if there is a growth detected in the bowel routine 
investigations are performed to check whether this a cancer or a benign growth. All 
patients would normally have a colonoscopy and a CT scan of the abdomen. A scan of 
the growth can also be done from inside the bowel at the same time as the colonoscopy 
using a ultrasound probe which is attached to the colonoscope. Ultrasound is 
commonly used and you or a family member may have had a scan before. This has 
been shown to be very good at detecting growths in the bowel and has the advantage of 
being done at the same time as the colonoscopy.  
 
What is involved? 
 
The ultrasound scan will take place during your colonoscopy using a mini ultrasound 
probe attached to the colonsocpe. This examination only occurs during the 
colonoscopy if the consultant finds any growths in the bowel, and will not affect the 
way you feel during the colonoscopy. However, it will increase the time taken to 
complete the colonoscopy by 5-10 minutes. During the scan, some water may be 
placed into the bowel for the scan to give better pictures. We sometimes flush water 
into the bowel during a routine colonoscopy so that we can see better and this does not 
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cause any irritation to the bowel, nor will you feel any discomfort while this is 
happening.  
 
You will only be asked to have this scan only once at the same time of your scheduled 
colonsoscopy. There will be no additional investigations done for the study unless it is 
indicated for the management of your condition.  
 
What data will be collected? 
The ultrasound scan image will give us information about how deep the growth in the 
bowel is and whether there are any lymph glands surrounding the growth outside the 
bowel. 
The information gathered from this research will then be used to compare the accuracy 
of colonoscopic ultrasound with that of a routine CT scan of the abdomen. This will 
then be able to direct different treatments in the future for patients with colonic cancers 
and benign growth. 
 
What are the possible risks and disadvantages of taking part in the research? 
Ultrasound has been routinely used in medicine and we are not aware of any potential 
risks from its use. However, as the scan will take a few minutes to perform, this will 
increase your colonscopy time by 5-10 minutes.  
 
Protection of information and confidentiality 
All the information we obtain will be strictly confidential. Only study investigators 
(named above) will have access to the data stored within double password-protected 
databases within a locked office.  We are required to keep the data for a minimum of 2 
years after the study has been completed.  Information about you is bound by the 
regulations of medical confidentiality and will not be made available to outside 
organisations or insurance companies. 
 
 
For any further information or concerns regarding the study please contact  
 
Mr Amyn Haji 
Clinical Research Fellow in Colorectal Surgery 
Kings College Hospital 
Denmark Hill SE5 9RS 
 











Letter to General Practitioner - Version 1.1 (12/08/2007) 
 
 
Title of project: The use of colonoscopic ultrasound to assess colonic tumours 
 
Investigators: Mr Savvas Papagrigoriadis, Mr Amyn Haji 










Date of Birth : 
 
 
This letter is to inform you that the above patient has volunteered to participate in a 
clinical research project at Kings College Hospital. I have enclosed a copy of the 
information leaflet and protocol for your information. 
 







Amyn Haji MA MBBChir MRCS 
Colorectal Research Fellow 

























Protocol for research to assess the use of 
colonoscopic ultrasound in the assessment of 
diverticular disease  
Version 1.1 
 





























1. Site of Study 
 




2.1 Principal Investigator 
 
Mr S Papagrigoriadis 
Consultant Colorectal Surgeon 






Mr Amyn Haji 
Colorectal Research Fellow 
Kings College Hospital 
 
Dr Suzanne Ryan 
Consultant Radiologist 
Kings College Hospital 
 
Dr John Devlin 
Consultant Hepatologist 








Diverticular disease in an increasingly common benign disease of the colon which 
causes significant morbidity and mortality.  
 
The colon in diverticular disease appears shortened with a thickened muscular wall, 
redundant mucosal folds, and diverticula disposed in two to four parallel longitudinal 
rows between the mesenteric and the antimesenteric teniae. The longitudinal and 





There is an abnormality of muscularis propria in diverticular disease leading to its 
shortening and thickening, causing it to behave like myostatic contracture (Morson 
1963). The consequent plication of the circular layer narrows the lumen, thus 
increasing the intraluminal pressure according to Laplace's law. The resulting 
hypersegmentation is thought to be important in the pathogenesis of the diverticula 
(Painter 1969). 
 
The primary muscle abnormality leading to a non-compliant wall seems to be due to 
mychosis and the intrinsic derangement of collagen fibres (Thomson, Busuttil et al. 
1987). Mychosis refers to the progressive elastosis of the taenia coli attributed to the 
increased proline in the western diet (Whiteway and Morson 1985). Abnormalities in 
increased collagen deposition and cross linking are also implicated in decreased 
colonic tensile strength (Wess L 1995; Wess L 1996). 
 
Left-sided diverticula occur most often in the sigmoid colon, which has the smallest 
diameter, lowest compliance and therefore the highest intraluminal pressures (Waldron 
et al, 1989, Ford et al, 1995). Not only do patients with diverticular disease have 
higher colonic intraluminal pressures than control subjects (Painter & Truelove, 1964, 
Arfwidsson et al, 1964, Parks, 1970, Shafik et al, 2004, Trotman et al, 1988), but it has 
also been shown that basal and post prandial intraluminal pressures are higher in 
patients with symptomatic diverticular disease compared to those with asymptomatic 
diverticular disease. (Cortisini & Pantalone, 1991). The motility patterns in diverticular 
disease show similarity to those of Irritable Bowel Syndrome (IBS) to the extent that 
some researchers have suggested that the two conditions may be two forms of the 
same. 
 
Serotonin (5-HT) is 3-(β-aminoethyl)-5-hydroxyindole. The gut contains over 95% of 
the body's 5-HT (Gershon MD et al, 1977, Erspamer V, 1967).
  
Enteric neurones 
synthesize 5-HT and store it. Serotonin has been found to be increased in the colonic 
mucosa of resected specimens in patients with diverticular disease (Banerjee, Akbar et 
al. 2007). This relates to the increased colonic motility seen in diverticular disease. 
Therefore serotonin antagonists may have a role in slowing progression of this disease 
and also reducing symptoms, particularly in those patients whose predominant 
symptom is diarrhoea. Current research in the department at Kings College Hospital 
suggests that an increased concentration of serotonin is present in patients with 
worsening symptoms relating to diverticular disease. 
 
Currently, patients suspected to have diverticular disease are investigated using 
colonoscopy and Computerised Tomography of the abdomen and pelvis. Neither of 
these investigations are accurate in the assessment of bowel wall thickness. 
Endoscopic ultrasound has become the standard for pre-operative staging of cancers of 
the oesophagus, stomach and rectum but has not been used in the routine evaluation of 
benign colonic conditions. This study will assess the bowel wall thickness in patients 
with diverticular disease and correlate these findings with their symptoms. In addition, 
the findings will also be correlated with the levels of serotonin observed in the colonic 
mucosa.  
 
It is hoped that the colonoscopic ultrasound findings will aid in the future selection of 








 To assess the thickness of bowel wall in patients with symptomatic and 
asymptomatic Diverticular Disease 
 To develop a link between bowel wall thickness with relation  to patients 
symptoms and levels of Serotonin on mucosal biopsy 
 
 
5. Materials and Method 
 
5.1 Study population and Method 
 
All patients with diverticular disease will be eligible for entry into the study. 
Colonoscopy will be performed only for appropriate clinical reasons. Patients will not 
undergo any additional investigations.  Participants with the following colonoscopic 
diagnosis will be recruited:  
a) Asymptomatic Diverticular disease 
b) Symptomatic Diverticular disease 
c) Patients with complicated diverticular disease requiring further assessment 
 i.e: strictures, pericolic abscess, fistulae 
A sample size will be calculated based on results from the pilot study. Approximately 
three groups of twenty patients will be participants.  
 
5.4 Exclusion criteria 
 Patients from vulnerable groups (groups of patients in question A24 of COREC 
form3) 
 
5.5 Study period 
Recruitment for the study will be from October 2007. The study period will be 
for a period of 2 years. 
 
5.4 Data Protection 
The data will consist of documents and computer files. Documents will be 
stored in a locked office in the Department of Colorectal Surgery. Computer 
files will be password protected and exist on a computer in the same office. 




5.5 Data Analysis 
All data will be expressed as mean ± standard deviation or percentage. Student’s t-test 
and chi-squared test will be used for statistical analysis, with the level of statistical 
significance set at P < 0.05. In addition further analyses using statistical models with 











The results of the study will aim to primarily assess the thickness of bowel wall in 
asymptomatic and symptomatic diverticular disease. This will be in turn be correlated 



















































CONSENT FORM (Version 1.1 (19/09/2007)) 
 
Title of project: The use of colonoscopic ultrasound to assess diverticular disease 
 
Investigators: Mr Savvas Papagrigoriadis, Mr Amyn Haji, Dr Suzanne Ryan 
 Dr John Devlin, Dr David Reffitt, Professor Ingvar Bjarnason 
 
Researcher obtaining consent:  
 
Name …………………………………   Signature ………………………………….. 
 
 
To be completed by the volunteer     Circle as Necessary 
 
1. Have you read the information sheet about this study?   YES/ NO 
2. Have you had the opportunity to ask questions and discuss the study?   YES/ NO 
3. Have you received satisfactory answers to all your questions?   YES/ NO 
4. Have you received enough information about this study?     YES/ NO 
5. Do you understand that you are free to withdraw from this study and ask for your   
 information to be destroyed? 
 *at any time 
 *without giving a reason 
 *without affecting your future medical care or legal rights   YES/ NO 
 
6. Do you agree to your General Practitioner being informed about your participation in this 
study?          YES/ NO 
 
7. I understand that relevant sections of my medical notes and data collected during the study 
may be looked at by the research investigators and that the data will be confidential and used 
only for research purposes       YES/ NO 
8.   Do you agree to take part in this study?     YES/ NO 
 
…………………………….  …………….  ………………………….. 
Name of patient    Date   Signature 
 
 










PATIENT INFORMATION SHEET - Version 1.1 (19/09/2007) 
 
Title of project: The use of colonoscopic ultrasound to assess diverticular disease 
 
Investigators: Mr Savvas Papagrigoriadis, Mr Amyn Haji, Dr Suzanne Ryan 
 Dr John Devlin, Dr David Reffitt 
 
As a patient of Kings College Hospital we invite you to participate in this research 
study. Before you decide you need to understand why the research is being done and 
what it would involve for you. Please take time to read the following information 
carefully. 
You do not have to take part in this study if you do not want to.  If you decide to 
take part you may withdraw at any time without giving a reason.  Your decision 
whether to take part or not will not affect your care and management in any way. 
 
Introduction 
The following relates to a research project being undertaken at King’s College 
Hospital. The information sheet is being given to all patients who have been advised 
by their doctor to have a form of bowel investigation called Colonoscopy. This 
investigation involves a camera that images the inner lining of the large bowel. The 
leaflet will explain about the research project and provide information to help you 
make up your mind about participation. Information about Colonoscopy is included 
separately in the pack.  
 
Diverticular Disease is a condition that affects the large bowel. It is a common 
condition affecting approximately 70% of people over the age of seventy. It also 
affects younger age groups. Diverticular disease occurs when the inner lining of the 
large bowel balloons through the outer wall of the bowel. This is thought to occur from 
high pressure within the bowel forcing the inner lining to balloon out. The condition is 
essentially progressive – the longer the duration the worse the symptoms and the 
greater risk of complications. This may cause symptoms of distension, flatulence and a 
sense of heaviness in the lower abdomen. It is not a condition that leads to cancer, but 
cancers may co-exist.  
 
Currently, if there is diverticular disease suspected in the bowel and you are having 
increasing symptoms from this, routine investigations are performed to check for any 
complications from the diverticular disease and to exclude other conditions which may 
cause similar symptoms. All patients would normally have a colonoscopy and a CT 
scan of the abdomen. A scan of the bowel can also be done from inside the bowel at 
the same time as the colonoscopy using an ultrasound probe which is attached to the 
colonoscope. This has been shown to be very accurate at measuring the thickness of 
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the bowel wall and has the advantage of being done at the same time of the 
colonoscopy.  
 
What is involved? 
The ultrasound scan will take place during your colonoscopy using a mini ultrasound 
probe attached to the colonsocpe. This examination only occurs during the 
colonoscopy if the consultant finds any diverticular disease in the bowel, and will not 
affect the way you feel during the colonoscopy. During the scan, some water may be 
placed into the bowel for the scan to give better pictures. We sometimes flush water 
into the bowel during a routine colonoscopy so that we can see better and this does not 
cause any irritation to the bowel, nor will you feel any discomfort while this is 
happening.  
You will only be asked to have this scan only once at the same time of your scheduled 
colonsoscopy. There will be no additional investigations done for the study unless it is 
indicated for the management of your condition.  
 
What happens if I have diverticular disease? 
You will be offered expert advice regarding the condition and be offered the 
opportunity to visit a specialist clinic at Kings College Hospital which is already in 
place. Here you will have the opportunity to discuss your symptoms and plan treatment 
if necessary 
 
What data will be collected? 
The ultrasound scan images will be used to measure the thickness of the bowel wall in 
diverticular disease. The results may lead to better understanding of Diverticular 
Disease. It may also increase the probability of detecting complications of diverticular 
disease. 
 
What are the possible risks and disadvantages of taking part in the research? 
Ultrasound has been routinely used in medicine and we are not aware of any potential 
risks from its use. However, as the scan will take a few minutes to perform, this will 
increase your colonoscopy time by 5-10 minutes.  
 
Protection of information and confidentiality 
All the information we obtain will be strictly confidential. Only study investigators 
(named above) will have access to the data stored within double password-protected 
databases within a locked office.  We are required to keep the data for a minimum of 2 
years after the study has been completed.  Information about you is bound by the 
regulations of medical confidentiality and will not be made available to outside 
organisations or insurance companies. 
 
For any further information or concerns regarding the study please contact:  
Mr Amyn Haji 
Clinical Research Fellow in Colorectal Surgery 
Kings College Hospital 
Denmark Hill SE5 9RS 













Letter to General Practitioner - Version 1.1 (19/09/2007) 
 
 
Title of project: The use of colonoscopic ultrasound to assess diverticular disease 
 
Investigators: Mr Savvas Papagrigoriadis, Mr Amyn Haji 










Date of Birth 
 
This letter is to inform you that the above patient has volunteered to participate in a 
clinical research project at Kings College Hospital. I have enclosed a copy of the 
information leaflet and protocol for your information. 
 







Amyn Haji MA MBBChir MRCS 
Colorectal Research Fellow 






















APPENDIX 2 – QUALITY OF LIFE QUESTIONNAIRES 
 
1. Diverticular disease – Quality of life questionnaire (Guyatt) 
 
2. SF-36 Questionnaire 
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Diverticular Disease – Quality of Life Questionnaire (Guyatt) 
The following questionnaire includes 32 questions which are grouped into four 
categories – bowel symptoms (B), systemic symptoms (S), emotional functions (E) 
and social functions (SF). 
Response options are presented as a seven-point scale where number 1 on the scale is 
the most frequent /troublesome and number 7 is no problem/normal. Please circle the 
most appropriate option. 
 
For example 
No 1. How frequent have your bowel movements been during the last two weeks? 
Options 
1. Bowel movements as or more frequent than they have ever been 
2. extremely frequent 
3. very frequent 
4. moderate increase in frequency of bowel movements 
5. some increase in frequency of bowel movements 
6. slight increase in frequency of bowel movements 
7. normal, no oncrease in frequency of bowel movements 
 






Date of birth 
Date and type of surgery if any 
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(B) 1. How frequently have your bowel movements been during the last two 
weeks? 
1  2  3  4  5  6  7 
(S) 2. How often has the feeling of fatigue or being tired and worn out been a 
problem for you in the last two weeks? 
1  2  3  4  5  6  7 
 (E) 3. How often during the last two weeks have you felt frustrated, impatient 
or restless? 
1  2  3  4  5  6  7 
 (SF) 4. How often during the last two weeks have you been unable to attend 
work or undertake every day activities because of your bowel problem? 
1  2  3  4  5  6  7 
 (B) 5. How much of the time during the last two weeks have your bowel 
movements been loose? 
1  2  3  4  5  6  7 
 (S) 6. How much of energy have you had during the last two weeks? 
1  2  3  4  5  6  7 
 (E) 7. How often during the last two weeks did you feel worried about the 
possibility of needing to have surgery because of your bowel problem? 
1  2  3  4  5  6  7 
 (SF) 8. How often during the last two weeks have you had to delay or cancel a 
social engagement because of your bowel problem? 
1  2  3  4  5  6  7 
 (B) 9. How often during the last two weeks have you been troubled by 
cramps in your abdomen? 




(S) 10. How often during the last two weeks have you felt generally unwell? 
1  2  3  4  5  6  7 
 (E) 11. How often during the last two weeks have you been troubled because 
of fear of not finding a washroom? 
1  2  3  4  5  6  7 
 (SF) 12. How much difficulty have you had, as a result of your bowel problems, 
doing leisure or sports activities you would have liked to have done during the 
last two weeks? 
1  2  3  4  5  6  7 
 (B) 13. How often during the last two weeks have you been troubled by pain in 
the abdomen? 
1  2  3  4  5  6  7 
 (S) 14. How often during the last two weeks have you had problems getting a 
good nights sleep, or been troubled by waking up in the night? 
1  2  3  4  5  6  7 
 (E) 15. How often during the last two weeks have you felt depressed or 
discouraged? 
1  2  3  4  5  6  7 
 (SF) 16. How often during the last two weeks have you had to avoid attending 
events where there was no washroom close at hand? 
1  2  3  4  5  6  7 
 (B) 17. Overall in the last two weeks, how much of a problem have you had 
with passing large amounts of gas? 
1  2  3  4  5  6  7 
 (S) 18. Overall in the last two weeks, how much of a problem have you had 
maintaining, or getting to, the weight you would like to be at? 
1  2  3  4  5  6  7 
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 (E) 19. Many patients with bowel problems often have worries and anxieties 
relating to their illness. These include worries about getting cancer, worries 
about never feeling any better and worries about having a relapse. In general, 
how often during the last two weeks have you felt worried or anxious? 
1  2  3  4  5  6  7 
 (B) 20. How much of time during the last two weeks have you been troubled 
by a feeling of abdominal bloating? 
1  2  3  4  5  6  7 
 (E) 21. How often during the last two weeks have you felt relaxed and free 
from tension? 
1  2  3  4  5  6  7 
 (B) 22. How much of the time during the last two weeks have you had a 
problem with rectal bleeding with your bowel movements? 
1  2  3  4  5  6  7 
 (E) 23. How much of time during the last two weeks have you felt 
embarrassed as a result of your bowel problem? 
1  2  3  4  5  6  7 
 (B) 24. How much of the time during the last two weeks have you been 
troubled by a feeling of having to go the bathroom even though your bowels 
are empty? 
1  2  3  4  5  6  7 
 (E) 25. How much time during the last two weeks have you felt tearful or 
upset? 
1  2  3  4  5  6  7 
 (B) 26. How much of the time during the last two weeks have you been 
troubled by accidental soiling of your underpants? 
1  2  3  4  5  6  7 
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 (E) 27. How much of the time during the last two weeks have you felt angry as 
a result of your bowel problem? 
1  2  3  4  5  6  7 
 (SF) 28. To what extent had your bowel problem limited sexual activity during 
the last two weeks? 
1  2  3  4  5  6  7 
 (B) 29. How much of the time during the last two weeks have you been 
troubled by feeling sick to your stomach? 
1  2  3  4  5  6  7 
 (E) 30. How much of the time during the last two weeks have you felt 
irritable? 
1  2  3  4  5  6  7 
 (E) 31. How often during the last two weeks have you felt a lack of 
understanding from others? 
1  2  3  4  5  6  7 
 (E) 32. How satisfied, happy or pleased have you been with your personal life 
during the past two weeks? 
1  2  3  4  5  6  7 
 
Thank you for completing this questionnaire 
 
Mr Amyn Haji 
Clinical Research Registrar in Colorectal Surgery 
Kings College Hospital 
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